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Abstract 
Building A Better Transcriptome 
By Ashley L. Byrne 
 
From a single embryo to billions of cells, a whole organism is constructed in a carefully 
regulated symphony. Every cell in our body shares the same sheet of music in the form of 
DNA but it is through RNA transcription that rhyme and meter are kept; comprised of a 
complex regulatory system determining when genes get turned on or off. It is through this 
regulation that alterations occur, allowing two identical cells to ultimately give rise to 
completely separate organs and tissue systems. Our current understanding of these 
processes relies heavily on using short-read sequencing technology to analyze whole 
transcriptomes. However, this method requires fragmentation of full-length molecules, 
making it difficult to recapitulate the transcriptome landscape in its entirety. Requiring 
heavy computational tools to assemble the transcriptome, which only provides an 
estimation. This loss of contiguity makes it clear we cannot depend on short-read RNA 
sequencing alone to truly understand the complexities within our transcriptome. Thus, I 
have established a toolset for creating better, more precise transcriptomes from single 
cells to bulk RNA studies. This body of work entails how we can elucidate transcript 
features that tend to be lost in short-read sequencing data. These improvements include 
developing a 5’ capturing method for single cell data, employing a long-read single cell 
full-length cDNA sequencing method, increasing throughput and limiting length bias for 
bulk transcriptomic studies. Together, these improvements create a better snapshot of the 
transcriptome and will help change how we analyze transcriptomes.  
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Abstract 
 
Long-read sequencing holds great potential for transcriptome analysis because it offers 
researchers an affordable method to annotate transcriptomes for not only well-studied 
organisms but for less researched organisms such as non-models. However, non-model 
organisms have much more to gain using this technology as they  cannot rely on large 
consortia projects to generate these transcriptome annotations. To utilize this 
technology to its full potential, several remaining molecular and computational 
challenges will have to be overcome. In this review, we have outlined the limitations 
of short-read sequencing technology and how long-read sequencing technology 
overcomes these limitations. We have also highlighted the unique challenges still 
present for long-read sequencing technology and provided some suggestions on how to 
overcome these challenges going forward.  
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Introduction 
The rapid progress and application of sequencing technology after the completion of 
the Human Genome Project has led to a vastly expanded knowledge of the genome 
sequences present in the eukaryotic tree of life. However, due to cost and technological 
limitations, truly high-quality genome references have been limited to a core of 
organisms of large scientific or economic interest. Further, our knowledge of which 
parts of genomes constitute genes and which transcript isoforms these genes produce, 
i.e. high-quality transcriptome annotation, is even more scarce (Salzberg 2019). 
However, sequencing technology might be reaching a point where it will become 
feasible to affordably generate high-quality genome references and transcriptome 
annotations of a much wider range of organisms.     
High-throughput sequencing technologies have grown massively more 
powerful over the last decade. During this time the ability to assemble genomes has 
outpaced the ability to annotate the transcriptomes they produce. Genome assembly is 
now entering a golden age where, for a moderate investment, high-quality “centromere-
to-telomere” genome sequences can be assembled through a mix of several 
technologies, including short-read sequencing, linked short-read sequencing (HiC), 
long-read sequencing and optical mapping (Jain et al. 2018; Putnam et al. 2016; Dixon 
et al. 2018). These powerful and relatively affordable approaches are going to be of 
outsize benefit for non-model organisms from unicellular eukaryotes to polar bears that 
in the past did not receive the attention and large sums of money required to generate 
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a high-quality genome reference the hard way - Chromosome maps, Sanger sequencing 
of BAC libraries, etc.  
However, while we are quickly reaching a point at which genomes can 
relatively reliably be assembled into chromosome-scale scaffolds, transcriptome 
annotation lags behind in its ability to identify the genes and isoforms expressed from 
these chromosomes.  
Transcriptome annotations are required for us to understand how genome 
sequences and changes to these sequences are interpreted by the cellular machinery. 
They are also required for many functional analyses. The process of genome 
annotation, using RNAseq often relies heavily on machine learning using in-silico ab 
algorithms to predict protein coding genes. However, these predictions become less 
accurate when dealing with organism specific protein coding genes when intron-exon 
boundaries and transcript features such as transcription start (TSS) and end sites (TES) 
differ substantially. Thus, without accurate transcriptome annotations, it can be 
difficult to investigate differential expression of mRNA isoforms or predict which 
proteins are present in a particular tissue or organism.  Further, transcriptome 
annotation allows us to modify cellular behavior by allowing the design of siRNA or 
gRNA sequences that will effectively silence the expression of a targeted gene. This 
can especially be problematic for researchers who cannot accurately identify these 
features causing headaches for those trying to perform knock-in or knock-down 
experiments. 
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  Currently, short- and long-read sequencing are used for transcriptome 
annotation but have underlying limitations that make reaching a “reference-level” 
transcriptome annotation both highly labor intensive and often simply impossible.  
Here we discuss the potential and limitations of long-read based full-length 
transcriptome sequencing for transcriptome annotation and lay out a path towards 
realizing said potential. 
 
1) What are the limitations of short-read sequencing technology? 
The analysis of what RNA transcripts (annotation) are present in a sample and at what 
level (quantification) has relied on a mix of technologies over the last three decades. 
Early efforts to annotate and quantify complex eukaryotic transcriptomes were highly 
labor intensive. During the early 1990’s, efforts to evaluate RNA sequences on a large 
scale relied heavily on  ESTs (Expressed Sequence Tags) whereby cDNA molecules 
were individually cloned, screened, and Sanger-sequenced to determine full-length 
mRNA sequences and observe semi-quantitative changes in gene expression (Adams 
et al. 1992). The Sanger-sequencing based SAGE (Serial Analysis of Gene Expression) 
method improved quantification and reduced cost by concatenating smaller 15-20 bp 
fragments of many cDNA molecules together for sequencing (Velculescu et al. 1995). 
However, because of the short length of analyzed fragments SAGE was inherently less 
useful for annotation. Hybridization-based microarray approaches completely 
eschewed annotation but simplified the quantification of already annotated genes 
(Lockhart et al. 1996).  
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The introduction of massively parallel sequencing in the mid-to-late 2000s 
completely changed transcriptome annotation and quantification. When massively 
parallel sequencing – best represented by the now dominant Illumina technology – 
became available to research labs it could generate millions of sequencing reads at a 
length of ~30 nucleotides (nt). Although initially intended for the sequencing of 
genomic DNA, researchers quickly found ways to leverage the power of these 
sequencers for transcriptome analysis in the form of the RNA-seq assay. RNA-seq 
sequences short cDNA fragments at extremely high throughput and quickly displaced 
microarray-based transcriptome analysis for a number of reasons including cost 
considerations as well as the ability to detect previously unknown transcripts and 
quantify the use of individual splice sites. In the last decade, Illumina sequencers have 
steadily and massively improved, although these improvements have come with 
compromises in experimental design. Most prominently newer Illumina sequencers 
require additional precautions to avoid sample cross-contamination during the 
sequencing reaction (Sinha et al. 2017).  
Current Illumina sequencers like the NovaSeq can generate billions of 
sequencing reads at a length of 250 nt allowing the multiplexed analysis of hundreds 
to thousands of samples in a single run (Table 0.1). At this read-length and output, 
RNA-seq reads aren’t only useful for transcriptome quantification but also for 
annotation. Consequently, efforts like GENCODE and RefSeq heavily rely on this data 
type for their respective annotation approaches (Harrow et al. 2012; Pruitt et al. 2014). 
Paired with literally hundreds of sample preparation techniques and analysis pipelines, 
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transcriptome analysis by short-read RNA-seq (Mortazavi et al. 2008) is now a core 
component of research in nearly all fields of biology.  
So, while it is clear that RNA-seq has revolutionized transcriptome annotation 
and quantification it is also becoming increasingly clear that it is ultimately a stop-gap 
solution of limited power born out the limitations of short-read sequencing. These 
limitations prevent RNA-seq from annotating and quantifying transcriptomes on the 
level of RNA transcript isoforms, i.e. transcript variants expressed by the same gene 
utilizing combinations of alternative splice sites, transcription start sites, and 
transcription termination or polyA sites. Thus, to fully understand the fundamentals of 
gene expression, isoform information is crucial. 
Technology Read Throughput 
per $1K 
Accuracy Base Accuracy Max 
Read Length 
 
Illumina NextSeq  ~2x108  99.9% N/A   75-300 bp  
Pacific Biosciences 
(PacBio) Sequel 
~4x105 89% >99%   50,000 bp 
Oxford Nanopore 
Technologies  
(ONT) MinION 
~5x106 88% >97.5%* Up to 2Mb 
 
Table 0.1: Sequencing technology characteristics. Read number per dollar is hard to 
establish considering different pricing structures and instrument costs. Here, we assume 
a lab would use sequencing cores for Illumina and PacBio sequencing while performing 
Oxford Nanopore Technologies (ONT) MinION sequencing themselves. *Consensus 
accuracy using our R2C2 approach as published (Volden et al., 2018).   
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a) Limitations in transcriptome assembly algorithms 
Despite its dominant position in transcriptome analysis, short-read RNA-seq has failed 
at capturing the true complexity of eukaryotic transcriptomes. While RNA-seq can 
interrogate individual transcript features like splice sites, transcription start sites, and 
polyA sites, it fails at determining how these individual features are combined together 
into comprehensive transcript isoforms. This is due to the fact that the read length of 
short-read sequencers is too short to capture entire transcripts from end-to-end (Fig. 
0.1). Incomplete fragments of transcripts therefore have to be computationally 
assembled into full-length isoforms. This is done using powerful algorithms 
performing de-novo (e.g. Trinity, rnaSPAdes (Grabherr et al. 2011; Bankevich et al. 
2012)) or genome-guided transcriptome assemblies (e.g. Cufflinks, StringTie (Pertea 
et al. 2015; Trapnell et al. 2010)). All of these assemblers ultimately fail at discerning 
complex transcript isoforms expressed by the same gene because of limitations of the 
underlying data. First, RNA-seq reads often do not cover the ends of transcripts leaving 
TSS and polyA sites unresolved (Picelli, Faridani, et al. 2014). Second, although early 
studies have indicated that the mean exon size in the human genome is 147 bp, large 
exons > 300 bp are thought to occur in about 5% of the genome (Lander et al. 2001; 
Bolisetty and Beemon 2012). Large exons that are > 300bp may be too far apart to be 
resolved by normal short-read RNA-seq raw data, i.e. if a transcript has two alternative 
splice sites 1000 bp apart, no individual RNA-seq read will ever connect those two 
events. Given the relatively small exons sizes, exon chaining whereby exons are linked 
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together by identifying all splice junctions is still problematic due to unequal read 
coverage. Computational methods that take this into account have been developed, 
however they still fail at deconvoluting complex isoform mixtures (Kanitz et al. 2015). 
b) Limitations in short-read sequencing technology 
To date, no RNA-seq protocol has succeeded in providing data capable of overcoming 
this assembly challenge and recovering full-length isoforms in a high-throughput 
manner. Although short-read sequencing technology has increased its sequencing 
length capability to ~300 nt from the original ~30 nt, it still can’t sequence the vast 
majority of transcripts from end-to-end. To get around the read length limitation, 
creative specialized protocols have been developed. The most successful methods 
include Synthetic Long Read (SLR) and spISO-seq which operates on the principle of 
splitting one sample into hundreds or thousands of separate reactions using either 384-
well plates or microdroplets (Tilgner et al. 2015, 2017). This separation allows the 
generation of individual sequencing libraries that ideally only contain one transcript 
isoform for any specific gene. These libraries can then be sequenced and analyzed 
separately which massively simplifies computational assembly and reduces mis 
assemblies. However, while improving on general RNA-seq methods, neither method 
succeeds at effectively generating transcript isoforms. SLR generates a low number of 
transcripts most of which are incomplete at the 3’ end while spISO-seq generates sparse 
“read-clouds” that can connect individual splice sites but fail at consistently capturing 
5’ and 3’ ends of transcripts. Additionally, both SLR and spISO-seq approaches have 
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complex library preparation workflows that cannot be multiplexed and require 
specialized instrumentation which has prevented them from being widely adopted.  
While it is not inconceivable that a future short-read based protocol will 
ultimately succeed at isoform-level analysis, this task currently appears to be well 
beyond the capabilities of short-read sequencing. 
2) How can the potential of long-read transcriptome sequencing be realized? 
We believe that long-read sequencing is on the verge of transforming transcriptome 
analysis similarly to how short-read sequencing did a decade ago. In contrast to short-
read sequencing, long-read sequencing technology as provided by Pacific Biosciences 
(PacBio) and Oxford Nanopore Technologies (ONT) has the potential to identify and 
quantify isoforms simply by sequencing cDNA or mRNA molecules end-to-end from 
3’ polyA tail to 5’ CAP.  
 
Figure 0.1: Fundamental difference between short- and long-read sequencing of 
transcripts. Short RNA-seq reads only capture small fragments of transcripts. RNA-seq 
data therefore lacks unambiguous isoform data leading to the inference of many erroneous 
isoforms. Long-read full-length cDNA data captures transcripts end-to-end making 
isoform inference unambiguous. 
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Just like short-read sequencing, long-read technology was initially intended for 
genomic DNA sequencing, but it was only a matter of time until cDNA copies of RNA 
transcript molecules were sequenced on PacBio and ONT sequencers.  
Initial studies used long reads for the targeted analysis of specific highly 
complex transcripts (Treutlein, Gokce, et al. 2014) or to add small amounts of long-
read data to short-read RNA-seq data (Koren et al. 2012; Au et al. 2013). Increasing 
read throughput has allowed the analysis of whole transcriptomes of diverse organisms 
with long-read data alone (B. Wang et al. 2016; Sharon et al. 2013; Tilgner et al. 2013, 
2014) and in addition to the analysis of cDNA, ONT sequencers now offer the ability 
to sequence RNA directly (Workman et al. 2018; Garalde et al. 2018). Finally, long-
read technology has been used to analyze the transcriptomes of single cells (Gupta et 
al. 2018; Volden et al. 2018; Byrne et al. 2017).  
These papers clearly highlight the potential of long-read sequencing to identify 
new isoforms and isoform features like new splice sites, TSSs, and polyA sites which 
is essential to unambiguously annotate and quantify transcriptomes. These papers also 
lay out a path for the future: In the short-term, long-read technology will be a boon for 
the transcriptome annotation. With a moderate investment generating long-read 
transcriptome data for a variety of tissues and organs present in a non-model organism, 
transcriptome annotations will get closer to the comprehensiveness and quality of 
highly curated mouse and human transcriptomes. In the long-term, we believe long-
read technology has the potential to entirely replace short-read RNA-seq for 
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transcriptome analysis. However, to realize this potential, long-read transcriptome 
analysis still has to overcome several challenges that are currently limiting its progress.  
3) What are the challenges of long-read sequencing? 
Although the above examples have highlighted the potential of long-read technology, 
there still remains significant challenges which affect both PacBio and ONT to varying 
degrees: a) RNA integrity, b) length bias, c) read throughput, d) read accuracy, and 5) 
data analysis.  
In order for long-read sequencing to be a main driver in pushing the 
transcriptome field forward these challenges will have to be overcome:  
 
a) RNA integrity 
All current long-read transcriptome sequencing approaches suffer from experimental 
artifacts caused by degraded RNA molecules. While ONT and PacBio sequencers make 
it possible to sequence entire transcripts from end-to-end, this only matters if the vast 
majority of sequenced transcript molecules are fully intact. The integrity of RNA going 
into long-read sequencing experiments is therefore of the highest importance. 
However, it is not yet clear what represents the best extraction and processing method 
for RNA. 
Single-cell studies circumvent this issue by performing reverse transcription 
(RT) directly on cell lysates resulting in high quality results (Byrne et al. 2017; Gupta 
et al. 2018), but this is not the case for bulk samples comprised of tissues or many cells 
because highly concentrated cell lysates tend to inhibit RT reactions. Current efforts to 
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dissociate, lyse, and extract RNA from bulk samples mostly rely on physical disruption 
and Trizol or Tri-reagent based protocols. These protocols are either followed by 
precipitations often resulting in Phenol and Guanidium contamination which can 
compromise RNA integrity or require a column-based clean-up potentially fragmenting 
long RNA transcripts in a way similar to high molecular weight genomic DNA.  
Going forward we will need systematic studies comparing extraction methods 
for the integrity for very long transcripts (>10kb) which cannot be measured by the 
frequently used RIN value which is calculated by evaluating the integrity of the much 
shorter rRNA transcripts at ~2kb (18S) and ~5kb (28S). Additionally, similar to how 
Spike-In RNA Variants (SIRVs) or ERCC spike-ins are used to validate quantification 
it is possible that 5’ capped synthetic transcripts could help indicate the integrity of 
RNA transcripts to identify the percentage of RNA degradation occurring within a 
given method (Cronin et al. 2004; Hardwick et al. 2016).  
We believe these efforts are likely to succeed. Moving from short-read to long-
read sequencing has already led to the genomics community rethinking the way it 
extracts DNA - from mostly column-based to precipitation-based approaches - leading 
to the successful sequencing of DNA molecules almost 1 million base-pairs in length 
(Jain et al. 2018). 
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b) Length bias 
All current long-read transcriptome sequencing approaches are biased towards 
shorter transcripts. As a result, the read lengths produced do not reflect the transcript 
lengths as determined by annotation efforts like GENCODE. While the expression of 
short and long transcripts surely varies for each sample and each sample will only 
include a fraction of all transcripts in the GENCODE annotation, the fact remains that 
current long-read approaches appear to have a hard time capturing long transcripts. 
 
Figure 0.2: Long-read transcriptome sequencing approaches don’t cover long 
transcripts. Swarmplots of length distributions of 1000 randomly sampled PacBio 
(Tilgner et al. 2014), ONT dRNA, and cDNA (Workman et al. 2018) reads covering the 
GM12878 (human lymphoblast cell line) transcriptome. These distributions are not 
representative of the length distribution of the human transcriptome as annotated by 
GENCODE.  *While we show the most recent data set on GM12878 we could find for 
PacBio technology it is several years old and might not be fully representative of current 
platform performance. 
 
This bias is rooted in the way samples are prepared for sequencing as well as the 
sequencing technology itself. To prepare full-length eukaryotic mRNA molecules for 
sequencing, protocols for PacBio and ONT sequencers today rely on some version of 
reverse transcription (RT) using oligo-dT priming most often paired with template 
switching as featured in the Smart-seq2 protocol (Picelli, Faridani, et al. 2014). This 
reverse transcription step generates cDNA with known 3’ and 5’ ends that can be PCR 
	 15	
amplified. PCR amplification is required to generate enough cDNA for sequencing 
library preparation - several micrograms for either technology. However, if cDNA is 
PCR amplified, shorter transcripts are more likely to be successfully amplified, thereby 
generating a pool of cDNA skewed towards full-length short transcripts (<2kb) and 
shorter amplification artifacts of long transcripts.  
While ONT sequencers can now sequence RNA directly, recent studies have 
shown that this does not overcome RNA degradation or length-bias issues. In fact, 
incomplete transcript sequences represent the majority of the produced data and this 
issue gets exacerbated with increased transcript length making direct RNA sequencing 
currently challenging for transcripts over 2kb in length (Fig. 0.2) (Workman et al. 
2018).  
In addition to length biases of sample preparation, both PacBio and ONT 
sequencers themselves have a bias towards shorter molecules. To systematically test 
this bias derived from different RNA extraction, sample preparation and sequencing 
methods new approaches will be needed. Unfortunately, current synthetic RNA spike-
in mixtures like ERCC and SIRV (Lexogen), only contain molecules <2.5kb which is 
simply not long enough to determine bias against long transcript molecules (Fig. 0.2). 
To truly determine length bias, it would require sequencing of a well-defined 
eukaryotic human transcriptome, e.g. human cell line GM12878, using an RNA 
molecule length independent short-read RNA-seq method. While short-read RNA-seq 
won’t be able to systematically resolve isoforms, assemblies of these reads can be used 
to estimate transcript lengths. Comparing representation of transcripts of different 
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lengths in long-read data sets prepared with different protocols will then help reveal 
biases of these protocols.  
The question then still remains: How do we overcome the inherent limitations 
of PCR amplification, sequencing library preparation, and the cDNA and direct RNA 
sequencing process itself. One thing is for certain future efforts will have to overcome 
these limitations or, ironically, the world of long transcripts will remain closed to long-
read transcriptomics. 
It will be up to the wider genomics community as well as PacBio and ONT to 
address these limitations. While adding complexity to sample preparations and 
distorting sample compositions, size selections on the RNA or cDNA level might 
mitigate length bias in sample preparation. Also, reducing cDNA amounts required for 
sequencing reactions might eliminate the need for PCR entirely. Additionally, PacBio 
sequencers have already made big strides reducing the length bias of their library 
preparation and sequencing reactions in the last few years and it would be surprising if 
this wasn’t a big focus of ONT as well. Finally, one way to get around the length-bias 
of sequencing library preparation and sequencing reactions themselves is to dissociate 
transcript length from the length of the DNA/RNA being sequenced, i.e. making all 
DNA/RNA going into a sequencing reaction approximately the same length. This could 
be done by randomly ligating transcripts into large chimeric molecules or generating 
large DNA concatemers containing many copies of the same transcript (Volden et al. 
2018). 
 
	 17	
c) Read throughput 
All sequencing based transcriptome analysis is ultimately limited by the number of 
reads available for analysis. More reads result in better data but so far there hasn’t been 
a rigorous study to identify the exact numbers of long sequencing reads required to 
exhaustively analyze a complex eukaryotic transcriptome. Because sequencing-based 
transcriptome analysis follows the same sampling principle regardless of read length, 
it stands to reason that these numbers will be similar to those required for short-read 
RNA-seq assays. Therefore, >30 million reads will be required for a shallow analysis 
of a transcriptome of a bulk sample capturing the isoforms of genes with medium and 
high expression (Sims et al. 2014). This however represents an ideal scenario assuming 
a single isoform per gene. If we think about treating individual isoforms as individual 
genes, it follows that significantly deeper sequencing will be needed to identify and 
quantify them. Indeed, it has been suggested by a deep-sequencing survey of 
alternative-splicing in human tissue that there are, on average, seven alternative 
splicing events per multi-exon gene (Pan et al. 2008). Therefore, to truly explore the 
complexity of mammalian transcriptomes, >100,000,000 of reads covering full-length 
transcripts will be required per tissue or organ.  
In contrast to bulk samples, estimating the read depth required for single cell 
analysis is more straightforward as it is limited by experimental constraints. Most 
workflows in the rapidly expanding field of single cell transcriptome analysis attach 
unique molecular identifiers (UMIs) to each cDNA molecule generated for each 
individual cell, thereby giving us a direct way to determine the number of reads needed 
	 18	
to capture all or most of these molecules (Ziegenhain et al. 2017). 10X Genomics single 
cell analysis approach for example generates <20,000 cDNA molecules per cell (Zheng 
et al. 2017). To reliably capture >90% of these molecules, sampling statistics dictate 
the need for ~45,000 sequencing reads per cell and consequently 45,000,000 
sequencing reads for the analysis of a 1,000 cell cDNA pool. 
In short, future long-read transcriptome analysis of bulk and single cell samples 
will require tens to hundreds of millions of reads at a reasonable cost. While ONT 
sequencers now routinely generate several millions of reads per $1000 of sequencing, 
PacBio sequencers produce ~400,000 reads per $1000 of sequencing (Table 0.1). This 
means that achieving the sequencing depth required for exhaustive transcriptome 
analysis is now borderline feasible with ONT sequencers but would deplete all but the 
largest of research budgets if using PacBio sequencers. It will be interesting to see how 
the newly released ONT PromethION and PacBio Sequel II will change this equation 
once in researchers’ hands as they both represent significant improvements in read 
throughput over the ONT MinION and PacBio Sequel, respectively. 
 
d) Read accuracy 
As long as a PacBio or ONT read captures the sequence of a full-length transcript and 
is accurate enough to be correctly aligned to a single genomic location, it is useful for 
analysis. There is no line in the metaphorical read-accuracy sand beyond which this 
transcript sequence becomes useless for analysis, because different downstream 
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applications will require different levels of accuracy to be implemented. It is, however, 
no surprise that more accurate reads are always preferable over less accurate reads.   
Both PacBio and ONT long-read technologies sequence individual DNA (or 
RNA) molecules and as such are inherently more error-prone than short-read Illumina 
sequencing which can rely on the combined signal of thousands of copies of DNA 
molecules to determine base sequence. Because the raw read length of PacBio 
sequencers is much longer than an average transcript molecule, circularized cDNA 
molecules can be read multiple times to generate a more accurate consensus. As a 
result, PacBio’s IsoSeq protocol generates cDNA circular consensus sequences (CCS) 
that can achieve >99% (Q20) accuracy (Table 0.1) (Gupta et al. 2018; Tilgner et al. 
2014). 
While ONT raw read length far exceeds transcript length, there currently exists 
no commercial product to - like PacBio’s CCS approach - take advantage of this read 
length to improve read accuracy through consensus generation. Because of this, cDNA 
or direct RNA sequencing on ONT (1D) generates sequences of 88% (Q9) accuracy 
(Fig. 0.3).  
This low accuracy creates some serious drawbacks regarding downstream 
analysis including the inability to accurately demultiplex single cell data. Single cell 
approaches like 10X Genomics Chromium workflow or the Drop-seq protocol can 
process many hundreds to thousands of cells in parallel using water-in-oil emulsions to 
produce highly multiplexed single cell cDNA pools (Zheng et al. 2017; Macosko et al. 
2015). In this process, cell-specific identifiers - short nucleotide sequences - are 
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attached to each cDNA molecule that is reverse transcribed from mRNA. 
Consequently, assigning a cDNA molecule to the cell it originated from, i.e. 
demultiplexing, requires accurately determining the sequence of its cell-specific 
identifier. Without sufficiently accurate sequencing, molecules will therefore be mis-
assigned or lost (Gupta et al. 2018). 
 
Figure 0.3: Error-prone reads pose analysis challenge. Representative alignments of 
ONT cDNA (Workman et al. 2018) reads. 30 read alignments (grey) to the first two exons 
of the CD19 gene (dark blue) are shown. Read alignments contain many insertions 
(orange), mismatches (red), and deletions (thin line) within exons. These errors complicate 
detection of exact transcript sequences and exact positions of splice sites, TSSs, and polyA 
sites. 
 
Currently, ONT is working on improving their basecalling accuracy and have 
announced a commercial consensus approach to be released in 2019 that should address 
this issue. Until then the ONT research community including our own laboratory has 
recognized this issue and developed consensus sequencing approaches (C. Li et al. 
2016). Specifically targeted for cDNA, the R2C2 approach we developed circularizes 
cDNA and uses rolling circle amplification to generate long concatemeric molecules 
that can be sequenced and processed into consensus sequences (Volden et al. 2018) 
(Fig. 0.4). At $1000 sequencing cost the R2C2 approach can currently produce several 
million sequencing reads at >97.5% (~Q16) (Fig 0.5) median accuracy (Byrne et al. 
2019).  Additionally, the R2C2 approach has proven very useful for de-multiplexing 
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single cell data where 74% of the total reads containing cellular indexes derived from 
7nt and 8nt combinations were able to be assigned. Given ONT’s new basecalling 
algorithm we are confident this number will eventually increase. 
  
 
Figure 0.4: R2C2 method overview. Figure adapted from (Volden et al., 2018). cDNA 
is circularized using Gibson Assembly, amplified using RCA, and sequenced using the 
ONT MinION. The resulting raw reads are split into subreads containing full-length or 
partial cDNA sequences, which are combined into an accurate consensus sequence 
using our C3POa workflow, which relies on a custom algorithm to detect DNA splints 
as well as poaV2 and racon. 
 
It is unclear whether ONT consensus approaches will be able to reach the 
accuracy of PacBio circular consensus reads, since the errors in PacBio sequencing 
data aren’t entirely random they are less systematic than ONT errors (Weirather et al. 
2017). Systematic errors which recur in the same base context, e.g. around 
homopolymers (stretches of the same base longer than 5nt) can pose insurmountable 
challenges for consensus-based error-correction. Error-correcting algorithms like 
Nanopolish (Loman, Quick, and Simpson 2015), Racon (Vaser et al. 2017), or Medaka 
(Medaka n.d.) are beginning to address this by either making use of the ionic current 
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based raw signal generated by ONT sequencers or by incorporating ONT specific error 
models. While it is not yet clear what accuracy will be sufficient for reliably identifying 
regular transcript isoforms, increasing the accuracy of individual reads to beyond 99% 
will not only be required for single cell cDNA demultiplexing but also the analysis of 
individual transcripts that contain unique sequences not encoded in the genome, i.e. B 
and T cell receptor transcripts, as well as transcripts containing base modifications.  
 
Fig. 0.5 Increase R2C2 subreads decreases indels and mismatches.  
Figure adapted from (Volden et al., 2018). PacBio Isoseq, standard ONT 1D, and 1D2 
are compared with R2C2 at different subread coverages. Read accuracy is determined 
by minimap2 alignments to SIRV transcripts. Median accuracy is shown as a red line. 
Accuracy distribution is shown as a swarm plot of 250 randomly subsampled reads. 
Average raw read quality of ONT reads is indicated by the color of the individual 
points. 
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e) Data analysis 
The goal of long-read transcriptome analysis is two-fold. First, it aims to identify all 
transcript isoforms present in a sample, then quantify their expression (ideally in an 
allele specific manner). 
In contrast to short-read RNA-seq where bioinformaticians have spent the last 
decade creating a large number of tools for data analysis steps including read 
alignment, expression quantification, and transcriptome assembly, the tools for long-
read analysis are still in their infancy. Although long-read technology circumvents 
many of the bioinformatic assembly challenges of short-read data, error-prone long-
read data has created its own new set of challenges. These challenges have necessitated 
new algorithms for the efficient analysis of longer reads.  
Nevertheless, interest among bioinformaticians towards long-read technology 
is steadily increasing and off-the-shelf tools to analyze long reads are being developed 
and published. Below is an overview of what the current state of tools is and what we 
perceive the outstanding challenges in the long-read cDNA field are. 
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Figure 0.6: Analysis challenges of long-read full-length sequencing. A simplified  
schematic shows the steps required to extract information out of long-read sequencing data. 
Each read has to be aligned, ideally in an allele-aware manner to the genome it originated 
from. Read alignments then have to be analyzed to identify RNA modifications as well as 
new isoform features that are missing in the current transcriptome annotation. For each 
allele, reads then have to be grouped into isoforms which allows isoform identification and 
quantification. For real data sets, all these steps have to take into account the often-
substantial rates of sequencing errors and incomplete reads in long-read sequencing. These 
will complicate all steps of the analysis.  
 
i) Aligning long-read data 
Aligning reads to a genome sequences is at the core of most transcriptome analysis 
(Fig. 0.6). Luckily there are several good options available for the spliced alignment of 
noisy long reads. The GMAP (T. D. Wu and Watanabe 2005) and BLAT (Kent 2002) 
aligners, originally developed for the alignment of ESTs perform surprisingly well for 
aligning noisy long reads. However, just like the PacBio developed BLASR (Chaisson 
and Tesler 2012) aligner, they are simply too slow for the effective analysis of millions 
of reads. The recently released minimap2 (H. Li 2017) aligner seems to address the 
issue of speed while maintaining alignment accuracy and has quickly been adopted 
amongst the ONT community. The only trade-off we have observed (however not 
systematically investigated) is that minimap2 – potentially due to the relatively large 
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default seed size of 15nt – seems to lack sensitivity when aligning reads to very short 
terminal exons. We hope that future improvements in long-read accuracy will allow 
alignment algorithms to “dial in” that trade-off between avoiding spurious short 
alignments and detecting even the shortest of potentially un-annotated terminal exons.   
 
ii) Isoform identification 
Transcriptome annotation includes the identification of new gene features as well as 
how these new features are combined with known features into isoforms (Fig. 0.6). 
This is where long-read transcriptome sequencing holds the largest promise. However, 
the tools available for the identification isoforms from long read data are still in their 
infancy. 
While PacBio supplies the IsoSeq3 analysis pipeline for the analysis of their 
cDNA CCS reads, previous work indicates that this pipeline tends to over-report 
potential isoforms (Tardaguila et al. 2017). There currently exist three pipelines for the 
analysis of ONT direct cDNA or direct RNA sequencing data. Both Pinfish released by 
ONT and FLAIR released by the Brooks lab at UCSC are intended for regular 1D ONT 
data and deal with the high error-rate in different ways. Of these two pipelines, only 
FLAIR has been used in a publicly available manuscript [ref] and deals with inaccurate 
ONT reads by using short-read Illumina reads to correct splice junctions and identifies 
and quantifies isoform data; however, it does not use nanopore reads for de novo splice 
site detection and relies on annotation and short-read data (Workman et al. 2018).  
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Specifically designed for the analysis of R2C2 reads, the Mandalorion pipeline 
developed by our lab at UCSC takes advantage of the higher accuracy of R2C2 reads 
to identify and quantify isoforms without the need for Illumina data, while also 
identifying new gene features and isoforms (Volden et al. 2018).  
One consideration when identifying isoforms is how to deal with raw data 
containing molecular biology artifacts. First and foremost, this includes the 
amplification of either fragmented RNA or genomic DNA. While, ideally, these 
artifacts should be minimized during sample preparation, any pipeline should be 
equipped to recognize potentially incorrect isoforms stemming from them. Tools like 
Sqanti which can detect these types of artifacts can serve as quality control for future 
isoform identification pipelines (Tardaguila et al. 2018). 
 
iii) Isoform quantification 
Quantifying and performing differential expression analysis of transcript levels on the 
isoform instead of the gene level brings with it a large set of new challenges.  
First, it will be a challenge to decide at which point a known and a newly identified 
isoform should be treated as the same or equivalent isoforms. Containing different 
splice sites surely differentiates isoforms, but whether different TSSs that are only 3 
nucleotides apart and reside within the 5’ UTR differentiate isoforms is not at all clear.   
FLAIR and Mandalorion deal with this by analyzing all samples that have to be 
compared at the same time to create a shared list of isoforms. This creates large 
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computational overhead because adding a single sample to a data set requires the 
reanalysis of the entire data set.  
Second, it will be a challenge to systematically differentiate allele-specific 
isoform expression (Fig. 0.6). To differentiate alleles, we will need accurate and phased 
information of sequence variants differentiating the haplotypes present in a sample, 
because extracting this information from error-prone long-read transcriptome data is 
inherently suboptimal. However, if sequence variants are known, tools like HapCUT2 
can be used to assign full-length cDNA to parental alleles (Edge, Bafna, and Bansal 
2017). This in principle allows for allele-specific expression analysis.  
We are, however, optimistic that approaches that sort aligned reads based on 
variants are only a temporary solution. In the future, it is likely that alignment 
algorithms will be able to take advantage of fully diploid genome sequences during 
alignment to immediately align reads to the haplotype they originate from. Then, 
ideally, future tools will identify allele-specific isoforms based on these alignments and 
quantify them using approaches similar to RSEM which uses expectation maximization 
to accurately quantify expression using short read data (B. Li and Dewey 2011).  
 
iv) Modification detection 
RNA transcripts are known to host a variety of base modifications than genomic DNA. 
Except for A-to-I modifications which are read by the RT enzyme as G and therefore 
appear in cDNA, RNA modification cannot be detected by standard cDNA sequencing 
as performed by Illumina, PacBio and ONT (Park et al. 2012).  
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Direct RNA sequencing, which is now possible on ONT sequencers, therefore 
holds great potential for modification discovery (Fig. 0.6). To realize this potential both 
computational and experimental workflows will need to be developed and improved. 
Although anecdotal evidence exists that modification information can be extracted 
from ONT base and raw data, no experimental and computational workflows exist yet 
to systematically establish and validate the detection of the large variety of 
modifications present in RNA (Workman et al. 2018). Furthermore, improvements to 
experimental workflows will have to reduce the RNA input requirements which 
currently limit direct RNA sequencing to large samples or cell lines. 
The detection of DNA modifications using raw PacBio data may serve as a 
cautionary tale here (Flusberg et al. 2010). While the detection of methylated bases was 
shown to be possible using raw PacBio data, this approach never managed to compete 
with Illumina-based bisulfite sequencing for methylation detection. However, direct 
RNA sequencing has the potential to detect RNA modifications for which currently no 
other sequencing assay exist and might therefore fill a unique niche in the genomic 
toolset. 
 
Conclusion  
There is little doubt in my mind that full-length transcriptome sequencing using long-
read technologies is the future of transcriptome annotation because it has too many 
inherent advantages over short-read approaches. 
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A single long read covering a full-length transcript can determine its 
transcription start site (TSS), all splice sites, and polyA site, thereby immediately 
identifying the isoform the transcript represents. In contrast, regular short-read RNA-
seq protocols rarely detect TSSs and polyA sites and usually only cover a subset of 
splice-sites, leaving the researcher with a large computational problem when trying to 
identify isoforms which often has no clear solution.  
We are confident that in the next few years, by addressing the challenges we 
describe here, long-read sequencing will make high-quality transcriptome annotations 
readily achievable within a reasonable budget. This will be of particular interest to 
researchers working on organisms that haven’t attracted the attention of large consortia. 
Going forward, using 10X Genomics or Drop-seq approaches paired with long-read 
sequencing technology would allow for the amplification and sequencing of full-length 
cDNA from single-cell organisms to generate detailed isoform-level transcriptome 
annotations. Processing tens of thousands of cells this way could help generate an atlas 
of cells and would vastly expand our knowledge of the diversity of eukaryotic 
transcriptomes.  
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Abstract 
RNA-seq is a powerful technique to investigate and quantify entire transcriptomes. 
Recent advances in the field have made it possible to explore the transcriptomes of 
single cells. However, most widely used RNA-seq protocols fail to provide crucial 
information regarding transcription start sites. Here we present a protocol, Tn5Prime, 
that takes advantage of the Tn5 transposase based Smartseq2 protocol to create RNA-
seq libraries that capture the 5’ end of transcripts. The Tn5Prime method dramatically 
streamlines the 5’ capture process and is both cost effective and reliable. By applying 
Tn5Prime to bulk RNA and single cell samples we were able to define transcription 
start sites as well as quantify transcriptomes at high accuracy and reproducibility. 
Additionally, similar to 3’ end based high-throughput methods like Drop-Seq and 
10X Genomics Chromium, the 5’ capture Tn5Prime method allows the introduction 
of cellular identifiers during reverse transcription, simplifying the analysis of large 
numbers of single cells. In contrast to 3’ end based methods, Tn5Prime also enables 
the assembly of the variable 5’ ends of antibody sequences present in single B-cell 
data. Therefore, Tn5Prime presents a robust tool for both basic and applied research 
into the adaptive immune system and beyond.  
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Introduction 
As the cost of RNA-sequencing has decreased, it has become the gold standard in 
interrogating complete transcriptomes from bulk samples and single cells. RNA-seq 
is a powerful tool to determine gene expression profiles and identify transcript 
features like splice-sites. However, standard approaches lose sequencing coverage 
towards the very end of transcripts. This reduced coverage means that we cannot 
confidently define the 5’ ends of mRNA transcripts which contain crucial information 
on transcription initiation start sites (TSSs) and 5’ untranslated regions (5’UTRs). 
Analyzing TSSs can help infer the active promoter landscape, which may vary from 
tissue to tissue and cell to cell. Analyzing 5’UTRs, which may contain regulatory 
elements and structural variations can help infer mRNA stability, localization, and 
translational efficiency. Identifying such features can help elucidate our 
understanding of the molecular mechanisms that regulate gene expression. 
The loss of sequencing coverage towards the 5’ end of transcripts is often 
attributed to how sequencing libraries are constructed. For example, the widely used 
Smart-seq2 RNA-seq protocol, a powerful tool in deciphering the complexity of 
single cell heterogeneity (Picelli, Faridani, et al. 2014; Treutlein, Brownfield, et al. 
2014; Darmanis et al. 2015), features reduced sequencing coverage towards transcript 
ends. This lost information is a result of cDNA fragmentation using Tn5 transposase. 
Several technologies have tried to compensate for the lack of coverage by specifically 
targeting the 5’ ends of transcripts. The most notable methods include cap analysis of 
gene expression (CAGE), NanoCAGE, and single-cell tagged reverse transcription 
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sequencing (STRT) (S. Islam et al. 2011, 2014; Salimullah et al. 2011; Shiraki et al. 
2003). CAGE uses a 5’ trapping technique to enrich for the 5’-capped regions by 
reverse transcription (Shiraki et al. 2003). This technique is extremely labor intensive 
and involves large amounts of input RNA. The NanoCAGE and STRT methods target 
transcripts using random or polyA priming and a template-switch oligo technique to 
generate cDNA (S. Islam et al. 2011; Salimullah et al. 2011). While NanoCAGE can 
analyze samples as low as a few nanograms of RNA, and STRT can be used to 
analyze single cells, they both require long and labor-intensive workflows including 
fragmentation, ligation, or enrichment steps. These workflows can become costly and 
labor intensive, making it difficult to interrogate complex mixtures of cells like those 
found in the adaptive immune system or cancer. 
New droplet based high-throughput single cell RNAseq approaches like Drop-
Seq and 10X Genomics Chromium platform can process thousands of cells but 
require intricate or expensive proprietary instrumentation. Importantly they are 
primarily focused on the 3’ end of transcripts due to integrating a sequencing priming 
site onto the oligodT primer used for reverse transcription. By losing information of 
the 5’ end almost entirely, these approaches are not capable of comprehensively 
analyzing cells of the adaptive immune cells which express antibody or T cell 
receptor transcripts featuring unique V(D)J rearrangement sequence information on 
their 5’ end. While 10X Genomics has recently introduced their new Single Cell 
V(D)J solution platform to address this we have yet to discover how well this new 
method works. 
	 34	
To overcome this lack of easy-to-implement, inexpensive, and high-
throughput single cell 5’ capture methods, we chose to modify the Smart-seq2 library 
preparation protocol, which is relatively cost-effective and simple with features of 
STRT which captures 5’ ends effectively. Here we describe a robust and easily 
implemented method called Tn5Prime that performs genome-wide profiling across 
the 5’ end of mRNA transcripts in both bulk and single cell samples. The protocol is 
based on integrating one sequencing priming site into the template switch oligo used 
for reverse transcription and subsequently tagmenting the resulting amplified cDNA 
by Tn5 enzyme loaded with an adapter carrying the other sequencing priming site. 
This combination allows for the construction of directional RNAseq libraries with 
one read anchored to the 5’ end of transcripts without the need for separate 
fragmentation, ligation, and, most importantly, enrichment steps. Additionally, by 
incorporating cellular identifiers into the template switch oligo makes it conducive for 
pooling samples after reverse transcription, thereby increasing throughput and 
reducing cost. Finally, data produced by this novel approach allows for the 
identification of transcription start sites, the quantification of transcripts, and the 
assembly of antibody heavy and light chain sequences from single B cells at low 
sequencing depth.  
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Results 
Construction of Tn5Prime libraries 
Tn5Prime libraries can be constructed from either purified total RNA or single cells 
sorted by Fluorescence-activated cell sorting (FACS) into multiwell PCR plates. 
Tn5Prime libraries create a directional paired-end Illumina RNAseq library with read 
1 anchored to the 5’ end of transcripts. Directionality and read 1 anchoring is 
achieved through the use of our modified template-switch oligo and custom Tn5 
enzyme. After the addition of reverse transcriptase to total RNA or cell lysate, first-
strand synthesis occurs using a modified oligo-dT and a template-switch oligo (TSO) 
containing a partial Nextera A adapter sequence and, optionally, a cellular index 
sequence (Supplementary Table S1.1, Fig. 1.1A). During reverse transcription, the 
oligo-dT serves as a primer at the 3’ polyA tail of mRNA transcripts, while the 
sequence of the partial Nextera A template-switch oligo is attached to the 3’ end of 
the synthesized cDNA corresponding to the 5’ end of transcript sequences. After 
reverse transcription, samples with non-overlapping cellular indexes can be pooled. 
The cDNA product is then amplified using a complete Nextera A primer and a primer 
complementary to the modified 5’ end of the oligo-dT. After amplification, the cDNA 
product will contain a complete Nextera A adapter including Illumina indexes. At this 
point, samples that contain the non-overlapping Illumina indexes can be pooled. By 
pooling after reverse transcription and PCR amplification, we can dramatically reduce 
the workflow complexity and reagent usage. 
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Next, Tn5 transposase, loaded only with a partial Nextera B adapters, 
fragments the cDNA and attaches the partial Nextera B adapters to the cDNA in a 
single reaction. The cDNA fragments are then amplified using a universal A primer 
and a Nextera B primer that primes off the partial Nextera B adapter sequences 
attached by the Tn5 enzyme. The final product is compatible with the Illumina 
platform by containing the complete Nextera A and Nextera B adapters. Libraries are 
then ready to be size selected and quantified prior to sequencing. At this point, no 
enrichment step is necessary, as only molecules containing both Nextera A and B 
adapters will be targeted for sequencing. Since only the TSOs associated with the 5’ 
end of transcripts contains Nextera A adapters, read 1 of all read pairs in the 
sequencing reaction begins at these 5’ ends and extends into the transcript body, 
thereby identifying transcription start site and directionality (Fig. 1.1A-C). Read 2 is 
distributed throughout the gene body, as each location represents the random insertion 
of Nextera B adapters by Tn5 and library size selection (Fig. 1.1B, C)  
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Fig. 1.1 Tn5Prime Library construction and 5’ capture 
A.) Schematic of the Tn5Prime library construction. No enrichment steps are required to 
generate a library that captures the 5’ end of transcripts. B.) Read alignment plots 
comparing 5’ end capture by Tn5Prime to random fragmentation by Smartseq2 using 
lymphoblast cell line GM12878. A total input of 50 ng of RNA was used. Individual 
alignments for the first (Read1, blue) and second (Read2, red) read of each read pair are 
shown. Read1 density is shown for both library types as a histogram (blue). Gene models 
are shown on the top panel (Color indicates transcriptional direction.) 
 
Creating and analyzing Tn5Prime data of GM12878 cell line RNA                   
To evaluate whether our Tn5Prime protocol consistently identifies the 5’ end of the 
transcript we first performed low coverage RNAseq of total RNA of GM12878 
cultured lymphoblast cells. We performed a side-by-side comparison of our protocol 
with a modified version of the Smart-seq2 (Picelli, Faridani, et al. 2014; Byrne et al. 
2017) (see Methods) protocol using the same starting material. Using the HiSeq2500 
platform (Illumina) we obtained 570805 and 453761 raw read pairs for two replicate 
Tn5Prime libraries. We next obtained 1094530 raw read pairs from the Smart-seq2 
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library. Adapter sequences and low quality reads were removed using Trimmomatic 
(Bolger, Lohse, and Usadel 2014). In the Tn5Prime replicates, 92.51% and 92.62% of 
the trimmed and filtered reads mapped uniquely to the human genome using the 
STAR alignment tool (Dobin et al. 2013), surpassing the Smart-seq2 protocol at 
88.50%. The uniquely aligned reads from the TN5Prime replicates collectively had a 
redundancy of 1.34. This high unique alignment percentage indicates that our 
Tn5Prime protocol produces libraries of high complexity. 
  
Detecting Transcription Start Sites using Tn5Prime 
We analyzed the read distribution across transcripts both visually and systematically 
to determine the 5’ specificity of our protocol. Visual inspection found that while 
Smart-seq2 reads are distributed across the entire body of genes, Tn5Prime reads 
follow two distinct patterns: First, the start of the read 1 is anchored to the 
transcription start site. Second, the start of read 2 is variable and likely dependent on 
size selection during library preparation (Fig. 1.1B-C). Next, systematic analysis was 
based on mapping the start of read 1 to identify putative transcription initiation start 
sites (TSSs). To test our ability to identify TSSs, we compared our Tn5Prime data to 
the Gencode genome annotation and CAGE data which was generated from the same 
GM12878 cell line from the ENCODE project. We identified putative TSSs by 
calling peaks enriched from the start of read 1 in our Tn5Prime data (see Methods). 
We found that 89.7% of the 17,853 peaks fell within TSSs (0-25bp upstream) with 
the vast majority of them falling near promoter regions (26bp-1000bp upstream) or 
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5’UTRs (Fig.1.2A). Next, we subsampled the CAGE data to levels similar to the 
Tn5Prime data and called peaks in the same manner. We found 73% of the 17,853 
Tn5Prime peaks fell within 25bp to the nearest of 27,526 CAGE peaks, indicating 
high concordance between the two approaches (Fig. 1.2B). Tn5Prime peaks (3,746) 
that were not within 25bp of a CAGE peak contained far less sequencing reads on 
average than those within 25bp of a CAGE peak. These results indicate that these 
transcripts might be expressed at lower levels and show more variance between the 
Tn5Prime and CAGE datasets (Fig. 1.2B). Next, as a comparison we looked at our 
GM12878 data generated using the Smart-seq2 method in the same way. We found 
that 7.9% of the 23,451 peaks called based on the Smart-seq2 fell within TSSs (0-
25bp upstream) (Fig. 1.2C). Further, we found 10.4% of the 23,451 peaks fell within 
25bp to the nearest CAGE peaks (Fig. 1.2D). This showed that in contrast to the 
Smart-seq2 method our TN5Prime approach effectively identified putative TSS sites. 
Ultimately, this data suggests that our Tn5Prime protocol is equivalent to the gold 
standard CAGE technique in targeting transcription start sites. 
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Fig. 1.2 Tn5Prime peaks are highly concordant with GENCODE annotation and 
CAGE peaks  
Peaks were detected from sequencing reads produced by Tn5Prime and Smart-seq2 
libraries generated from total GM12878 RNA. (A and C) Tn5Prime (A) and Smart-seq2 
(C) were matched to features in the Gencode annotation and the feature they matched are 
shown as a pie chart. (B and D) Tn5Prime (B) and Smart-seq2 (D) peaks were matched to 
CAGE peaks.  The yellow bar on top indicates the peaks within 25 bp and the green bar 
indicates all other peaks. Peaks in each were rank sorted according to their read coverage 
and shown as a histogram. 
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Quantifying the Transcriptome using Tn5Prime 
After validating the ability of Tn5Prime to detect transcription start sites, we next 
wanted to examine whether it is capable of transcript quantification. To determine 
whether our Tn5Prime method is quantitative we compared GM12878 data generated 
from four different protocols: Tn5Prime, Smart-seq2 data generated by our lab, as 
well as CAGE and RNA-seq data produced by the Encyclopedia of DNA Elements 
(ENCODE) project (Fig. 1.3). We used the Tn5Prime data mentioned in the previous 
section and generated the Smart-seq2 data on the same cell line as described by 
(Picelli, Faridani, et al. 2014). We performed replicates using the Tn5Prime protocols 
to define overall reproducibility and accuracy. Based upon our results, transcript 
quantification by Tn5Prime replicates showed extremely high correlation with a 
Pearson correlation coefficient of r=0.97 (95% C.I. 0.97-0.97). Quantification by 
Tn5Prime also correlated very well with Smart-seq2 with a Pearson r of 0.87 (95% 
C.I. 0.86-0.87). Tn5Prime and Smart-seq2 data were comparable with ENCODE 
RNA-seq and CAGE data (Fig. 1.3), indicating that the Tn5Prime protocol is 
equivalent to the conventional Smart-seq2 method in measuring transcript abundance. 
Together, these data show that Tn5Prime can accurately identify transcription start 
sites and quantitatively measure transcript abundance. 
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Fig 1.3. Tn5Prime quantifies transcriptomes accurately and reproducibly. 
Pairwise correlations of transcript levels between Tn5Prime, Smartseq2, ENCODE 
CAGE and ENCODE RNAseq experiments using GM12878 cell line are shown as 
scatter plots. A total of 50 ng of input RNA was used. Each transcript is shown as a black 
dot with an opacity of 5%. Distribution of transcript levels is shown on the outside of the 
plots in grey histograms. 
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Transcript quantification and start site localization in single B cells. 
 As the Tn5Prime protocol is based on the same cDNA amplification strategy as the 
Smart-seq2 protocol, we expected it capable of generating sequencing libraries from 
single cells. Indeed, we successfully generated single cell libraries using the 
Tn5Prime protocol from primary murine B-lymphocytes (B2 cells; IgM+B220+CD5-
CD11b-) (n=12) isolated from the peritoneal cavity. We generated between 17,534-
93,429 2x300 bp read pairs per cell using the Illumina MiSeq of which 62% passed 
quality filtering. Of the filtered reads, an average of 91.48% uniquely mapped to the 
mouse genome. The high alignment percentage indicates we are able to generate high 
quality libraries from single cells using our Tn5Prime. Despite the very low total 
number of read pairs we collected, we still detected 339 expressed genes per cell on 
average. Although these numbers may seem low, they are in line with previous 
published single B cell RNAseq studies (Gierahn et al. 2017; Zheng et al. 2017; Jaitin 
et al. 2014). Also, it is known that B cells can show transcriptional heterogeneity 
depending upon their cell state (Y. L. Wu et al. 2017). Among the genes expressed in 
many of the single cells were genes corresponding to B cell function, including 
CD19, CD79a and components of the MHC complexes (Supplementary Fig. S1.1). 
This data indicates that we were able to effectively identify cell type specific genes. 
 
Analysis of 192 Single CD27high CD38high Human B Cells 
After successfully testing our Tn5Prime method on single mouse B cells, we next 
wanted to develop a multiplex approach capable of evaluating hundreds of human 
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single cells. To this end, we FACS sorted 192 single B cells into individual wells of 
96 well plates using the canonical surface molecules CD19, CD27 and CD38 to sub-
select the plasmablast subpopulation (Supplementary Fig. S1.2). Plasmablasts are one 
of the most widely studied B cell populations and are frequently monitored after 
vaccination or infections by flow cytometry. The plasmablast cell compartment can 
be defined primarily by looking at high levels of surface markers CD27 and CD38, 
however memory B cells may also express these markers, albeit at lower levels, 
making it difficult to parse out these two populations. Therefore, analyzing these cell 
types at the single cell level should help further delineate these populations. 
Our multiplex strategy entails inserting cellular indexes into the template 
switch oligo allowing the libraries to be pooled after reverse transcription. This 
streamlines our method and increases our throughput by decreasing the PCR and Tn5 
reactions required. Using our multiplexing strategy, we generated Tn5 libraries for 
192 single B cells using 192 RT reactions, 24 PCR reactions and 24 Tn5 reactions. 
Although this was not performed, library pools carrying distinct Illumina sample 
indexes could have been further pooled following PCR to reduce the numbers of Tn5 
reactions from 24 to 2. The entire Tn5Prime library preparation workflow for 
hundreds of cells can be completed in two days. 
We generated 194,553,648 150 bp paired end reads total. To determine gene 
expression for each cell, reads were assigned to one of 192 single cells based on its 
Illumina index reads and by comparing the sequence of the first 8 bases of read 1 to 
the cellular index sequences.  91% of the 194,553,648 150bp paired end reads were 
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successfully assigned to one of the 192 single B cells. 90.75% of cell-assigned reads 
were successfully aligned to the human genome using the STAR alignment tool with 
a median of 74.59% or 505,665 of cell-assigned reads being uniquely assigned to an 
annotated gene. Each cell expressed a median of 534 genes. We then compared the 
number of genes detected by Tn5Prime and modified Smart-seq2. To this end, we 
sequenced 13 Smart-seq2 B cells libraries to a median depth of 275,762 reads 
uniquely aligned to genes. When subsampled to the median Smart-seq2 read depth of 
275,000 reads Tn5Prime detected a median 409 genes while Smart-seq2 detected 910. 
While detecting less genes than Smart-seq2, the Tn5Prime method is comparable to 
other high-throughput single cell methods like MARS-seq (Jaitin et al. 2014) (Median 
of 671 genes per B cell), 10X Genomics (Zheng et al. 2017) (Median of 478 genes 
per B cell), and Seq-well (Gierahn et al. 2017) (Median of 874 genes per B cell). 
Overall, of the 58234 annotated genes in GENCODE, 5414 genes had at least 
one read per cell on average among the 192 B cells analyzed with Tn5Prime. The 
median redundancy for each cell is 13.92 which means that, on average, each 
uniquely aligned cDNA fragment was sequenced 13.92 times. This indicates that the 
libraries were sequenced exhaustively. 
 
Detecting Transcription Start Sites in single CD27high CD38high B cells using 
Tn5Prime 
To determine if transcription start site specificity is maintained within the single cell 
data, read 1 start distribution was compared to annotated transcription start sites 
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found in the ENCODE and CAGE datasets. By calling peaks, we found that our 
single cell results were able to maintain transcription start site specificity, with peaks 
predominantly falling within the annotated transcription start sites with 92.4% of the 
peaks falling within TSSs (Fig. 1.4A-B). In addition to the transcription start site, the 
directionality of transcription can be inferred due to our custom template switch oligo 
incorporating a forward-read priming site to the 5’ region of the transcript which is an 
advantage over many other single cell RNAseq protocols (Fig. 1.4C-D). 
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Fig 1.4. Transcription start sites detected in single CD27high CD38high B cells 
A) CD27high CD38high Tn5Prime peaks matching features in the Gencode annotation. TSS 
= on or < 25bp behind the start of an annotated GENCODE gene, 5’UTR = inside 5’ 
UTR, Promoter = between 26 -1000bp behind start of annotated gene. B) Tn5 peaks 
shown in two groups. Group 1 contains all peaks within 25bp of a peak identified in the 
complete RIKEN CAGE peak Human peak database and group 2 contains all other 
peaks. Peaks were sorted by the number of cells associated with that peak in CD27high 
CD28high B cells and displayed in figure 5a. The yellow bar indicates peaks within 25bp, 
and the green bar indicates all other peaks. C, D) Genome Browser view of reads of Actb 
(C) and LTB (D) genes. In addition to TSS information, read alignments also show 
differential isoform usage between cells.   
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Detecting Subpopulations within CD27high CD38high B cells using Tn5Prime 
Since separating memory B cells and plasmablasts by FACS based on surface 
markers can be challenging, especially when the adaptive immune system is 
unperturbed, we wanted to see whether we could do so post-sorting using their gene 
expression profiles. Cells outside more than three median absolute deviations from 
the median for percent alignment, Mitochondrial transcript percentage, or number of 
detected genes were marked as outliers and eliminated prior to normalization of 
transcript counts (Supplementary Fig. S1.3). After normalizing raw gene expression 
counts and removing non-recombined and therefore non-applicable antibody gene 
segments from the annotation (Lun, Bach, and Marioni 2016), we clustered the 
remaining 159 sorted B cells using t-SNE dimensional reduction. The clusters were 
robust when the data was subsampled to 100,000 reads per cell (Supplementary Fig. 
S1.4). We then identified genes that showed significant differences between the two 
clusters. We detected 411 genes with significant changes including J-chain, LTB 
(Lymphotoxin Beta), XBP-1 (X-box binding protein 1), HSPA5 (Heat-shock protein 
family A), and MZB1 (Marginal Zone B1).  We also found genes HLA-DRA, HLA-
DRB5, and HLA-DPB1, which encode for the alpha and beta chains of the MHC II 
(Major Histocompatibility Complex II) to be differentially expressed (Supplementary 
Table S1.2). The J-chain was upregulated in cluster 2 and is involved in antibody 
secretion of IgM and IgA (Lamson and Koshland 1984) (Fig. 1.5). XBP-1, MZB1 and 
HSPA5 were upregulated within cluster 2 and are known targets of BLIMP-1. 
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BLIMP-1 and XBP-1 are known to be essential in plasmablast differentiation 
(Supplementary Fig. S1.5) (Minnich et al. 2016; Nutt et al. 2015). LTB was 
downregulated in cluster 2 and has been shown to be downregulated upon B cell 
activation (Zhu et al. 2004) (Fig. 1.5). HLA-DRA, HLA-DRB5, and HLA-DPB1 
were downregulated in cluster 2, indicating less MHC II presentation to T cells, 
which is indicative of plasma cells and plasmablasts (Calame, Lin, and Tunyaplin 
2003). Together, this suggests that cluster 2 does represent activated plasmablasts, 
which are known to secrete more antibodies and display less MHC II than the 
memory B cells represented in cluster 1. 
 
 
Figure 1.5. Clustering of CD27high CD38high B cells 
159 B cells were divided into two populations by t-SNE dimensionality reduction 
(Maaten and Hinton 2008). In the three subplots, cells are colored based on their 
expression of example genes that were significantly differentially expressed between the 
two populations as determined by a multiple hypothesis testing corrected Mann-Whitney 
U tests. The cells inside the boxed area belong to cluster 2 and all other cells belong to 
cluster 1. 
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Assembly of antibody heavy and light chain sequences from single B cell 
Tn5Prime data 
 Ideally, we would not only want to identify plasmablasts based on their gene 
expression profile, but also determine their antibody sequences. Sequencing 
antibodies has been a long-standing challenge in B cell biology and antibody 
engineering because it requires the identification of unique pairs of rearranged 
antibody heavy and light chains for each cell. Current techniques rely either on the 
targeted amplification and sequencing of antibody heavy and light chain genes 
(Wrammert et al. 2008) in single cells or on the assembly of their sequences from 
non-targeted RNA-seq data (Canzar et al. 2017). As a result, our 5’ capturing 
approach we could potentially provide antibody sequence information in addition to 
genome wide expression profiling, because the 5’ region contains the unique V(D)J 
rearrangement of heavy and light chain transcripts. 
To determine if our Tn5Prime protocol could be used for assembling antibody 
heavy and light chain sequences, we assembled whole transcriptomes using SPAdes 
(Bankevich et al. 2012). IgBLAST (Ye et al. 2013) was then used to identify 
transcripts containing V, D, and J gene segments rearranged in a productive manner. 
These transcripts were aligned on to Constant gene segments to identify isotype. The 
list of putative antibodies was then filtered for obvious cross-contamination and mis-
assemblies (see Methods). In this way, we effectively determined heavy and light 
chain sequences and identify their unique pairings within single B cells (Fig. 1.6A). 
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Of the 192 B-cells we analyzed, we were able to assemble one heavy chain 
and one light chain to 117 B-cells. Of these 117 B-cells 46 cells had a Lambda light 
chain and 71 cells had a Kappa light chain. Five additional cells had one heavy chain 
and two light chains, 35 cells had no heavy chains but at least one light chain, and 35 
cells had no heavy chains and no light chains. To determine the sequencing depth 
requirement for successful heavy and light chain assembly, subsampling was 
performed on the reads and the assembly and pairing analysis redone (Supplementary 
Fig. S1.6). We found 100,000 reads per cell was sufficient to assemble one heavy and 
one light chains for 91 of 117 B cells with successfully assembled chain pairs without 
subsampling. 
We found that 101 of the 117 cells with paired heavy and light chains also 
passed all other quality filters and were clustered by t-SNE into the putative 
plasmablast and memory B cell clusters. This combination of single cell identity and 
paired antibody sequences allowed us to perform detailed analysis of differences in 
antibody usage and characteristics between those two populations. Firstly, the 
putative plasmablast population featured less IgM antibodies than the memory B cell 
population (19% IgM in plasmablasts vs 53% in memory B cells). Secondly, using 
IgBlast (Ye et al. 2013), we found that both heavy (Fig. 1.6B) and light chain 
sequences showed significantly higher levels of somatic hypermutation in 
plasmablasts than memory B cells (Heavy chain: median 8.0% vs 3.8% somatic 
hypermutation, two-sided Monte Carlo permutation test p-value=0.0081; Light chain: 
median 4.9% vs 2.7% somatic hypermutation, two-sided Monte Carlo permutation 
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test p-value=0.0117). Thirdly, by counting and normalizing sequencing reads 
originating from antibody transcripts, we could determine and compare heavy and 
light chain expression in these two populations. Generally, light chains were 
expressed about 3-fold higher than heavy chains (Fig. 1.6C) with no significant 
difference between plasmablasts and memory B cells (two-sided Monte Carlo 
permutation test p-value=0.533). However, the percentage of all aligned sequencing 
reads that originated from antibody transcripts showed dramatic differences between 
plasmablasts and memory B cells. The median percentage of reads that originated 
from antibody transcripts was 23.5% in plasmablasts and only 2.2% in memory B 
cells (Fig. 1.6D) (Monte Carlo Permutation test two-sided p-value=0). In one 
plasmablast over 60% of all aligned sequencing reads originated from antibody 
transcripts indicating just how much of the plasmablast transcriptome can be 
dedicated to the production and secretion of antibodies. In summary, our analysis of 
antibody usage and characteristics showed that plasmablasts express more mutated 
and class-switched antibodies at much higher levels than memory B cells. 
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Figure 1.6. Assembling Antibody transcripts from Tn5Prime data 
Antibody transcripts were assembled by generating complete assembled transcriptomes 
for each cell with SPADES and then using IGBLAST to search for transcripts with 
antibody features. Antibody transcripts for each cell were filtered for mis-assemblies and 
mis-annotations. Cells were sorted by the abundance of heavy chain transcripts in their 
Tn5Prime data and V (D) and J segment information for their heavy and light chains are 
shown in the schematic in the center. The putative cell type determined by clustering with 
t-SNE is indicated on the left. Yellow: plasmablasts, Green: Memory B cells. (B-D) 
Antibody usage and characteristics were compared between plasmablasts and memory B 
cells. Somatic Hypermutation rates (B), light to heavy chain expression ratios (C) and the 
percentage of all aligned sequencing reads that originated from antibody transcripts (D) 
were compared using dot plots. Yellow: plasmablasts, Green: Memory B cells. Medians 
are shown as red lines. All p-values are calculated using two-sided Monte Carlo 
permutation test with 10000 permutations. 
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Discussion 
 Here we present a novel method for the genome-wide identification of transcription 
start sites in bulk samples and single cells. The method combines aspects of both 
Smart-seq2 and STRT. By modifying template-switch oligos used during reverse 
transcription to carry one sequencing adapter and loading the other sequencing 
adapter on the Tn5 enzyme used for cDNA fragmentation we anchor the sequence 
priming sites for read 1 of an Illumina read pair to the 5’ end of transcripts without 
the need for fragmentation, ligation, and enrichment steps. The resulting workflow is 
easy to implement and capable of generating hundreds of libraries within a day. An 
important feature of our Tn5Prime method is the option to integrate cellular indexes 
during reverse transcription and Illumina sample indexes during PCR before Tn5 
tagmentation. This allows the pooling of samples early in the workflow and thereby 
reduces experiment complexity and reagent costs. 
We validated the Tn5Prime protocol on both bulk RNA and single cells. First, 
using 5ng of total RNA from the GM12878 cell line, we yielded similar results as the 
ENCODE CAGE data with respect to the identification of transcripts start sites. 
However, the CAGE protocol used by the ENCODE consortium used several orders 
of magnitude more RNA. As the Smart-seq2 protocol is already widely used, we 
expect that the Tn5Prime assay with its similar workflow and low RNA input has the 
potential to become a valuable tool for transcriptome annotation and quantification in 
the RNA-seq toolbox. 
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In addition to the analysis of bulk samples, we show that our Tn5Prime 
method can be utilized for interrogating single cells, both human and mouse. The 
TSO-based multiplexing approach we implemented makes it possible to efficiently 
analyze thousands of cells, thereby increasing the throughput of plate based RNAseq 
library protocols in a manner that is straightforward and economical. While the 
Tn5Prime approach detects less genes than the Smart-seq2 approach, as determined 
by gene detection, this could be improved by increasing the amount of cDNA pooled 
for amplification (currently only ~60% of cDNA is used) as well as by using LNA 
bases in the Tn5Prime TSOs (Picelli, Faridani, et al. 2014), although the latter 
approach might affect 5’ specificity (Harbers et al. 2013). 
Our Tn5Prime approach interrogates the 5’ ends of transcripts, thereby 
capturing the unique sequence information of adaptive immune system receptors 
expressed on B and T cells. These receptors are often hard to assemble due to their 
unique genomic rearrangement. Our data shows that by limiting sequencing reads to 
the 5’ end of transcripts we can analyze both transcriptomes as well as paired 
antibody heavy and light sequences with the low sequencing coverage of ~100,000 
reads per cell, thereby enabling the analysis of thousands of B cells in a single 
sequencing run. This approach should, without any modification, also be applicable to 
T cells to map rearrangement of the T cell receptors. This can provide novel insights 
into the composition of B and T cell malignancies as well as the state and 
composition of the adaptive immune system with regards to solid tumors. This sets 
Tn5Prime apart from general purpose high-throughput single cell library preparation 
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methods like Drop-Seq, Seq-well, and 10X Genomics which target the 3’ end of the 
transcripts making them incapable of interrogating antibody sequences. We are 
looking forward to more published data on the recently released 10X Genomics 
Single Cell V(D)J platform which should be able to, like Tn5Prime, investigate V(D)J 
expression and gene expression in parallel. Overall, determining per cell library 
preparation cost, required sequencing depth, and cell capture rate will help establish 
ideal use-cases for either Tn5Prime or 10X methods. 
To highlight the power of our Tn5Prime approach we isolated 192 single 
human B cells from PBMCs using canonical plasmablast markers. Not only were we 
able to assemble paired antibody transcripts, but we succeeded in clustering the cells 
into two populations based on their gene expression profiles. The genes differentially 
expressed between those clustered suggested their putative cell types. Cells in the 
putative plasmablast cluster expressed more XBP-1, J-chain, HSPA5, and MZB1, 
which are all involved in either B cell activation or antibody production and secretion. 
Consistent with less antigen presentation, cells in the putative plasmablast cluster also 
expressed less MHC II transcripts including HLA-DRA, HLA-DRB5, and HLA-
DPB1. Finally, MS4A1 (CD20) is also expressed less in the cells of the putative 
plasmablast cluster and is known to be downregulated in activated B cells. Overall, 
this clearly established that we could distinguish activated, antibody secreting 
plasmablasts from resting, antigen presenting memory B-cells; cell-types which are 
difficult to distinguish using conventional FACS analysis. 
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In addition to cell-types, we showed that Tn5Prime can be used to determine 
individual B cells’ paired antibody sequences. Together, these data allowed us to 
compare antibody usage in plasmablasts and memory B cells, showing that 
plasmablast expressed higher levels of more mutated and class-switched antibodies. 
In addition to providing functional insight into cell populations, this information will 
make it possible to make informed decisions as to which antibody sequences could be 
further cloned and tested functionally for clinical, diagnostic, and research 
applications. 
         In summary, Tn5Prime is an RNAseq library construction protocol with a 
streamlined workflow that surpasses the economy and throughput of other plate-based 
protocols. While not reaching the throughput of droplet- and microwell-based 
protocols, it generates high quality data that enables the identification of transcription 
start sites and could be useful for analyzing 5’ UTR features or help improve 
incomplete genome annotations. Finally, Tn5Prime is currently the highest 
throughput library preparation method that doesn’t require proprietary 
instrumentation to comprehensively analyze the individual cells of the adaptive 
immune system by determining both paired adaptive immune receptor sequences and 
gene expression profiles. 
 
Materials and Methods 
Cell purification, RNA isolation and sorting 
GM12878: RNA from 500,000 GM12878 cells was extracted using the RNeasy kit 
(Qiagen) according to manufacturer’s instructions. 
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Murine B2 cells: Mice were maintained in the UCSC (University of California, Santa 
Cruz) vivarium according to IACUC (Institutional Animal Care and Use Committee) 
approved protocols. Single murine Ter119-CD3-CD4-CD8-B220+ IgM+CD11b- CD5- 
B2 cells were isolated from wild-type C57Bl/6 mice by peritoneal lavage and 
incubated with fluorescently-labeled antibodies prior to sorting. The following 
antibodies were used to stain B-cells: Ter119, CD3 (Biolegend; 145-2C11), CD4 
(Biolegend; GK1.5), CD8a (Biolegend; 53-6.7), B220 (Biolegend; RA3-6B2), IgM 
(Biolegend; RMM-1), CD5 (Biolegend; 53-7.3), and CD11b (Biolegend; M1/70). 
Cells were analyzed and sorted using a FACS Aria II (BD), as described(Ugarte et al. 
2015; Smith-Berdan et al. 2015; Beaudin, Boyer, and Forsberg 2014). 
Human B cells: Primary human cells were collected from the blood of a fully 
consented healthy adult in a study approved by the Institutional Review Board (IRB) 
at UCSC. For the Tn5Prime analysis, single human B cells were isolated from 
Peripheral Blood Mononuclear Cells (PBMCs) using negative selection using 
RosetteSep (StemCell). The resulting B cells were sorted for CD19+ CD27high and 
CD38high.The following antibodies were used for staining B cells: CD19 (BD 
Pharmingen; HIB19), CD27 (Biolegend; 0323), and CD38 (Biolegend; HB-7). Cells 
were sorted using FACS Aria II (BD) and analyzed using FlowJo v10.2 (FlowJo, 
TreeStar Software, Ashland, OR). For the Smart-seq2 analysis, individual PBMCs 
were sequenced and B cells for further analysis were identified based on their 
expression of antibody genes.  
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Both murine and human single cells were sorted into 96 well plates and 
directly placed into 4ul of Lysis Buffer - 0.1% Triton X-100, 0.2ul of SuperaseIn 
(Thermo), 1ul of oligodT primer (IDT), 1ul of dNTP (10mM each)(NEB) - and 
frozen at -80°C. 
 
RNA-seq library construction and sequencing 
2ul of RNA (5 ng) or Single Cell Lysate was reverse transcribed using Smartscribe 
Reverse Transcriptase (Clontech) in a 10ul reaction including either a Smart-seq2 
TSO (Smart-seq2 libraries) or a Nextera A TSO (Tn5Prime libraries) according to 
manufacturer’s instructions for 60min at 42°C (Table S1). The resulting cDNA was 
treated with 1 ul of 1:10 dilutions of RNAse A (Thermo) and Lambda Exonuclease 
(NEB) for 30min at 37°C. The treated cDNA was then amplified using KAPA Hifi 
Readymix 2x (KAPA) and incubated at 95°C for 3 mins, followed by 15 cycles 
(GM12878) or 27 cycles (single B cells) of (98°C for 20 s, 67°C for 15 s, 72°C for 4 
mins), with a final extension at 72°C for 5 mins. For our Tn5Prime method, the 
cDNA amplification requires both the ISPCR primer and a Nextera A Index primer. 
For the Smart-seq2 method, the cDNA amplification requires only the ISPCR primer 
(Table S1). The resulting PCR product was then treated with our Tn5 enzyme (Picelli, 
Björklund, et al. 2014) custom loaded with either Tn5ME-A/R and Tn5ME-B/R 
(Smart-seq2) or Tn5ME-B/R adapters only (Tn5Prime). The Tn5 reaction was 
performed using 5ul of the PCR product, 1ul of the loaded Tn5 enzyme, 10ul of H2O 
and 4ul of 5X TAPS-PEG buffer and incubated at 55°C for 5 mins. The Tn5 reaction 
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was then inactivated by the addition of 5ul of 0.2% SDS and 5ul of the product was 
then nick-translated at 72°C for 6 minutes and further amplified using KAPA Hifi 
Polymerase (KAPA) using Nextera_Primer_B and Nextera_Primer_A_Universal 
(Tn5Prime) or Nextera_Primer_A (Smart-seq2) (Table S1) with an incubation of 
98°C for 30 s, followed by 13 cycles of (98°C for 10 s, 63°C for 30 s, 72°C for 2 
mins) with a final extension at 72°C for 5 minutes. The Tn5 treated PCR product was 
then size selected using a E-gel 2% EX (Thermo) to a size range of 400-1000bp. 
GM12878 RNA Smart-seq2 and Tn5Prime libraries were sequenced on an Illumina 
HiSeq2500 2x150 run, mouse B2 cell Tn5Prime libraries were sequenced on an 
Illumina MiSeq 2x300 run, human B cell Tn5Prime libraries were sequenced on two 
Illumina HiSeq3000 2x150 run and human B cell Smart-seq2 libraries were 
sequenced on a MiSeq 2x75 run. 
  
Sequencing alignment and analysis 
Datasets generated from Smart-seq2, Tn5Prime, ENCODE CAGE (GEO accession 
GSM849368; produced by the lab of Piero Carnici at RIKEN), and ENCODE 
RNAseq (GEO accession GSM958742; produced by the lab of Barbara Wold at 
Caltech) (ENCODE Project Consortium 2012) derived from the GM12878 cell line 
were all trimmed of adapters and low quality bases using trimmomatic (v0.33) 
(Bolger, Lohse, and Usadel 2014) with a quality cutoff of Q15. Tn5Prime and Smart-
seq2 data generated from human single B cells were all trimmed of adapters 
containing low quality bases using Cutadapt (Martin 2011) and with a quality cutoff 
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of Q15. All paired reads where one or more of the reads contain a post-trimming 
length of less than 25 bp were filtered out. 
  Trimmed reads derived from the GM12878 cell line and human single B cells 
were aligned to the human genome (GRCh38) annotated with Ensembl GRCh38.78 
GTF release using STAR (v2.4) (Dobin et al. 2013). Trimmed reads derived from the 
B2 cells were aligned to the mouse genome (GRCm38) annotated with Ensembl 
GRCm38.80 GTF release using STAR (v2.4). Expression levels were quantified 
using featureCounts (v1.4.6-p1) (Liao, Smyth, and Shi 2014) and normalized by total 
read number resulting in RPM (Reads Per Million). 
  Peaks for CAGE, Tn5Prime and Smart-seq2 data were called by counting the 
number of unique fragments which began their forward read alignments (R1 for 
Tn5Prime) at each position within each chromosome and for each orientation 
(positive or negative). A peak was called at a position and orientation if at least five 
alignments begin at that position, the position one nucleotide downstream has fewer 
alignments beginning at that position, and the position one nucleotide upstream has 
fewer alignments beginning at that position. For the single cell data, peaks were 
filtered out unless they appeared in more than one cell. The distance between the 
Tn5Prime/Smart-seq2 peaks and the nearest CAGE peak was called by inserting the 
nucleotide coordinates of the CAGE peaks into kd-trees and then performing a 
nearest neighbor search on them using the Tn5Prime/Smart-seq2 peak coordinates. 
Each chromosome and orientation had its own kd-tree. 
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Antibody Assembly 
Data generated from our single human B cells were used to identify antibody 
transcripts. After assigning reads into each cell based upon their cellular index, they 
were then assembled into transcriptomes using rnaSPAdes (Bankevich et al. 2012) 
using the single-cell parameters. Putative immunoglobulin transcripts are detected 
and annotated by running IGBLAST (Ye et al. 2013) against the assembled 
transcriptome using Human V,D and J segments from the IMGT database (Lefranc et 
al. 2004). Isotypes are assigned to putative IG transcripts by aligning constant regions 
to the transcripts with BWA-MEM (H. Li 2013). 
Antibody transcripts were filtered using the following process: 
 
1. A table is generated from the SPADES/IGBLAST/BWA pipeline listing each 
putative IG transcript for each cell in which each row represents one assembled 
antibody transcript and contains information indicating which cell it came from, 
overall abundance (as determined by BWA), the CDR3 sequence and the type IGH 
(Heavy) ,IGK (Kappa) ,IGL (Light) as well as the inferred segments used during VDJ 
recombination. 
2. The transcripts are then clustered by CDR3 sequencing similarity using a single-
linkage clustering algorithm Based on the Levenshtein distance where two clusters of 
transcripts are merged when at least one transcript CDR3 has a Levenshtein distance 
of 2 or less with the CDR3 of any transcript in another cluster. 
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3. Transcripts belonging to the same cluster are merged so that highly similar 
transcripts belonging to the same cell are combined and their transcript counts are 
added together. This is done to correct for spurious alternative assemblies produced 
by SPADES within each cell's assembled transcriptome. 
4. A list is then generated for each transcript of the cells in which they appear. The 
lists are then sorted by the transcript abundance within each cell. 
6. Each entry in the list are marked by its relative abundance. If the number of reads 
aligned to the transcript in a cell is less than 10% of the largest number of reads 
aligned to that transcript within any cell, it is marked as being a potential 
contaminant. 
7. For each type of immunoglobulin transcript (i.e. IGH,IGK,IGL) found within each 
cell, the largest unique (non-contaminant) transcript (i.e. only found in that cell) is 
chosen. If a unique transcript cannot be found, then the most highly expressed 
immunoglobulin transcript is selected. 
8. If both a IGK and IGL are present within a cell, the unique transcript is selected. If 
both are unique or non-unique then the most highly expressed transcript is selected 
unless either transcript has an abundance of at least 10% of the other. 
9. After this elimination process, most cells should have a single heavy chain and 
light chain. 
 
Visualization 
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All data visualization was done using Python/Numpy/Scipy/Matplotlib(Hunter 2007; 
Oliphant 2007; van der Walt, Colbert, and Varoquaux 2011; Jones, Oliphant, and 
Peterson 2001--). Schematics were drawn in Inkscape (https://inkscape.org/en/).  
 
Data and Script Access 
Raw data has been uploaded to the Sequence Read Archive (SRA) and processed 
gene expression counts are available as supplementary tables S3 (GM12878 Smart-
seq2 and Tn5Prime), S4 (Mouse B2 Cells), S5 (Human CD27high CD38high 
Tn5Prime), and S6 (Human B cells Smart-seq2). Bioproject accession for the SRA 
are as follows: PRJNA320873 (GM12878 Smart-seq2 and Tn5Prime), PRJNA320902 
(Mouse B2 Cells), and PRJNA415475 (Human CD27high CD38high Tn5Prime) and 
PRJNA433736 (Human B cells Smart-seq2). A UCSC genome browser track is 
available at 
https://genome.ucsc.edu/cgi-
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=chkcole&hgS_other
UserSessionName=TN5_Prime_Alignments 
The Tn5Prime/Smart-seq2, and CAGE Peak Caller and peak distance calculator are 
available at https://github.com/chkcole/Peak-Calling. All other Scripts are available 
upon request. 
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Supplemental  
 
 
 
Fig S1.1. Tn5Prime detects B cell specific genes in single B2 cells.  
A.) Genes are sorted by the number of B2 cells their transcripts are detected in. Each row 
represents a gene with its name given on one side. Each column represents are cell. A 
grey box indicates that gene’s transcript was detected in the respective cell. MHC 
transcripts are bold. B cell markers in red  
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Fig. S1.2. FACS gating strategy for the isolation of CD27high CD38high human B 
cells  
Fluorescence-activated-cell-sorting (FACS) profile of human CD27high and CD38high B 
cell population. Purified B cells were isolated from PBMCs using a human B cell 
enrichment method, RosetteSep. Single B cell suspensions were made and stained with 
anti-CD19-FITC, anti-CD27-BV421 and anti-CD38-PE-A and analyzed using FLOWJO 
v10.2. Doublets were excluded by SSC-W x SSC-H and FSC-W x FSC-H. Dead cells 
were excluded using Propidium Iodide staining, only cells which were PI- were kept for 
analysis. 
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Fig S1.3. Quality Metrics Determined By Alignment Percentage and Read 
number 
A scatter plot of the library size of 192 single CD27+ CD38+ B cells versus their percent 
alignment. Cells outside more than three median absolute deviations from the median for 
percent alignment, Mitochondrial transcript percentage, or number of detected genes 
were marked as outliers and eliminated prior to normalization of transcript counts.   
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Fig. S1.4. tSNE on subsampled data 
In order to test the robustness of the embedding, sampling was performed on each cell’s 
data to a uniform level of depth and t-SNE performed. The embedding was plotted, and 
cells were colored by the abundance of J-chain. These results indicate that discrimination 
between the two populations can still be achieved at 100,000 reads, one tenth of the 
average sequencing depth achieved for each cell. 
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Fig. S1.5. Clustering of CD27+ CD38+ B cells 
Cells were plotted in two dimensions using t-SNE based on their normalized transcript 
counts and colored by the normalized transcript counts of several genes of interest.  
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Fig S1.6. Heavy and Chain Pairings Determined by Read Depth 
Reads were subsampled in increments of: 1000, 10000, 50000, 100000, 500000 and 
1000000 reads per cell to determine read depth necessary for assigning proper heavy and 
light chain transcripts together. Plot shows on the x-axis reads subsampled per cell and y-
axis shows number of light/heavy chain pairs assembled.  
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RT 
 
Primer 
 
Oligo-dT-smartseq2 /5Me-
isodC/AAGCAGTGGTATCAACGCAGAGTACTTTTTTTTTTTTTTTTTTTTTTTTTTTT
TTVN 
 
TSOs - Tn5Prime 
      
GM12878 
TSO_Nextera_Index1 TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG 
GCCTAAGCCATC rGrGrG  
B2 cells 
TSO_Nextera_Index2 TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG GATCTG 
rGrGrG 
Human CD27high;CD38high 
TSO1_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG rUGA 
ArU rUC TGGTrGrGrG 
TSO2_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG ACrU CrU 
GrU TGGTrGrGrG 
TSO3_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG CrUC rUG 
rUA TGGTrGrGrG 
TSO4_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG rUAG 
rUA CrU TGGTrGrGrG 
TSO5_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG GGrU CrU 
rUG TGGTrGrGrG 
TSO6_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG ArUA 
GrU ArU TGGTrGrGrG 
TSO7_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG rUCC rUA 
rUC TGGTrGrGrG 
TSO8_Nextera  TCGTCGGCAGCGTCAGATGTGTATAAGAGArCAG CArU rUC 
GrU TGGTrGrGrG 
 
TSO - Smartseq2 
 
TSO_Smartseq2  AAGCAGTGGTATCAACGCAGAGTACATrGrGrG 
 
Primers for amplifying cDNA 
 
ISPCR   AAGCAGTGGTATCAACGCAGAGT 
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Nextera_Primer_A AATGATACGGCGACCACCGAGATCTACAC [8bp i5 index] 
TCGTCGGCAGCGTCAGATG 
 
*Tn5 Oligos 
 
Tn5ME-R   [phos]CTGTCTCTTATACACATCT 
Tn5ME-A   TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 
Tn5ME-B   GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG 
 
Primers for amplifying Tn5 Product 
 
Nextera_Primer_B  CAAGCAGAAGACGGCATACGAGAT [8bp i7 index] 
GTCTCGTGGGCTCGGAGATGTGTAT 
Nextera_Primer_A_Universal AATGATACGGCGACCACCGAGATCTACAC 
 
*Note: Tn5ME-A primer is used for SmartSeq2 protocol. 
 
Table S1.1 Oligos used in the Tn5 Prime Manuscript 
All oligos are shown 5’->3’ and were ordered from Integrated DNA Technologies (IDT).  
Lower case ‘r’ indicates RNA bases. Spaces in sequences are for visual emphasis only. 
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Nanopore Long-Read RNAseq Reveals 
Widespread Transcriptional Variation Among the 
Surface Receptors of Individual B cells 
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Abstract 
 
Understanding of gene regulation and function requires a genome-wide method 
capable of capturing both gene expression levels and isoform diversity at the single 
cell level. Short-read RNAseq, while the current standard for gene expression 
quantification, is limited in its ability to resolve complex isoforms because it cannot 
sequence full-length cDNA copies of RNA molecules. Here, we investigated whether 
full-length RNAseq can be accomplished using the long-read single-molecule Oxford 
Nanopore MinION sequencing technology (full-length cDNA RNAseq) would be 
able to identify and quantify complex isoforms without sacrificing accurate gene 
expression quantification. After successfully benchmarking our experimental and 
computational approaches on a mixture of synthetic transcripts, we analyzed 
individual murine B1a cells using a new cellular indexing strategy. Using our 
computational approaches, we identified thousands of novel, unannotated 
transcription start and end sites, as well as hundreds of alternative splicing events in 
these B1a cells. We also identified hundreds of genes expressed across the B1a cells 
that displayed multiple complex isoforms, including several B cell specific surface 
receptors and the antibody heavy chain (IGH) locus. Our results show that not only 
can we identify complex isoforms, but also quantify their expression, at the single cell 
level. 
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Introduction 
Over the last decade, RNAseq has vastly increased our knowledge of eukaryotic gene 
expression and the unique transcript isoform signatures that differentiate 
developmental stages, organs, and single cells (A. R. Wu et al. 2014; Treutlein, 
Brownfield, et al. 2014; Shalek et al. 2013; Welch, Hu, and Prins 2016). Proteins that 
arise from transcript isoforms of a single gene can vary in their biological properties 
including stability, intracellular localization, enzymatic activity, and post-translational 
modifications (Stamm et al. 2005). Transcript isoforms are the product of alternative 
transcription start sites (TSSs), transcription end sites (TESs), and alternative splicing 
events that include alternative splice sites, intron retention, and exon skipping (Sugnet 
et al. 2004). It has been predicted that a large fraction of human genes are 
alternatively spliced (Modrek and Lee 2002; E. T. Wang et al. 2008). Although 
alternative splicing enables increased transcriptome diversity, aberrations in splicing 
have been implicated in several human diseases, including cancer. In fact, it has been 
observed that 15% of point mutations are associated with splicing defects, resulting in 
human genetic disorders (Krawczak, Reiss, and Cooper 1992) and somatic mutations 
within 12 different cancer types (Brooks et al. 2014). 
Consequently, it is important to determine the true transcriptional diversity of 
cells. This requires that gene expression is analyzed not only at the gene-level but 
also at the isoform-level. However, current short-read RNAseq methods are 
inherently limited in their ability to identify complex transcript isoforms, as they 
cannot sequence full-length transcripts. Instead, transcripts are fragmented for 
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sequencing, resulting in short individual reads that fail to span the entirety of the 
transcript. Computational tools can be used to assemble full-length transcripts from 
these reads, but different assembly algorithms can result in conflicting outcomes and 
varying overall assembly quality (Salzberg et al. 2012).  
To offset this limitation of short-read RNAseq, studies have successfully used 
both single-molecule long-read PacBio and synthetic long-read MOLECULO 
methodologies (Tilgner et al. 2015; Sharon et al. 2013; Treutlein, Gokce, et al. 2014; 
Vollmers et al. 2015) to sequence full-length cDNA. However, PacBio technology 
has a strong bias toward shorter fragments necessitating the separation of cDNA by 
length before library preparation, which complicates sample preparation and analysis 
(Bulletin, n.d.). Furthermore, MOLECULO  depends on the assembly of short 
Illumina reads that suffer from the biases inherent in Illumina data and relies on the 
separation of individual transcript molecules into distinct wells. This complicates 
quantification as well as the analysis of highly abundant or similar isoforms. 
Recently, the Oxford Nanopore Technologies (ONT) MinION has been used to 
analyze  full-length cDNA samples derived from both defined synthetic RNA 
molecules as well as RNA from tissue culture cells (Oikonomopoulos et al. 2016).  
With the exception of a single study using single cell RNA-seq to focus its 
analysis on a single gene locus using PacBio technology (Macaulay et al. 2015), these 
long-read technologies have been used exclusively to evaluate transcriptome diversity 
across bulk cell populations. However, recent studies have highlighted that cells 
found within seemingly homogeneous populations can differ in gene expression (Graf 
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and Stadtfeld 2008),(Irish, Kotecha, and Nolan 2006),(Warren et al. 2006). 
Understanding heterogeneity within cell populations has shown promise across 
multiple disciplines including developmental biology, neurobiology, cancer and 
immunology. Single cell approaches can help illuminate biological questions 
regarding cell function, development and dysfunction. Knowing the exact state of the 
cell can help determine its fate or reflect changes with response to stimuli or drug 
treatment, as well as its ability to neutralize a pathogen, respectively. Cell-to-cell 
heterogeneity (Shalek et al. 2013) makes immune cells a fascinating target for in-
depth analysis of transcriptional diversity. Current approaches that measure RNA 
transcripts within single cells rely on short-read RNA-seq, single molecule RNA-
fluorescence in-situ Hybridization (SM-RNA FISH), or single-cell RT-qPCR 
(Cornelison and Wold 1997; Raj et al. 2008),(Tang, Lao, and Surani 2011; Femino et 
al. 1998). These current methods can either be applied to a few genes or are under the 
same constraints of short-read RNA-seq, which we described earlier. Ultimately, 
these approaches are unable to identify and quantify complex isoforms on a 
transcriptome-wide level.  
To make it possible to identify and quantify complex isoforms on a 
transcriptome-wide single cell level, we have developed a nanopore sequencing 
approach for the analysis of full-length cDNA in single cells. The Oxford Nanopore 
Technologies (ONT) MinION sequencer is a portable device that is based on single 
molecule sequencing technology that provides reads of unprecedented length by 
performing voltage driven molecule translocations through small nanosensors (Cherf 
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et al. 2012). Although the MinION platform has been most useful for interrogating 
viral and bacterial genomes, recently it has been applied for analyzing cDNA in both 
targeted as well as genome-wide approaches (Hargreaves and Mulley 2015; Kilianski 
et al. 2015; Jain et al. 2015; Bolisetty, Rajadinakaran, and Graveley 2015; 
Oikonomopoulos et al. 2016). Taking advantage of its unprecedented read length, we 
wanted to interrogate single-cell transcriptomes of mouse B1a cells by sequencing 
full-length cDNA molecules using the ONT MinION sequencer.  
We implemented an integrated informatics pipeline for gene-level and 
transcript isoform-level expression quantification to overcome the sequencing 
accuracy limitations of the ONT MinION. To identify transcript isoforms, this 
pipeline predicted  transcription start and end sites, as well as splice sites and their 
alternative usage. After benchmarking the ONT RNAseq approach on a complex 
mixture of synthetic transcripts, we sequenced seven individual mouse B1a cells and 
showed that we could accurately quantify gene expression and identify and quantify 
novel isoforms at the single-cell level. Our analysis identified differential usage of 
complex isoforms in over a hundred genes including several surface molecules like 
CD19, CD20, and IGH, the very receptors defining B cell identity. 
 
Results 
Generating and Sequencing Single-Cell RNAseq Libraries 
We first investigated the ability of the ONT MinION platform to interrogate 
transcriptomes at the single-cell level. To test this, we used our ONT RNAseq 
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approach to analyze seven individual mouse B1a cells (Beaudin et al. 2016; Beaudin 
and Forsberg 2016) and compared it with the standard Illumina RNAseq approach . 
To this end, we FACS-sorted single B1a cells into individual wells containing lysis 
buffer and amplified cDNA from each individual cell using the Smartseq2 protocol 
with  modifications (see Methods, Supplementary Table S2.1) (Picelli et al. 2013). 
The cDNA generated by the Smartseq2 protocol was split and processed in-parallel 
using the Illumina and ONT library preparation protocols. Sequencing the fragmented 
cDNA of the seven cells on the HiSeq2500, we generated between 73,086-351,876 
150bp  Illumina reads per cell. Sequencing the full-length cDNA of the first three 
cells on individual ONT MinION flow cells using the R7.3 chemistry generated 
between 17,749-52,696 ONT 2D reads per cell (Supplementary Table S2.2). Taking 
advantage of the improved MinION throughput using the R9.4 chemistry, we 
multiplexed the full-length cDNA of the other four cells on a single MinION flow cell 
and generated between 57,874-128,726 ONT 2D reads per cell. To enable this 
multiplexing, we introduced custom 60 nucleotide cellular indexes during PCR 
amplification (see Methods, Supplementary Table S2.1, Fig. 2.1a). 
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Figure 2.1: Experimental Design and Oxford Nanopore Sequencing read 
characteristics. 
a) Schematic of experimental design. FACS-sorted single B1a cells were lysed. PolyA-
RNA was then reverse transcribed, and PCR amplified using template switching. Full-
length cDNA was split into two reactions. Half of the reaction was tagmented by Tn5 and 
sequenced using a Illumina HiSeq2500 sequencer. The other half of the reaction was 
ligated to ONT adapters and sequenced on an ONT MinION sequencer. b) Schematic of 
the computational pipeline for ONT 2D read data. 
 
Comparison of Gene Expression Quantification 
To assess whether ONT RNAseq is capable of quantifying gene expression, we 
compared RNAseq data produced with ONT and Illumina, the current benchmark for 
gene expression quantification. Because standard gene quantification tools (e.g. 
STAR (Dobin et al. 2013), Cufflinks (Trapnell et al. 2010)) are not compatible with 
nanopore reads, we aligned the ONT 2D reads using BLAT (Kent 2002) and 
quantified gene expression using our own algorithm. This algorithm determines how 
many reads overlap with the exons of a gene to produce a Reads Per Gene per 10K 
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reads (RPG10K) value. As ONT 2D reads are long enough to span the full-length of 
the transcripts, normalization for gene length was not performed (Fig. 2.1b). 
Comparing Illumina and ONT RNAseq gene expression quantification for the same 
cell showed high correlation (Pearson r ≥ 0.84-0.89 for R7.3 and 0.9-0.92 for R9.4), 
confirming that our ONT RNAseq approach recapitulates Illumina gene expression 
quantification (Fig. 2.2). Comparing Illumina and ONT RNAseq gene expression 
quantification across different cells showed low correlation with a Pearson r < 0.45, 
suggesting that ONT RNAseq can identify cell-to-cell variability (A. R. Wu et al. 
2014; Macosko et al. 2015) (Fig. 2.2).   
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Figure 2.2: ONT RNAseq recapitulates Illumina RNAseq gene expression 
quantification. 
Scatter plot grid at the center of the figure shows gene expression levels for each  
gene as determined by Illumina RNAseq and ONT RNAseq for the indicated cells. 
Correlations of transcript expression levels are given as reads per gene per 10,000 reads 
(RPG10K) across 7 single cells. Pearson r is given for each cell per sequencing method 
combination with each point representing transcript expression level (x-axes =Illumina 
and y-axes=ONT). Same cell comparison have a blue border. ONT sequencing chemistry 
is shown on the right. Histograms found on the left and top of the figure represent 
number of genes found binned by their expression levels. 
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These results show that even with the relative low number of reads produced, ONT 
RNAseq gene-expression quantification largely detects the same genes as Illumina 
RNAseq (Fig. 2.3a). Furthermore, subsampling ONT and Illumina raw reads showed 
that, for five of the seven cells analyzed, the detection of expressed genes had reached 
saturation (Supplementary Fig. 2.2). Unsurprisingly, genes that were detected by 
either ONT or Illumina RNAseq alone were expressed at lower levels, indicating that 
these genes were expressed at levels close to the detection limits of both technologies 
(Fig. 2.3b). We also observed that the genes detected by ONT RNAseq alone were 
comprised of smaller transcripts (Fig. 2.3c). Additionally, genes that were < 600 bp in 
length and were detected by both ONT and Illumina RNAseq had relatively lower 
expression levels in Illumina RNAseq data (Fig. 2.3d). While this is consistent with 
smaller transcripts being strongly selected against in the Tn5 based Illumina library 
prep, we couldn’t exclude that ONT RNAseq might have a bias towards shorter 
transcripts. To exclude this possibility, we chose to analyze a mix of synthetic 
transcripts. 
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Figure 2.3: Quantifying gene and transcript expression with ONT RNAseq data 
a) Stack barplots showing number of genes detected by each cell corresponding to 
different sequencing technologies (Ill - Illumina, ONT - Oxford Nanopore). b) Median 
expression levels of genes detected by both or individual technologies. Two expression 
levels (Ill and ONT) are given for genes detected in both technologies. c) Gene length of 
genes detected by both or individual technologies. d) Ratio of gene expression levels for 
genes detected by both technologies. Ratios are binned according to gene length and 
shown as boxplots with whiskers indicating 10th and 90th percentiles. e) SIRV transcript 
levels of Replicate 1 (Rep1: 100fg SIRV pool E2) as measured with ONT RNAseq. 
Transcripts are binned by their starting molecule numbers. f) SIRV transcript levels of 
Replicate 1 are plotted against transcript length with colors corresponding to groups in e). 
g)  Scatter plot showing correlation of SIRV transcript expression levels of Replicate 1 
(Rep1: 100fg SIRV pool E2) and Replicate 2 (Rep2: 100fg SIRV pool E2) , both 
measured by ONT RNAseq. r-value shown is Pearson-r. 
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Analysis of synthetic transcript mixtures 
To test whether transcript length had an effect on expression levels as measured by 
ONT RNAseq, we sequenced synthetic Spike-in RNA Variant Control Mixes (SIRVs, 
Lexogen) of known length, structure and sequence. SIRV transcripts provided in the 
E2 mix contained 69 transcripts ranging from 191-2528 nt. In the E2 mix 69 
transcripts were present in four groups of varying concentrations containing 19, 21, 
17 and 12 transcripts in each group, respectively. To test a wide range of possible 
transcript levels, we amplified (sub-) single cell amounts  (i.e. 10fg and 100fg) of the 
Lexogen SIRV E2 mix in duplicate. This reflected a wide range of possible transcript 
levels with 8-10,240 molecules of individual SIRV transcripts present before the 
amplification step. 
We quantified the 69 transcripts by aligning the resulting 5367-17915 2D 
ONT reads directly to the spliced SIRV transcriptome using BLAT and then counting 
and normalizing the matched ONT 2D reads for each transcript. As expected, when 
amplifying (sub-) single cell amounts of RNA, we observed transcript drop-out in the 
lower concentration groups and found that transcript quantification showed variations 
within each concentration group (Fig. 2.3e, Supplementary Fig. 2.3a). Most 
importantly, however, quantification was not affected by transcript length, with the 
exception that transcripts shorter than 500 bp were underrepresented or missed 
entirely (Fig. 2.3f). Generally, ONT RNAseq quantification agreed with the nominal 
concentration of the spike-in transcripts and, interestingly, the intra-group variations 
in transcript quantification were reproducible between replicates (Fig. 2.3g). This 
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intra-group variation might be due to variation in initial transcript levels, systematic 
amplification bias, or data analysis bias. Overall, the observed underrepresentation of 
short transcripts in ONT RNAseq and the differences between Illumina and ONT 
RNAseq quantification are consistent with cDNA molecules below 500 bp in length 
being selected against during cDNA synthesis and again during the Illumina library 
preparation using the Tn5 method. Ultimately, analyzing these synthetic transcripts at 
different concentrations allowed us to exclude the possibility that ONT RNAseq 
favors shorter transcripts. 
 Next, we wanted to test whether, in addition to largely unbiased 
quantification of SIRV transcripts 500-2,500 bp in length, ONT RNAseq reads cover 
transcripts in their entirety which would make them uniquely suitable to identify and 
quantify complex isoforms.  
 
Genome annotation and isoform identification with SIRV ONT RNAseq data 
The 69 synthetic SIRV transcripts are derived from 7 artificial gene loci that have 
been modeled after human genes with high isoform diversity, making them suitable 
for testing ONT RNAseq’s capability to capture isoform diversity in a genome 
annotation independent manner. To this end, we developed algorithms to analyze 
ONT RNAseq 2D read data to annotate the SIRV gene loci, which in turn could be 
utilized to further identify and quantify SIRV isoforms. First, we used read 
alignments to annotate Transcription Start Sites (TSS) and Transcription End Sites 
(TES), as well as splice sites (SS) of SIRV transcripts in the SIRV gene loci. The 
	 87	
annotation of TSS and TES was accomplished by end to end coverage of the entire 
RNA transcript by complete ONT 2D reads (i.e. reads for which both ISPCR adapters 
could be identified and trimmed, Supplementary Table 2.2) (Fig. 2.4a-c). Complete 
ONT 2D reads contained information regarding both TSS, TES in their read 
alignments. 
After combining and aligning ONT 2D reads of all replicates to the artificial 
SIRV genomic loci (Fig. 2.4c, Supplementary Figure S2.4), we categorized 20 bp 
bins containing TSS, TESs and splice sites using custom algorithms (see Methods). 
To avoid the detection of spurious TSS and TES by prematurely terminated read 
alignments, we required TSS/TES to be at least 60 bp apart. In this manner, we 
detected 20 TSS and 24 TES that all directly overlapped with an actual TSS and TES 
and were within 60 bp of 38 (of 57) actual TSSs and 41 (of 59) actual TESs present in 
the SIRV transcript annotation. Furthermore, we detected 76 (of 89) 5’ splice sites 
and 73 (of 93) 3’ splice sites present in the SIRV genome annotation. By analyzing 
the actual splicing pattern of ONT 2D reads we detected 11 (of 12) alternative 3’ 
splice site combinations and 12 (of 14) alternative 5’ splice site combinations as well 
as 12 (of 12) intron retention events present in the SIRV transcripts. 
ONT 2D reads were then sorted into isoform groups based on their TSS/TES 
and alternative splice site usage. We generated consensus sequences of these groups 
using POA (Lee, Grasso, and Sharlow 2002) (Partial Ordered Alignment) and 
compared these consensus sequences to SIRV transcript sequences using BLAT. All 
of the 33 consensus sequences we generated matched a SIRV transcript with between 
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97.8% and 100% identity (BLAT identity score) and in all cases matched its 
directionality. Of the resulting 33 consensus sequences, 26 matched one of the 29 
SIRV transcripts present in the two highest abundance groups (Fig. 2.4c,d , 
Supplementary Fig. 2.4). The other 7 consensus sequences matched one of the 40 
SIRV transcripts in the two low abundance groups. While this approach did not 
succeed in consistently identifying lower abundance isoforms, the consensus isoform 
sequences detected were very accurate. We also observed high correlation between 
quantification determined by sorting the reads into their isoform groups and  
quantification derived from directly aligning reads to the transcriptome (Fig. 2.4e) 
This means that in addition to identifying sequence, structure, and directionality of 
complex isoforms, we can also accurately quantify them in a genome annotation 
independent manner. As a result, we were encouraged to apply this pipeline to our 
single cell data. 
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Figure 2.4: Identifying and quantifying isoforms in SIRV E2 mixture 
a) Scatter plot shows correlation between ONT 2D reads and SIRV transcripts they align 
to. Pearson r is shown. Coloring same as Figure 3e-g b) Distance between read alignment 
ends and transcript ends are shown as heatmap, color indicating the normalized alignment 
numbers. 90% of read alignments terminated outside the red lines  c-d) Genome Browser 
view of SIRV3(c) and SIRV6(d) gene loci. Top box contains transcript annotations, 
second and third box contain TSS (Teal) /TES (Purple) and splice sites (5’SS: yellow, 
3’SS: blue) locations predicted from the read data. Black lines and grey areas in box 3 
indicate alternative splicing and intron retention events predicted from read data. Box 4 
contains read alignments of isoform consensus reads. Box 5 contains ONT 2D read 
alignments. Directionality of ONT 2D reads are indicated by color (Teal: 5’ to 3’, Purple: 
3’ to 5’). e.) Scatter plot shows correlation between SIRV transcript quantification by 
aligning to annotated transcripts or annotation-free isoform grouping. Pearson r is shown. 
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Identification of Transcription Start and End Sites used in individual B1a cells 
By analyzing the ONT 2D reads generated from the seven B1a cells we sequenced, 
we detected 4234 TSSs and 3883 TESs with only 2476 TSSs and 2448 TESs 
overlapping with the TSSs or TESs present in the Gencode annotation (vM10) 
(Stanke et al. 2004; Mudge and Harrow 2015) of the mouse genome (Fig. 2.5a). To 
determine whether the unannotated TSS and TES we detected were artifacts of our 
experimental and computational pipelines, we determined their Fantom5 (FANTOM 
Consortium and the RIKEN PMI and CLST (DGT) et al. 2014) CAGE peak and 
polyA signal enrichment. Fantom5 CAGE peaks are derived from capturing and 
sequencing the 5’ end of transcripts and should therefore be enriched in TSSs. Indeed, 
we found that in contrast to TESs (49/3883 or 1.3%), a high percentage of both 
annotated (2356/2476 or 95%) and unannotated (1052/1799 or 58%) TSSs overlapped 
with high scoring Fantom5 CAGE peaks (Fig. 2.5b). Conversely, both annotated and 
unannotated TESs were highly enriched for polyA signals, while TSSs were not (Fig. 
2.5c). When we assigned the detected TSSs and TESs to annotated genes, we found 
that most genes contained exactly one TSS and one TES, as expected. However, 696 
genes contained more than one TSS or TES indicating the presence of more than one 
isoform (Fig. 2.5d). Overall, this suggested that we successfully identified thousands 
of unannotated TSSs and TESs and hundreds of genes with differential TSS/TES 
usage by analysing individual cells.  
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Figure 2.5: Analysis of ONT RNAseq data identifies isoform features in mouse 
B1A cells  
a) TSSs and TESs predicted based on read data were separated into sites with or without 
GENCODE vM10 annotation matches. b-c) TSSs/TESs with or without GENCODE 
matches were tested for FANTOM5 CAGE area enrichment (b) and polyA signals (c). d) 
Overlap of TSSs and TESs with genes. Genes were sorted according to the number of 
TSSs and TESs they overlapped with. e) Predicted base composition at 5’ and 3’ SS 
based on read data is shown as sequences logos. f) Schematic for detection and 
corresponding number of detected alternative splice site combinations. g-i) Genome 
Browser view of CD19, CD20, and IGH gene loci as shown  in Figure 4. ONT 2D reads 
and consensus sequence alignments are shown for the indicated cells. Splice sites for the 
highly repetitive IGH locus were not considered for isoform grouping due to the 
difficulty of aligning reads unambiguously. 
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Identification of Alternative Splicing Events used in individual B1a cells 
In addition to TSSs and TESs, we identified a total of 24,887 5’ splice sites and 
24,756 3’ splice sites. The vast majority of these splice sites were supported by the 
GENCODE annotation or splice junctions found in Illumina reads. Of the 24,887 
5’SS and 24,756 3’SS we identified, 24,298 (97.6%) and 24,220 (97.8%) matched 
GENCODE annotation, respectively. Of the 589 5’SS and 536 3’SS that did not 
match GENCODE annotation, 250 (42.4%) and 216 (40.2%) were supported by 
splice junctions in Illumina reads, respectively. Even if all splice sites that were not 
supported by GENCODE annotation or Illumina reads were false, which is unlikely, 
the false discovery rate of our approach would only be 1.3% (659/49,643). 
Furthermore, while we defined our splice sites as 20 bp bins, we were relatively 
successful in defining the exact splice site as shown by the base context of the 
determined splice sites (Fig. 2.5e). By determining alternative splice sites, we found 
296 intron retention events, 134 alternative 5’ splice sites and 173 alternative 3’ splice 
site combinations. The majority of these events were also observed in Illumina read 
data, which supported 216 (of 296) intron retention events, 99 (of 134) alternative 5’ 
splice sites, 123 (of 173) alternative 3’ splice sites and 72 (of 92) exon skipping 
events (Fig.2.5f). Alternative events not supported by Illumina read data had 
significantly lower ONT 2D read counts than those that were supported 
(Supplementary Table S2.3), indicating they might be closer to the detection limits of 
both technologies. 
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Identification of Complex Isoforms 
Having established that ONT RNAseq can be used to identify isoform features like 
TSSs and TESs as well as alternative splicing events, we aimed to identify complex 
isoforms. We defined genes as expressing complex isoforms if they contained 
alternative TSS/TES as well as alternative splice sites. We identified 169 genes that 
expressed complex isoforms. By identifying and quantifying all isoforms we detected 
of these 169 genes, we found highly significant differential isoform usage between 
cells in 55 of the genes (Chi2-contigency test, alpha=0.001, holm-sidak multiple-
testing correction). These genes with significant differential isoform usage included B 
cell specific surface receptors CD19 and CD20, the antibody heavy chain locus (IGH) 
(Fig. 2.5g,h,i), CD37 (Fig. 2.6), as well as CD2 and CD79b, and CD45 
(Supplementary Fig. 2.5). We created consensus sequences of the isoforms at these 
gene loci in each B1a cell and found that across the individual B1a cells, isoforms 
derived from CD19 showed a combination of alternative TSSs and intron retention 
events. Isoforms derived from CD20, on the other hand, showed a combination of 
alternative TESs, as well as an exon skipping event including a previously 
unannotated exon. The IGH locus was even more complex, with canonical isoforms 
containing VDJ recombinations and the IGHM constant region exons. In addition, we 
observed isoforms containing the IGHM constant region exon but originating from 1.) 
abortive DJ recombinations 2.) I-exon 3.) miRNA loci in the IGHM Switch-region, 
and 4.) a J-segment. Finally, one isoform in cell 1 originated from the IGHM I-exon 
but contained the IGHD constant region exons. While IGH isoform diversity has been 
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previously observed and has been known for a long time to be involved in class-
switching (K. B. Islam et al. 1994), the ability of ONT RNAseq to sequence full-
length cDNA at the single cell level truly highlights and confirms the exceptional 
transcriptional diversity of the IGH locus. 
The ability to sequence entire cDNA molecules from end to end presents an 
advantage over assembling transcript isoform using Illumina data. While assembling 
Illumina data using Trinity (Grabherr et al. 2011) is likely to succeed if a gene locus 
only expresses a single isoform, it appears to struggle with analyzing multiple 
isoforms of a gene locus that contain multiple distant alternative features. For 
example, ONT RNAseq identified several distinct isoforms of the CD37 gene across 
the individual cells analyzed. In most cases, when we assembled the Illumina data 
from individual cells, Trinity was either unable to form complete contigs or produced 
contigs that were shown by ONT RNAseq to be misassembled (Fig. 2.6). The CD37 
gene and its isoforms therefore highlight the strength of the ONT RNAseq approach 
to identify the diversity of complex isoforms beyond what is possible with either bulk 
or short reads technologies. 
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Figure 2.6: Uncovering isoform diversity in B cell surface receptors 
Genome Browser view of the CD37. 
In addition to isoform consensus derived from ONT 2D reads, contigs assembled  
from Illumina data using Trinity are shown in grey for the indicated cells. 
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Discussion 
The data we present here shows that RNAseq studies using the Oxford Nanopore 
Technologies MinION sequencer have the potential to redefine the level of 
information gathered by a single RNAseq experiment.  
By benchmarking our experimental and computational pipelines on ONT 
MinION data derived from a mix of synthetic transcripts, we showed that our 
approach identifies the location of transcription start and end sites as well as splice 
sites in a genome. Furthermore, we have shown that these experimentally determined 
annotations can then be used to identify and quantify complex isoforms longer than 
~500 bp in an otherwise largely transcript length independent manner. It is likely that 
if we use less stringent size selection methodologies during library preparation, we 
could capture transcripts < 500 bp as well. Although we were only able to 
consistently identify the SIRV transcripts found among the high abundance groups, 
we expect that the less abundant transcripts could be identified using our pipeline by 
increasing the sequencing depth. Variation in the quantification of transcripts in the 
SIRV mix indicated that quantification might be improved by using Unique 
Molecular Identifiers (UMI) (S. Islam et al. 2014) during cDNA amplification. 
However, UMI length would have to be at least >30bp to be resolved unambiguously 
with the current error-rate of the ONT MinION. Introducing random nucleotides of 
this length during priming is likely to create short, unwanted PCR artifacts which 
would greatly increase the noise of the amplification reaction. Ultimately, until ONT 
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sequencing accuracy improves, the Smart-seq approach employed in this study is 
currently the best choice for UMI free library generation, as it has been shown by a 
comparison study to generate the smallest amount of PCR duplicates and the highest 
transcriptome coverage when comparing low input methodologies (Bhargava et al. 
2014). 
By focusing on single cells transcriptomes, we demonstrated the capability of 
sequencing read output and accuracy of ONT MinION sequencer.  We showed that 
ONT RNAseq can not only quantify known genes with a high correlation to Illumina 
RNAseq but also annotate transcript features, thereby allowing us to identify and 
quantify complex, never before observed, isoforms. Using ONT RNAseq on only 
seven B1a cells, we identified thousands of unannotated transcription start and end 
sites which we then validated using FANTOM5 CAGE data and polyA signals, 
respectively. Furthermore, we identified 696 genes displaying alternative 
transcription start and end site usage, and 354 genes with alternative splicing events. 
Although not all alternative splicing events we detected were supported by single cell 
Illumina data, the events that weren’t supported were of significantly lower coverage, 
indicating they might be closer to the detection limits in either technology 
(Supplementary Table 2.3). Combined with the relatively low Illumina sequencing 
depth per cell in our study, this suggests that larger Illumina depth might aid in the 
validation of individual events in future studies.  
In addition to the identification of individual alternative events, the read 
length of the ONT MinION sequencer paired with our analysis pipeline enabled us to 
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identify 169 genes expressing complex isoforms containing both alternative TSS/TES 
and splice sites. Interestingly, among the genes expressing these complex isoforms 
were surface receptors, including the very surface receptors distinguishing B cells 
from other immune cells. For example, we found that CD19, CD20 (Ms4a1), IGH, 
CD45 (B220 or Ptprc), CD2, CD79b, and CD37 were expressed as multiple complex 
isoforms across the seven B1a cells. This indicates that the diversity of the surface 
receptors found on B-cells is not fully understood, which could have important 
implications on all facets of B cell biology. Our data suggest that we are currently 
only scratching the surface of the true transcriptional diversity of B1a cells. In the 
future, we aim to use the multiplexing strategy that we have developed to analyze 
hundreds of individual cells. This will make it possible to truly reconstitute the full 
transcriptome complexity of B1a and other cell types and will likely lead to discovery 
of additional subpopulations with distinct functional properties (A. R. Wu et al. 
2014). While we currently estimate the cost per cell at ~ $100-200, this is likely to 
decrease considering the rapidly increasing throughput of the ONT MinION and the 
soon-to-be-released ONT PromethION sequencer.  
Nanopore sequencing is still rapidly maturing and we believe that 
advancements in sequencing chemistries, nanopore design and analysis algorithms 
will vastly improve the technology and address the shortcomings of low read numbers 
and high error rates in the near future. Lower error-rates will, for example, allow us to 
improve our analysis pipeline further by allowing for the base accurate identification 
of TSS/TES and splice sites, instead of identifying 20 bp bins for these features. Even 
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with its current limitations, the data and analysis tools we present here demonstrate 
the potential of ONT RNAseq to revolutionize analysis of transcriptomes. Finally, 
while the ONT MinION has not quite caught up with the very capable PacBio Sequel 
long read sequencer, it is only a fraction of its price (~$1,000 vs. $300,000).  At this 
price, any molecular biology lab will be able to perform their own RNAseq 
experiments on-site, thereby increasing adoption of the single cell RNAseq approach 
and accelerating research. 
   
Methods 
FACS sorting of individual B cells 
Mice were maintained in the UCSC vivarium according to IACUC-approved 
protocols. Single murine Ter119-CD3-CD4-CD8-Gr1-B220+ IgM+CD11b-CD5+ B1a 
cells were isolated from wild-type C57Bl/6 mice by lavage and incubated with 
fluorescently-labeled antibodies prior to sorting (Beaudin et al. 2016). The following 
antibodies were purchased from Biolegend to stain B-cells: Ter119, CD3 (145-2C11), 
CD4 (GK1.5), CD8a (53-6.7), B220 (RA3-6B2), Gr1 (RB6-8C5), IgM (RMM-1), 
CD5 (53-7.3), and CD11b (M1/70). Cells were analyzed and sorted using a FACS 
Aria II (BD), as described previously (Ugarte et al. 2015), ,(Smith-Berdan et al. 
2015),(Beaudin, Boyer, and Forsberg 2014). Single cells were sorted into 96 well 
plates and directly placed into 4 ul of Lysis Buffer - 0.1% Triton X-100, 0.2 ul of 
SuperaseIn (Thermo), 1ul of oligodT primer (IDT), 1ul of dNTP (10mM each)(NEB) 
- and frozen at -80°C. 
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Smartseq2 cDNA synthesis 
Single cell lysate was reverse transcribed using Smartscribe Reverse Transcriptase 
(Clontech) in a 10 ul reaction including a Smartseq2 (Picelli et al. 2013)  TSO 
(Supplementary Table S1) according to manufacturer’s instructions at 42°C. The 
resulting cDNA was treated with 1 ul of 1:10 dilutions of RNAse A (Thermofisher) 
and Lambda Exonuclease (NEB) for 30 minutes at 37°C. A PCR amplification step 
using KAPA Hifi Readymix 2x (KAPA) step was performed incubating at 95°C for 3 
mins, followed by 27 cycles of (98°C for 20 s, 67°C for 15 s, 72°C for 4 mins), with a 
final extension at 72°C for 5 mins.  
 
Illumina Sequencing 
The resulting full-length cDNA PCR product was treated with Tn5 enzyme (Picelli, 
Björklund, et al. 2014) which was loaded with Tn5ME-A/R and Tn5ME-B/R adapters 
(Supplementary Table S1). The Tn5 treated PCR product was then nick-translated 
and amplified for 13 cycles with KAPA Hifi Polymerase (KAPA) and Nextera Index 
Primers (Supplementary Table S1). Libraries were then size selected using a E-gel 
2% EX (Thermo-Fisher) to a size range of 400-1000 bp and sequenced on an Illumina 
HiSeq2500 2x150 run.  
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Nanopore Sequencing 
To achieve the 1ug of DNA needed for the Oxford Nanopore library prep, the full-
length cDNA product was split into five aliquots and amplified for 13 cycles with 
KAPA Hifi Readymix 2X (KAPA) using the ISPCR or multiplex cellular index 
primers. The following reaction was incubated at 95°C for 3 mins, followed by 13 
cycles of (98°C for 20 s, 67°C for 15 s, 72°C for 4 mins) with a final extension at 
72°C for 5 mins. The single cDNA or multiplex product was further end-repaired and 
dA-tailed using NEBNext Ultra End Repair/dA tailing mix (NEB), and adapter 
ligated using the sequencing adapters provided by ONT (HP Adapter/Adapter Mix). 
Ligation reaction was performed using Blunt/TA ligase master mix (NEB). Reactions 
were then enriched using Dynabeads MyOne C1 Streptavidin (Life Technologies) to 
capture molecules that contain the HP Adapter. Enriched libraries were then mixed 
with Fuel mix and Running buffer provided by ONT. Single cell libraries were either 
sequenced solely on one (Cell1 and Cell2) or two (Cell3) separate MinION R7.3 flow 
cells and ran on the 48 hr 2D protocol. For our multiplexing strategy, single R9.4 
flow cells were used (Pool1: Cells4-7, Pool2: Lexogen libraries) and ran on the 48 hr 
2D protocol.    
 
Data Analysis 
Illumina data 
Illumina paired end 150 bp reads in fastq format were quality and adapter trimmed 
using trimmomatic (v0.33) (Bolger, Lohse, and Usadel 2014). The trimmed reads 
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were aligned using STAR (v2.4) (Dobin et al. 2013) to the mouse genome (Sequence: 
GRCm38, Annotation: gencode vM10 (Mudge and Harrow 2015)). Illumina reads 
were assembled for each cell separately using the Trinity (v2.2.0) (Grabherr et al. 
2011) set of tools.  
 
ONT data 
ONT reads were processed using the Metrichor cloud platform 2D workflow. For 
R7.3 runs, both reads that passed or failed Metrichor quality cutoffs were retained. 
For R9.4 runs, reads that failed Metrichor quality cutoffs were discarded as they also 
failed our alignment criteria. Fast5 files generated by Metrichor were converted into 
fastq and fasta formats using poretools (v0.5.1) (Loman and Quinlan 2014). For 
demultiplexing, index-sequences were aligned to the reads using BLAT with 
parameters: -noHead -stepSize=1 -minScore=20 -minIdentity=20. Reads for which 
index-sequences could be identified were trimmed and assigned to the respective 
libraries. Next, for multiplexed and non-multiplexed reads alike, ISPCR adapter 
sequences were identified and trimmed using Levenshtein distances. Reads for which 
ISPCR adapters could be identified and trimmed were marked but all reads, trimmed 
or not, were aligned to the mouse genome (GRCm38) using BLAT(v35x1) (Kent 
2002) with parameters: -stepSize=5 -repMatch=2253 -minScore=100 -
minIdentity=50 -maxIntron=2000000. Alignments were filtered for a single 
alignment per read. This filtering process involved three steps: (i) the highest scoring 
alignment for each read is identified, alignment scores within 2% of each other were 
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treated as ties, (ii) in case of ties the alignment with largest number of gaps is selected 
(this selects against alignment to unspliced pseudo-genes) and (iii) if the best 
alignment of a read has a ratio of aligned bases to read bases ≤0.6 the read and its 
alignment are discarded.  
 
 
Gene Expression 
Gene Expression for ONT and Illumina RNAseq was analyzed using custom scripts. 
For each gene, the number of reads overlapping with its exons was counted, 
normalized to total number of aligned reads in a library and reported as Reads Per 
Gene per 10,000 reads (RPG10K). Genes were counted as expressed if they had a 
RPG10K value>0. RPG can be calculated as: 𝑅𝑃𝐺10𝐾 = (𝑡𝑜𝑡𝑎𝑙#	𝑜𝑓	𝑟𝑒𝑎𝑑𝑠	𝑎𝑙𝑖𝑔𝑛𝑒𝑑	𝑡𝑜	𝑎	𝑔𝑒𝑛𝑒′𝑠	𝑒𝑥𝑜𝑛𝑠	÷ 𝑡𝑜𝑡𝑎𝑙	#	𝑜𝑓	𝑎𝑙𝑖𝑔𝑛𝑒𝑑	𝑟𝑒𝑎𝑑𝑠	𝑖𝑛	𝑠𝑎𝑚𝑝𝑙𝑒) × 10,000 
 
Transcription start and end site detection 
For the detection transcription start and end sites we limited our analysis to reads for 
which we detected and trimmed ISPCR adapter prior to read alignment. We then 
identified positions in the genome at which at least 2 alignments of these complete 
reads ended. We then further restricted our analysis by only considering positions 
with a median and 75th percentile of the number of clipped (unaligned) read bases 
between 6-15 and ≤ 20, respectively. This number of clipped (unaligned) bases 
corresponds to the length of bases contained in ISPCR TSO and oligodT primers that 
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were not trimmed. We then placed a 20 bp bin around these positions to include the 
highest number of read alignment ends possible. 
To filter false positive bins caused by incomplete read alignments in highly expressed 
genes bins were only considered as containing true TSS/TES if they met the 
following conditions:  
i) The total number of read alignment ends in the bins had to be > 2% of the total 
number of reads in the next 50 read covered bases. ii) The candidate site had to be at 
least 60 read covered bases away from the next closest TSS/TES.  
By only counting bases covered by read alignments we didn’t take non-covered 
introns into account which would skew our analysis. Next, in order to distinguish TSS 
and TES bins, we calculated median Levenshtein distances of the unaligned bases at 
all read alignment ends in a bin to nucleotides present in TSO (ATGG) or the 
OligodT (TTTT) primer. If the median Levenshtein of a bin to ATGG was ≤2 it was 
declared a TSS. If the median Levenshtein of a bin to TTTT was ≤2 it was declared a 
TES.  
 
Transcription start and end site validation 
To assess Fantom5(FANTOM Consortium and the RIKEN PMI and CLST (DGT) et 
al. 2014) CAGE scores we downloaded combined CAGE data 
(mm9.cage_peak_phase1and2combined_coord.bed.gz), converted the data to mm10 
coordinates using https://genome.ucsc.edu/cgi-bin/hgLiftOver (Kent et al. 2002) and 
investigated direct overlap between TSS/TES and CAGE peaks. We considered 
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TSS/TES and CAGE peaks to be overlapping if they were within 10 bp of each other. 
To assess polyA enrichment in TSS/TES, we extracted genomic sequences up- and 
downstream of these sites and looked for identical string matches to “AATAAA” and 
“ATTAAA”.  
 
Splice Site detection 
To identify 20 bp bins as splice sites only ONT 2D reads with a ratio of aligned 
bases/read bases of  > 0.9 were analyzed. We then identified positions in the genome 
at which at least two read alignments of these reads opened or closed an alignment 
gap larger than 50 bp. 
The 20 bp bins surrounding these positions were considered as containing a splice site 
if the following conditions are met:  
To filter false positive bins caused by spurious read alignment gaps in highly 
expressed genes bins were only considered as containing true splice sites if they met 
the following conditions:  
i) the number of reads opening or closing an alignment gap in the bin was at least 2% 
of the total number of reads in the preceding (5’) or subsequent (3’) 40 read covered 
bases. ii) not closer than 30 bp to another splice site. The directionality of the splice 
site bin containing either 5’ or 3’ status was based on the direction of the majority of 
reads containing the splice site. 
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Alternative Splicing 
To detect alternative splice sites, we counted how often 5’ and 3’ splice sites were 
spliced together in ONT 2D reads with aligned bases/read bases ratio of > 0.85. A 5’-
>3’ combination had to be present in at least 2 reads to be considered. We scored 
alternative splice site usage if the same 5’ splice site was spliced into two different 3’ 
splice sites or vice versa. To detect intron retentions, we identified areas between 5’ 
and 3’ splice sites that were covered to at least 70% by at least one ONT 2D read. 
 
Isoform identification and quantification. 
We detected isoform by grouping reads according the TSS/TES and alternative splice 
sites they contained. ONT read alignment ends found within 60 bp of a TSS and a 
TES were sorted based on which alternative splice sites it contained. Isoforms that 
contained at least 1% of all reads at a gene locus were retained. All the reads in these 
retained isoform groups were used to create consensus reads using POA(Lee, Grasso, 
and Sharlow 2002). In short, fasta files containing all read sequence are passed to 
POA which generates a consensus of the reads by creating a multiple sequence 
alignment of the reads in the form of a partially ordered graph. The program then 
returns the most heavily-weighted path as the consensus of the reads. The consensus 
reads are then aligned to genome using BLAT parameters: -stepSize=5 -
repMatch=2253 -minScore=10 -minIdentity=10. There was however, one exception 
regarding the highly complex variable regions derived from the IGH transcripts 
which were first aligned with IgBlast (Ye et al. 2013) and then with BLAT. IgBlast 
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alignment coordinates were converted to genome coordinates and BLAT and IgBlast 
portions of the read alignments were merged. 
 
Statistical test and multiple testing correction 
We used the ‘chi2_contingency’ function in the scipy.stats (Jones et al., n.d.) package 
to implement the Chi2 contingency test to detect differential expression of complex 
isoforms between cells. Multiple testing holm-sidak correction was performed with 
the ‘statsmodels.sandbox.stats.multicomp’ (Seabold and Perktold, n.d.) package. 
 
Data Visualization 
All data analysis and visualization was performed in python (Oliphant 2007) using 
the numpy/scipy/matplotlib (Jones et al., n.d.; van der Walt, Colbert, and Varoquaux 
2011; Hunter 2007) packages.  
 
Data Availability 
Illumina and ONT sequencing reads were uploaded to the SRA under accession 
number  SRP082530. All scripts are available upon request or will be available at 
https://vollmerslab.soe.ucsc.edu/ 
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Supplemental 
 
Fig. S2.1: Sequencing run characteristics 
The scatter plots on top shows read length and average sequence quality for ONT 2D 
reads that passed (blue) or failed (orange) the Metrichor analysis pipeline quality 
threshold in individual R7.3 (left) and R9.4 (right) sequencing runs. The histograms on 
the right of the scatter plots show the reads binned by read length using the same colors 
as the plot in the center to indicate passed (blue) or failed (orange). Using the same color 
scheme, the histogram at the bottom shows alignment success (percent of reads 
successfully aligned by BLAT) for reads binned by sequence quality score. 
The scatter plot on the bottom shows ONT 2D reads successfully aligned by BLAT. The 
ratio of aligned/total bases of each read (blue=pass, orange=fail) plotted against average 
sequence quality score. The alignment quality cut-off of 60% aligned bases is shown as a 
black line. 
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Fig. S2.2: Gene detection with 
subsampled data 
For each cell Illumina and ONT reads were 
subsampled in 5000 read bins until either the 
total number of Illumina or ONT reads was 
reached. The subsampled reads were used to 
quantify gene expression. Genes with a 
RPG10K value >0, i.e. with a single mapped 
read were scored as detected (x-axis = # of 
genes detected, y-axis= # of reads 
subsampled). Reads detected in both or 
either technology are shown in different 
colored bars. 
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Fig. S2.3: Quantifying SIRV transcripts amplified from 10fg starting material 
with ONT RNAseq 
Left: SIRV transcript levels of Replicate 1 (Rep1: 10fg SIRV pool E2) as measured with 
ONT RNAseq. Transcripts are binned by their starting molecule numbers.  
Middle: SIRV transcript levels of Replicate 1 are plotted against transcript length with 
colors corresponding to groups in shown on left.  
Right: Scatter plot showing correlation of SIRV transcript expression levels of Replicate 
1 (Rep1: 10fg SIRV pool E2) and Replicate 2 (Rep2: 10fg SIRV pool E2) , both 
measured by ONT RNAseq r-value is shown as Pearson-r. 
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Fig. S2.4: Identifying Transcript isoforms using ONT RNAseq 
Genome Browser view of indicated SIRV gene loci. Top box contains transcript 
annotations, second and third box contain TSS (Teal) /TES (Purple) and splice sites 
(5’SS: yellow, 3’SS: blue) locations predicted from the read data, respectively. Black 
lines and grey areas in box 3 indicate alternative splicing and intron retention events 
predicted from the read data. Box 4 contains read alignments of isoform consensus reads. 
Box 5 contains ONT 2D read alignments. Direction of transcripts, isoform consensus, 
and ONT 2D reads are indicated by their color (Teal:5’to3’, Purple:3’to5’). 
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Fig. S2.5: Diverse Isoforms of B cell surface receptors identified using ONT 
RNAseq 
Genome Browser view of the indicated B cell surface receptor gene loci. Top box 
contains transcript annotations, second and third box contain TSS (Teal) /TES (Purple) 
and splice site (5’SS: yellow, 3’SS: blue) locations predicted, respectively. Black lines 
and gray areas in box 3 indicate alternative splicing and intron retention events predicted. 
Below boxes alternatingly contain read alignments of isoform consensus reads and ONT 
2D read alignments. Direction of transcripts, isoform consensus, and ONT 2D reads are 
indicated by their color (Teal: 5’ to 3’, Purple: 3’ to 5’). 
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Table S.2.1 List of Oligos 
All oligos in the study are shown above 
1) Spaces in sequences are for visual emphasis and do not indicate gaps in the sequences. 
2) Nextera_Primer_A and Nextera_Primer_B represent groups of sequences. 3) (i5) and 
(i7) indicate different illumina indexes 
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Table S.2.2: Illumina and ONT Read Numbers 
Illumina Reads: Numbers indicate individual reads, not read pairs. “Aligned” Reads are 
reads successfully aligned using STAR. ONT 2D Reads: “Pass Filter” and “Fail Filter” 
are reads determined by Metrichor software based on quality scores. “Pass Alignment 
Filter” are reads that were aligned using BLAT and more than 60% of their bases aligned 
to the genome. Complete reads as mentioned in the manuscript are defined as reads for 
which both the ISPCR sequences are identified on both ends and trimmed. 
 
 
 
Table S2.3: Alternative Splice Site Predictions 
Median ONT 2D read count is shown for alternative splice sites. Splice sites are 
separated into sites with and without illumina read support. p-values are calculated using 
scipy.stats.mannwhitneyu function with keyword argument alternative = ‘greater’. 
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Abstract 
Transcriptome studies evaluating whole blood and tissues are often confounded by 
overrepresentation of highly abundant transcripts. These abundant transcripts are 
problematic as they compete with and prevent the detection of rare RNA transcripts, 
obscuring their biological importance. This issue is more pronounced when using long-
read sequencing technologies for isoform-level transcriptome analysis, as they have 
relatively lower throughput compared to short-read sequencers. As a result, long-read 
based transcriptome analysis is prohibitively expensive for non-model organisms. 
While there are off-the-shelf kits available for select model organisms capable of 
depleting highly abundant transcripts for alpha (HBA) and beta (HBB) hemoglobin, 
they are unsuitable for non-model organisms. To address this, we have adapted the 
recent CRISPR/Cas9 based depletion method (Depletion of Abundant Sequences by 
Hybridization) for long-read full-length cDNA sequencing approaches that we call 
Long-DASH. Using a recombinant Cas9 protein with appropriate guide RNAs, full-
length hemoglobin transcripts can be depleted in-vitro prior to performing any short- 
and long-read sequencing library preparations. Using this method, we sequenced 
depleted full-length cDNA in parallel using both our Oxford Nanopore Technology 
(ONT) based R2C2 long-read approach, as well as the Illumina short-read based Smart-
seq2 approach. To showcase this, we have applied our methods to create an isoform-
level transcriptome from whole blood samples derived from three polar bears (Ursus 
maritimus). Using Long-DASH, we succeeded in depleting hemoglobin transcripts and 
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generated deep Smart-seq2 Illumina datasets and 3.8 million R2C2 full-length cDNA 
consensus reads. Applying Long-DASH with our isoform identification pipeline, 
Mandalorion we discovered ~6,000 high-confidence isoforms and a number of novel 
genes. This indicates there is a high diversity of gene isoforms within Ursus maritimus 
not yet reported. This reproducible and straightforward approach has not only improved 
the polar bear transcriptome annotations but will serve as the foundation for future 
efforts to investigate transcriptional dynamics within the 19 polar bear subpopulations 
around the Arctic. 
 
Introduction 
Accurate isoform-level differential expression analysis of transcriptomes is essential 
for interpreting gene regulation under different biological, environmental or 
physiological conditions. RNA transcript isoforms – which are often unique among 
different cell types, tissues, developmental stages, and organisms (Zhang et al. 2016; 
E. T. Wang et al. 2008; Kalsotra et al. 2008) – are defined by the use of alternative 
transcription start sites (TSSs), polyA sites, and splice sites. Use of alternative isoforms 
is highly regulated and thought to contribute to cellular and organismal diversification 
within higher eukaryotes (Graveley 2001), adaptation and speciation (Harr and Turner 
2010; Shi et al. 2012) and can also reflect certain disease states (Busslinger, 
Moschonas, and Flavell 1981; Andreadis 2005; Ilagan et al. 2015).  
To perform this type of differential expression analysis on the isoform-level 
requires both short- and long-read sequencing technology. Short-read RNA-seq 
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provides the read depth necessary for gene expression quantification, but requires 
accurate and exhaustive isoform-level transcriptome annotations for its analysis. 
However, existing transcriptome annotations of non-model organisms are often 
incomplete or inaccurate (Ungaro et al. 2017) because they cannot rely on labor-
intensive efforts like Gencode, which are working to exhaustively annotate the isoform-
level transcriptomes of human and mouse. While short-read RNA-seq data can itself 
be used for transcriptome annotation, it fails at annotating transcriptomes on the 
isoform-level because it cannot recapitulate full-length transcripts. This inability to 
define full-length transcripts is due to the fragmentation of RNA, or their cDNA copies, 
prior to sequencing making it difficult to computationally re-assemble reliably 
(Grabherr et al. 2011; Pertea et al. 2015; Bankevich et al. 2012). To provide an accurate 
isoform-level transcriptome annotation for non-model organisms, long-read 
sequencing technology is required to sequence full-length cDNA molecules. 
The ability to perform combined short- and long-read transcriptome analysis on 
non-model organisms is further complicated by sample availability. In contrast to the 
organs and tissues of model organisms which can be easily acquired, availability of 
samples from non-model organisms are often more limited. In rare circumstances 
sampling can be performed through fat and muscle tissue biopsies (Khudyakov et al. 
2017), but the current gold standard still relies on whole blood RNA samples, especially 
for large non-model organisms (Du et al. 2015). This is particularly true for protected 
and endangered species (Huang et al. 2016; Hernández-Fernández, Pinzón, and 
Mariño-Ramírez 2017). While whole blood samples can be easily acquired and provide 
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a wealth of information regarding physiological or disease states in surrounding tissues 
(Liew et al. 2006), polyadenylated RNA extracted from whole blood can be comprised 
of >50% hemoglobin transcripts (Shin et al. 2014; Mastrokolias et al. 2012). In any 
high-throughput sequencing-based assay, these highly abundant transcripts will 
compete for a limited number of sequencing reads and as a result will be sequenced 
over and over again without generating any new information. This would waste 
valuable reads which could otherwise detect less abundant transcripts.  
Currently, there is no approach to deplete hemoglobin transcripts from whole 
blood RNA while enabling downstream analysis of the depleted RNA/cDNA with both 
short- and long-read sequencing. Commercially available hemoglobin depletion kits – 
including GLOBINclear (Ambion) or RiboZero (Illumina) – are specifically designed 
for human samples and rely on hemoglobin RNA pull-down methods (Field et al. 
2007). Even if they would succeed in depleting hemoglobin from non-model organism 
samples, which is far from guaranteed (Choi et al. 2014), these pull-down approaches 
use harsh conditions and high temperatures during long incubation steps which 
contribute to RNA fragmentation and introduce unwanted technical variability (Debey 
et al. 2004). While fragmented RNA is suitable as input into short-read RNA-seq, it is 
not suitable for long-read full-length cDNA sequencing.  
To perform a comprehensive analysis of non-model organism transcriptomes 
from whole-blood with short- and long-read technologies, we require a new approach 
that can deplete highly abundant transcripts like hemoglobin from whole-blood 
samples of a wide range of organisms without fragmenting transcripts. To this end, we 
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chose to adapt the powerful, recently published DASH (Depletion of Abundant 
Sequences by Hybridization) (Gu et al. 2016) method which utilizes a recombinant 
Cas9 to perform in-vitro depletion using sequence specific sgRNAs. Our adapted 
method which we will refer to as Long-DASH also takes advantage of the 
CRISPR/Cas9 system to selectively deplete hemoglobin alpha (HBA) and beta (HBB) 
transcripts but targets full-length cDNA instead of fragmented short-read Illumina 
sequencing libraries like regular DASH. By depleting full-length cDNA prior to any 
library preparation, this allows the user the choice to use any short- or long-read 
sequencing platform.  
As a proof-of-concept we evaluated three hemoglobin-depleted and non-
depleted polar bear whole blood transcriptomes using our ONT-based R2C2 (Volden 
et al. 2018) full-length cDNA sequencing method and an Illumina-based modified 
Smart-seq2 method. We found that by incorporating Long-DASH, we successfully 
depleted hemoglobin transcripts without non-specifically affecting the rest of the 
cDNA pool. Finally, we generated ~3.8 million ONT-based R2C2 consensus reads, 
dramatically refining the polar bear transcriptome annotations.  
 
RESULTS 
Long-DASH depletes hemoglobin transcripts from full-length cDNA 
We used a modified Smart-seq2 protocol (Picelli, Faridani, et al. 2014; Cole et al. 2018; 
Volden et al. 2018) to reverse transcribe and amplify full-length cDNA from 70 ng of 
whole blood RNA of three polar bears (PB3, PB19, PB21). We then performed a 
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targeted depletion of hemoglobin transcripts by incubating the full-length cDNA with 
Cas9 protein loaded with 16 guide RNAs (sgRNAs) specific to hemoglobin transcripts 
– 8 sgRNAs targeting the HBA transcripts and 8 sgRNAs targeting the HBB transcripts. 
The sgRNAs were selected to deplete hemoglobin transcripts from human and polar 
bear samples. The sgRNAs were chosen based upon sequence homology between these 
two species to eventually allow the removal of abundant of hemoglobin transcripts in 
whole blood from both human and polar bear samples using the same sgRNAs (Field 
et al. 2007) (Supplementary Fig. S3.1). Using the 16 sgRNA probes we designed should 
also allow for the depletion of samples of other vertebrates although sequence 
similarity should be checked before this is attempted.   
The depletion process using the Cas9 system should cut the ~700-800 bp 
transcripts at different sites allowing us to do two things. First, we can re-amplify the 
sample, thereby only enriching for full-length molecules since the cut cDNA molecules 
no longer contain two priming sites required for exponential amplification during PCR 
amplification (Fig. 3.1). Second, we can remove the cut transcripts by performing a 
SPRI-bead based size selection whereby only transcripts > 500 bp are retained. Indeed, 
prior to any depletion, we observed very strong bands located at ~700-800 bp in our 
agarose gels indicating the presence of a substantial amount of HBA and HBB 
hemoglobin transcripts (Fig. 3.2). After depletion, reamplification, and size selection, 
the full-length cDNA product was visualized again to reveal the removal of the putative 
hemoglobin bands (Fig. 3.2). After hemoglobin depletion is confirmed, the cDNA is 
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ready to be converted into ONT- and Illumina-based libraries, with each protocol using 
the same input cDNA (Fig. 3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Schematic of Long-DASH (Long Read Depletion of Abundant 
Sequences by Hybridization)  
A) Whole Blood RNA is extracted and full-length cDNA is generated with the first half of 
the Smart-seq2 protocol. The cDNA is then depleted of hemoglobin transcripts using the 
recombinant S. pyogenes Cas9 protein bound to hemoglobin specific sgRNA which cuts 
hemoglobin cDNA molecules by introducing double strand breaks (△) in a sequence 
specific manner. The cut molecules can no longer be exponentially amplified with PCR, 
so a subsequent PCR step is performed to enrich for complete non-hemoglobin cDNA 
molecules. The resulting hemoglobin depleted cDNA pool is then sequenced using the 
ONT-based R2C2 library prep and the Illumina-based Smart-seq2 library prep. 
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Figure 3.2: Long-DASH depletes hemoglobin from full-length cDNA.  
A) Depleted (D) or undepleted (U) cDNA was visualized on a 2% Agarose gel. DNA 
ladder (L) suggests highly abundant cDNA species - putatively hemoglobin around 
~700bp. B) Fluorescence analysis of the gel by ImageJ (Rasband 2011) further 
emphasizes the difference between depleted (blue) and undepleted (black) cDNA pool. 
Select size markers in the DNA ladder (red) are indicated. 
 
Long-DASH is compatible with Smart-seq2 library preparation and does not 
distort cDNA composition 
Next, we aimed to validate whether Long-DASH truly depletes hemoglobin transcripts 
in the cDNA pool and can be used for Illumina’s short-read RNA-seq sequencing 
platform. To show this we prepared independent Tn5 based Smart-seq2 sequencing 
libraries for each depleted and undepleted cDNA pool. We then sequenced the Smart-
seq2 libraries on a multiplexed Illumina HiSeq X 2 x151 bp run. We generated ~20 
million reads for depleted and ~60 million reads for undepleted samples. By sequencing 
the undepleted samples deeper, we reasoned that the non-hemoglobin genes should 
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receive equivalent read coverage in depleted and undepleted samples. This allowed us 
to perform a side by side comparison of the depleted and non-depleted samples to 
ensure no off-target effects. 
First, we analyzed the resulting sequencing data using a custom kmer based 
approach to estimate the number of reads originating from hemoglobin transcripts. In 
the undepleted cDNA pools 48-68% of reads were scored as originating from 
hemoglobin transcripts. In depleted samples this was reduced to 1-4% reads (Fig. 
3.3A). As a consequence, at the same read depth, RPM values for non-hemoglobin 
genes increased by a factor of 3 on average. 
Second, to show that the depletion of hemoglobin transcripts did not distort the 
rest of the cDNA pool, we aligned the reads to the polar bear genome and quantified 
the expression of all previously annotated genes. We observed that when reads aligning 
to the hemoglobin loci were included in the analysis, the reads aligning to the few 
hemoglobin loci in our undepleted samples skewed the RPM calculations. By 
sequencing undepleted samples to great depth, this allowed us to exclude hemoglobin 
from quantification of gene expression while matching non-hemoglobin read depth of 
depleted samples. This analysis showed that the overall gene expression patterns were 
not dramatically distorted between depleted and undepleted samples. The three polar 
bear samples showed a Pearson r-value of 0.97-0.98 (Fig. 3.3B) when the gene 
expression values of depleted and undepleted samples were compared and reads 
aligning to hemoglobin loci were discarded.  
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Next we checked for genes whose expression was systematically affected by 
depletion. No genes were downregulated more than 4-fold in all three polar bear 
samples suggesting that there was no strong systematic off-target effects using the Cas9 
based depletion. We did however find 151 genes out of ~12000 expressed genes to be 
upregulated by at least 4-fold in all 3 polar bears suggesting that Cas9 based depletion 
and subsequent second PCR amplification have had a systematic impact on a number 
of genes. We then investigated whether this effect would affect differential expression 
analysis between depleted samples. To this end, we calculated gene expression 
differences for each pair of polar bears twice, once pre- and once post-depletion. We 
then compare the pre- and post-depletion gene expression differences and found that, 
while depletion does introduce differences in the upregulated genes, these effects 
appear to be small, random in direction, and similar to a random selection of genes with 
similar expression levels (Supplementary Fig. S3.2).   
Overall, this indicates that the depletion of hemoglobin from full-length cDNA 
pools was successful, thereby freeing up the vast majority of sequencing reads to 
analyze the rest of the polar bear transcriptome. Although, the data suggests that a 
number of genes were systematically affected by depletion and additional PCR steps, 
further experiments including several technical replicates should enable differential 
expression analysis between depleted samples.  
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Figure 3.3: Long-DASH specifically targets hemoglobin from cDNA.  
A) Hemoglobin content was measured in Smart-seq2 (Illumina) libraries of depleted (blue) 
or undepleted (black) cDNA pools. B(Top) and C) Scatterplots comparing gene expression 
in undepleted and depleted Smart-seq2 libraries of PB3, PB19, and PB21 with reads 
aligning to hemoglobin loci (red) (Liu et al. 2014) either included (B) or excluded (C). 
B(Bottom) Scatterplots showing log2(fold-change) between depleted and undepleted 
cDNA pools as calculated by [Depleted (log2(RPM+1))-Undepleted (log2(RPM+1))] with 
hemoglobin loci included in the RPM normalization. 
 
Long-DASH is compatible with full-length cDNA sequencing methods 
Having established the compatibility of Long-DASH with the short-read RNA-seq 
assay, we investigated whether we could generate a long-read data set from the depleted 
cDNA using our R2C2 approach. By incorporating R2C2 we can generate error-
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corrected full-length cDNA reads using long-read ONT sequencers. We used 5 partially 
multiplexed flowcells to generate ~3.8 million R2C2 consensus reads of 5 depleted 
cDNA pools – two Long-DASH replicates (R1 and R2) for PB3 and PB19 as well as a 
single Long-DASH run for PB21. The R2C2 reads we generated had a median accuracy 
of 94%, which is between 8-10% more accurate than standard ONT cDNA sequencing 
protocols (Supplementary Table S3.1).  
We also generated ~5,000 R2C2 consensus reads of undepleted cDNA from 
one polar bear which allowed us to compare hemoglobin content and consensus read 
length distributions between depleted and undepleted samples (Fig 3.4). In the 
undepleted sample, the majority of R2C2 reads were of two distinct lengths, both 
around 700 bp, likely representing 79.3% of hemoglobin transcripts present in that 
sample. The 5 depleted samples showed a much more evenly distributed read length 
with a median hemoglobin content of 1.2% (0.6%-8.3%) (Fig. 3.4). Higher hemoglobin 
levels for R2C2 compared to Smart-seq2 based library preps (1-4%) using the same 
cDNA might be explained with R2C2 being somewhat biased towards transcripts 
between 500-1000 bp.  
The median read length of the depleted samples was slightly below 1 kb which 
is in line with cDNA read length distributions published to date (Workman et al. 2018). 
This means that despite the less than ideal conditions for RNA integrity given difficult 
field conditions and the lag time between sample collection and processing, the 
analyzed RNA molecules were largely intact.  
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Figure 3.4: Long-DASH depletes hemoglobin from cDNA.  
Length distribution of R2C2 consensus reads is shown as swarmplots in the indicated 
samples. Independent Long-DASH replicates (R1 and R2) were performed for samples 
PB3 and PB19 but not PB21. Percent of Hemoglobin reads as determined with a kmer 
approach is given in red on top.    
 
R2C2 reads of depleted full-length cDNA can refine transcriptome annotations 
Next, we generated high confidence isoform-level information from our full-length 
cDNA to refine the currently available polar bear transcriptome annotation. To this end, 
we analyzed our 3.8 million R2C2 consensus reads using the Mandalorion pipeline we 
previously developed (Byrne et al. 2017). We aligned the R2C2 reads to the polar bear 
genome sequence (Liu et al. 2014) using minimap2. These alignments, together with 
previously known individual splice sites (Genomic Resources Development 
Consortium et al. 2014; Liu et al. 2014), then serve as input into our Mandalorion 
pipeline which processes read alignments into high-confidence isoforms. 
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The Mandalorion pipeline first complements known splice sites with new splice 
sites it identifies de novo from R2C2 read alignments. It then groups R2C2 reads based 
on the splice sites they use. Pairs of transcription start sites (TSSs) and polyA sites are 
then determined for each group to identify full-length isoforms. Two additional 
processing steps were performed whereby isoforms were excluded if they were fully 
contained within longer isoforms or unspliced. This was to ensure removal of any non-
full-length isoforms that may result from RNA degradation, as well as isoforms 
potentially caused by DNA contamination, respectively. In total, this analysis produced 
5,831 high-confidence isoforms with a median accuracy of 99.1%.  
We then classified these 5831 high-confidence spliced isoforms using the 
Sqanti algorithm (Tardaguila et al. 2018) that determines what relationship an 
experimentally determined isoform has to genes and isoforms in a reference annotation 
(Fig. 3.5). As a reference, we downloaded 28,880 known and predicted mRNA 
sequences from NCBI by selecting “RefSeq” and “mRNA” filters in the NCBI 
Nucleotide database, most of which are based on the NCBI Ursus maritimus 
Annotation Release 100 catalog of polar bear mRNA sequences (Pruitt et al. 2014). 
1239 of the 5831 Mandalorion isoforms were classified as 
“novel_not_in_catalog” (NNC) which means that they overlapped a known gene but 
contained at least one unannotated splice site. In-depth analysis of this NNC group 
found that they contained a total of 521 new exons. In addition to R2C2 read coverage, 
Smart-seq2 read coverage was elevated in these new exons providing additional 
evidence for their inclusion in transcripts. Further, 1301 isoforms were classified as 
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“novel_in_catalog” (NIC), which means that they overlapped a known gene and used 
only annotated splice sites but at least once as part of a previously unannotated splice 
junction. In total we observed 2540 (1239 NNC and 1301 NIC) new isoforms with 
unannotated exon configurations. An additional 1893 isoforms were classified and 
“full_splice_match” (FSM) which means that their splice junctions matched an 
annotated isoform completely but it doesn’t mean that TSS and polyA sites also 
matched this isoform. In-depth analysis of the putative full-length NNC, NIC, and FSM 
isoform groups identified 2885 new TSSs and 1817 new polyA sites. R2C2 read 
coverage declined rapidly at TSSs and polyA sites providing clear evidence for their 
validity. Smart-seq2 read coverage was elevated inside TSS and polyA sites but 
declined slowly towards the respective features which is characteristic for standard 
short-read Illumina data (Fig.3.5). This is not surprising as short-read based protocols 
have to be specifically designed to capture those features (Salimullah et al. 2011; Cole 
et al. 2018; Ruan and Ruan 2011). So, while this data validates the existence of these 
features, it cannot be used for confirming their exact location.  
Finally, 769 isoforms were classified as “incomplete_splice_match” (ISM) 
which means that they contain a subset of splice junctions of an annotated isoform. 
While these isoforms could represent real, shorter transcripts, they might also represent 
experimental artifacts so we excluded them from TSS and polyA analysis. 
Considering RefSeq mRNA sets are in part based on deep short-read data and 
computational annotation, we did not expect to discover many entirely new gene loci. 
However, 509 of the 5831 isoforms were classified as “intergenic” (IG) which means 
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that they did not overlap with any annotated gene locus. By determining which of these 
isoforms overlapped with each other, we identified 176 new gene loci.  
Overall, this analysis dramatically refined our isoform-level knowledge of the 
whole blood polar bear transcriptome (Fig. 3.5). To make this knowledge 
straightforward to use for future analysis, we have generated a gtf annotation file 
containing RefSeq mRNA entries merged with our R2C2/Mandalorion isoforms. 
How these new isoforms and isoform features have improved the current 
annotation can be seen clearly in these three following examples. In the RBX1 gene, 
we discovered 10 new isoforms containing new TSSs and polyA sites, several of which 
were associated with new terminal first or last exons (Fig. 3.6A). In the GMFG gene, 
we similarly identified new isoforms containing unannotated internal and terminal 
exons, intron retention events, TSSs, and polyA sites (Fig. 3.6B). Finally, we 
discovered a new gene locus that contains two isoforms and is entirely absent in the 
polar bear RefSeq mRNA set. However, aligning the two isoforms to the Panda genome 
(R. Li et al. 2010) resulted in unique matches to the CCDC72 gene (Fig. 3.6C). 
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Figure 3.5: R2C2/Mandalorion identifies new isoform features in the polar bear 
transcriptome.  
(Top) General workflow for comparing RefSeq mRNAs and Mandalorion isoforms is 
shown on the left. RefSeq mRNAs were aligned to the polar genomes using minimap2 and 
converted to gtf format to create a reference annotation. Isoforms determined by 
Mandalorion were then classified using this reference annotation using the sqanti_qc 
algorithm. Isoforms were classified as Novel_not_in_catalog (NNC), Novel_in_catalog 
(NIC), Full_splice_match (FSM), Incomplete_splice_match (ISM) and Intergenic (IG). 
New transcriptome features were then determined based on the minimap2 alignments of 
isoforms in the indicated categories. (Bottom) R2C2 and Smart-seq2 read coverage around 
newly identified TSS, the splice sites (3’ and 5’) of newly identified exons, and newly 
identified polyA sites.  
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Figure 3.6: R2C2/Mandalorion refine transcriptome annotations.  
Genome Browser views of the RBX1 locus (A), the GMFG locus (B), a locus likely 
corresponding to the CCDC72 gene not yet included in the RefSeq mRNA set (C). From 
top to bottom, 1) RefSeq mRNAs alignments, 2) new features based on Mandalorion 
isoforms (green: TSS, red: polyA site, blue: new exon or locus), 3) Mandalotion isoforms, 
and 4) R2C2 reads. Plus, strand alignment are in blue, minus strand alignments in orange. 
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Discussion 
 
To better understand how humans and environmental perturbations impact threatened 
or endangered species, it is critical to understand changes in transcriptome dynamics. 
Fluctuations at the molecular and cellular level are sensitive indicators of 
environmental change (Brown et al. 2017; Kim et al. 2011); they are analogous to 
veterinary medicine where blood transcriptomes serve as proxies for identifying health 
status, disease, and exposures to environmental toxicants (Lv et al. 2018; McLoughlin 
et al. 2014; Burgess et al. 2012; Watson et al. 2017). Changes at the transcriptome level 
may also be useful indicators of ecological specialization, and therefore useful to design 
strategies for species management and conservation (Supple and Shapiro 2018). 
However, existing approaches to generate transcriptome data from whole blood RNA 
are either specifically designed for short-read sequencing (DASH) or human samples 
(commercial hemoglobin depletion kit like GLOBINclear) and therefore lack a cost-
effective approach for analyzing isoform-level transcriptomes of non-model 
organisms. 
Any study investigating whole blood transcriptomes using short- or long-read 
sequencing will greatly benefit from the Long-DASH method. Long-DASH effectively 
and economically depletes hemoglobin transcripts from whole blood full-length cDNA 
which can then be sequenced with short- or long-read sequencing. We validated Long-
DASH by depleting hemoglobin transcripts from polar bear whole blood cDNA pools 
and generated deep short-read Smart-seq2 RNA-seq data as well as 3.8 million R2C2 
full-length cDNA consensus reads. We processed the 3.8 million full-length R2C2 
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reads to identify close to 6000 high confidence isoforms which we then used to refine 
and improve the polar bear whole blood transcriptome annotation.    
 In addition to polar bear hemoglobin transcripts, the sgRNAs designed for this 
study will also target human hemoglobin transcripts making them useful for basic 
research as well as clinical applications in cancer biology and disease diagnosis (Fig. 
S1) (Valk et al. 2004; Borovecki et al. 2005; Gervasoni et al. 2008; Morey et al. 2016). 
Further, the sgRNA sequences used in Long-DASH can be easily adapted to any 
organisms or gene. The ease and adaptability places Long-DASH at an advantage over 
“as-is” commercial kits like GLOBINclear (Ambion), which promises >95% of 
depletion of human and mouse hemoglobin transcripts, but fails to efficiently deplete 
hemoglobin transcripts from pig whole blood RNA samples (Choi et al. 2014).  
Since cDNA can be generated from femtogram levels of polyA-RNA, Long-
DASH requires very little RNA input compared to RNA pull-down methods. This 
allows the investigator to gather small samples, or only process small aliquots of 
existing samples, thereby maximizing the usefulness of each sample collection and 
minimizing harm to animals. In its current state depletion by Long-DASH is still 
somewhat variable, resulting in hemoglobin levels from 0.6%-8.3%. While still a large 
improvement compared to the undepleted samples, future work on the method will 
center on removing this variability through either longer incubation times or higher 
number or concentration of sgRNA probes and the Cas9 protein. It may also be 
beneficial to measure depletion success by qPCR before sequencing a depleted cDNA 
pool.  
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 Going forward, the Long-DASH depletion method and the R2C2 long-read 
sequencing method will form a very powerful combination for transcriptome analysis 
and annotation from whole blood samples and beyond. The transcriptomes of many 
tissues contain several highly abundant transcripts that represent >50% of all transcript 
molecules (Mure et al. 2018). A set of sgRNAs targeting any abundant transcripts can 
be easily generated, making Long-DASH conducive for surveying other tissues as well. 
Specifically, depleted full-length cDNA libraries can be sequenced using our R2C2 
method, which currently represents the most powerful combination of throughput and 
accuracy in the long-read sequencing field. Our most recent R2C2 run emphasizes this 
by generating ~1,000,000 R2C2 reads at a median accuracy of 97.5% on a single ONT 
MinION flowcell at a cost of ~$650 (Table S1). This represents an increase in accuracy 
of >10% over standard ONT cDNA sequencing and 10-times more complete reads than 
the PacBio Sequel at the same cost. Combining our Long-DASH and R2C2 methods 
therefore brings the exhaustive annotation of non-model organisms within reach. 
 
Materials and Methods 
 Sample Collection/RNA Extraction from Whole Blood  
Permits for field operations and animal care were provided by the Government of 
Greenland (Permit numbers 2015-110281 and 2017-5446). Polar bear whole blood 
samples were collected in PAXgene Blood RNA tubes (PreAnalytiX GmbH, BD 
Biosciences, Mississauga, ON, Canada). Total RNA was isolated from whole blood 
(2.5mL) thawed at room temperature for 2 hours prior to using the PAXGene RNA 
	 137	
extraction kit (Qiagen, Chatsworth, CA, USA) according to manufacturer’s protocol. 
All samples were DNAse (Qiagen) treated and eluted in 50μL. The RNA yield and 
purity were accessed using a NanoDrop 8000 UV Spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA, USA). RNA quantities ranged from 110 - 310 ng/μL and the 
A260/280 ratio values were > 2.0. Human whole blood RNA was purchased from 
Zyagen Labs (NC1453913). 
  
 
Full-length cDNA Generation 
RNA was reverse transcribed (RT) using Smartscribe Reverse Transcriptase 
(Clonetech). We generated full-length cDNA using a modified Smart-seq2 approach 
(Cole et al. 2018). During the RT reaction a template-switch oligo and an oligodT 
primer was used to select for polyA+ RNA (Table S2). The RT reaction was performed 
in 10 μL reactions with an input of 70 ng of RNA and took place at 42°C for 1 hour. 
After cDNA synthesis, 1 μL of 1:10 dilutions of RNAse A (Thermofisher) and Lambda 
Exonuclease (NEB) were added and incubated at 37°C for 30 minutes. Following the 
incubation, an amplification step was performed in 25 μL final volumes using KAPA 
Hifi ReadyMix 2X (KapaBiosystems) containing 1 μL of the ISPCR primer (10 μM) 
primer. Samples were incubated at 95°C for 3 minutes, followed by 12 cycles of (98°C 
for 20 s, 67°C for 15 s, and 72°C for 4 minutes), with a final extension of 72°C for 5 
minutes. Samples were purified using Agencourt AMPure XP SPRI beads (Beckman 
	 138	
Coulter) and eluted at 25 mL. The final cDNA product was then visualized on an 
agarose gel to confirm distribution (Fig. 3.2). 
 
In-vitro Preparation of CRISPR/Cas9 
SpCas9-2xNLS was purified based on the protocol described in (Jinek et al. 2012). 
Briefly, a plasmid encoding His6MBP-SpCas9-2xNLS (Addgene plasmid #69090) was 
transformed into Rosetta2(DE3) E. coli cells. Cultures were grown at 37ºC in 2YT 
medium with shaking until they reached an OD600 of ~0.6, and then placed on ice for 5 
minutes before adding IPTG to a final concentration of 0.25 mM; cultures were then 
grown overnight at 18ºC with shaking. Cell pellets were harvested by centrifugation, 
and then lysed in an Avestin cell extruder in Ni-A buffer (20 mM Tris pH 8.0, 500 mM 
NaCl, 5% vol/vol glycerol, 25 mM imidazole) with EDTA-free protease inhibitors 
(Pierce). Clarified supernatants were purified by gravity column on Ni-NTA agarose 
(QIAGEN) using Ni-A buffer to load and wash, and Ni-B buffer (20 mM Tris pH 8.0, 
500 mM NaCl, 5% vol/vol glycerol, 250 mM imidazole) to elute. Peak fractions were 
concentrated in an Amicon Ultra spin concentrator with a 30 kDa molecular weight 
cutoff at 4ºC, and then loaded onto a 50 mL HiPrep Desalting Column (GE Healthcare) 
pre-equilibrated with 17% IEX-B (IEX-A buffer: 20 mM HEPES pH 7.5, 150 mM KCl, 
5% vol/vol glycerol; IEX-B 20 mM HEPES pH 7.5, 1 M KCl, 5% vol/vol glycerol). 
The flow-through was then loaded onto a 2 mL HiTrap SP column (GE Healthcare) in 
17% IEX-B buffer. After thoroughly washing the column in 17% IEX-B, the protein 
was eluted with a linear gradient from 17-50% IEX-B. Peak fractions were pooled and 
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loaded onto a Superdex 200 16/60 column (GE Healthcare) pre-equilibrated in 20 mM 
HEPES pH 7.5, 150 mM KCl, 1 mM DTT, 10% vol/vol glycerol. Peak fractions were 
concentrated in an Amicon Ultra spin concentrator with a 30 kDa molecular weight 
cutoff at 4ºC until a concentration of 40 μM, which was estimated using the calculated 
molar extinction coefficient of 120,575 M-1 cm-1. The protein was aliquoted into small 
volumes (10 μL), quick frozen in liquid nitrogen, and stored at -80ºC. 
  
sgRNA Design and Construction 
Other studies have shown that sgRNAs designed between 17-20 bp showed increased 
efficacy (Ren et al. 2014; Fu et al. 2014). As a result, the sgRNAs were designed 
between 17-20 bp in length. sgRNAs were designed to target hemoglobin transcripts in 
human and polar bear. A multi-sequence alignment was performed on the human and 
polar bear annotated HBA and HBB gene transcripts to find conserved regions using 
the Clustal Omega tool (W. Li et al. 2015; Sievers et al. 2011; McWilliam et al. 2013) 
(Fig. S3.3). Regions with high homology were chosen for sgRNA design. sgRNAs that 
did not share complete homology were designed to contain degenerate bases to ensure 
compatibility across species using the same sgRNA (Fig. S3.4). sgRNA specificity was 
determined by using BLAST (Altschul et al. 1990). One sgRNA was designed even 
though the N-GG (PAM motif) had been lost in the human but was still kept in the pool 
for the polar bear depletion (Fig. S3.3). A total of 16 sgRNAs were designed to target 
alpha and beta hemoglobin transcripts. The target oligos were then constructed into 
sgRNAs as previously described (Ren et al. 2014). Single stranded oligos were 
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designed to contain a T7 promoter attached to each sgRNA sequence (IDT) followed 
by the first 22 bases of the tracrRNA sequence (Fig. S3.3). The complementary 
tracrRNA and single stranded oligo were annealed and extended to form a dsDNA 
product containing the T7-sgRNA and tracrRNA template. The template was then used 
for in-vitro transcription using the HiScribe T7 High Yield RNA synthesis kit (NEB). 
The in-vitro transcription reaction was carried out at 37°C for 16 hrs. The in-vitro 
transcribed RNA was then purified using MEGAclear Transcription Clean-Up Kit 
(Invitrogen). The final sgRNA product was then checked for purity and quantified 
using NanoDrop 8000 UV Spectrophotometer (Thermofisher). All sgRNAs were then 
pooled at equal molar concentrations and stored in single-use aliquots at -80°C. 
  
CRISPR/Cas9 Treatment  
Since it has been predicted that human whole blood samples can contain up to ~50-
80% of hemoglobin transcripts of the total sample (Field et al. 2007; Mastrokolias et 
al. 2012), we calculated the ratio of sgRNA and Cas9 molar amounts to sample based 
upon this assumption. According to the DASH protocol it was determined that 150-
fold of Cas9 and 1500-fold of sgRNA should be sufficient (Gu et al. 2016). All cDNA 
samples were quantified by Qubit using the dsDNA HS assay kit (Thermofisher) to 
calculate the molar amounts. To calculate the expected molar amounts we use the 
following formula: 
 𝑛𝑀 =	 [𝐷𝑁𝐴	(𝑛𝑔/𝜇𝐿)] 	÷ (660𝑔/𝑚𝑜𝑙	𝑥	𝑠𝑖𝑧𝑒	𝑜𝑓	ℎ𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛	𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡𝑠	𝑖𝑛	𝑏𝑝) 
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Once the molar amounts were determined, the ribonucleoprotein (RNP) complex was 
formed by adding the 150-fold Cas9 and 1500-fold sgRNA excess amount with 1.0 μL 
of the 10X Cas9 Buffer (final concentration 50 mM Tris pH 8.0, 100 mM NaCl, 10 
mM MgCl2, and 1 mM TCEP) and incubated for 25°C for 10 minutes. Following the 
25°C incubation, the calculated cDNA amount was then added (final volume of 10 μL) 
and incubated at 37°C for 4 hrs to overnight. After the Cas9 depletion, 1 μL of 
Proteinase K and RNAse A were added to inactivate the Cas9 and remove excess 
sgRNAs from the reaction and incubated at 37°C for 15 minutes and 95°C for 15 
minutes. It is critical that the Proteinase K is deactivated properly as the samples are 
immediately used for amplification. Treated samples were PCR amplified (95°C for 3 
minutes, followed by 13 cycles of (98°C for 20 s, 67°C for 15 s, and 72°C for 4 minutes) 
followed by a final extension of 72°C for 5 minutes). PCR was performed using KAPA 
Hifi ReadyMix 2X (KapaBiosystems) and 1 μL of the (10 μM) ISPCR primer. The 
amplified product was then purified using SPRI beads to remove everything below 500 
bp. Selecting against cDNA below 500 bp ensured that all cut hemoglobin products 
were removed before making the Tn5 libraries. The depleted cDNA product was 
visualized on a 1-2% agarose gel to confirm depletion. Once confirmed, the depleted 
cDNA product was then prepped for either Illumina or Nanopore sequencing. 
 
R2C2 Library Preparation and ONT sequencing 
To prepare R2C2 libraries ~30 ng of the depleted cDNA was used. The R2C2 libraries 
were made as previously described (Volden et al. 2018). Briefly, an equal concentration 
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of splint to cDNA were combined (30ng of depleted cDNA and 30ng of our (~200 bp) 
DNA splint). The full-length cDNA was then circularized using the 2X NEBuilder Hifi 
DNA Assembly Mix (NEB). The reaction took place at 50°C for 1 hour per 
manufacturer protocol. Once the full-length cDNA was circularized, linear ssDNA and 
dsDNA was digested by adding 3μL each of Lambda Exonuclease, Exonuclease I and 
Exonuclease III (all NEB) and incubated at 37°C overnight. We performed the longer 
incubation overnight to ensure complete digestion. After digestion, the sample was 
further purified using SPRI beads and eluted in 30μL of ultrapure water. 30μL of 
sample was then split into three reactions containing 10μL each for the Phi29 
amplification. The Phi29 amplification took place in a reaction volume of 50μL 
containing 5μL of 10X Buffer, 2.5μL of 10uM each dNTPs, 2.5μL of random hexamers 
(10uM), 29μL of ultrapure water and 1μL of Phi29 Polymerase. The Phi29 reactions 
were incubated at 30°C for 16 hrs, 65°C for 15 minutes and held at 4°C. All three 
samples were pooled together and ultrapure water was added to make up the final 
volume to 300μL. The product was purified using SPRI beads with a 1:0.5 sample to 
bead ratio. This ratio was chosen as it removed all fragments < 2000 kb. The sample 
was then eluted in 90μL of ultrapure H20, 10μL of NEB2 Buffer (NEB) and 3μL of T7 
endonuclease (NEB) and incubated at 37°C for 2 hrs to ensure complete debranching 
of the Phi29 product. The eluted sample was again purified using SPRI beads with a 
1:0.5 sample to bead ratio. The product was eluted in 30μL and quantified using Qubit 
dsDNA HS kit (Thermofisher). The length distribution was verified on a 1% agarose 
gel prior to performing the ONT library prep.  
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For the library preparation ~1-2 μg of the final R2C2 product was converted 
into a ONT compatible library using the SQK-LSK109 kit according to ONT 
instructions with minor modifications. First, during the End Repair and A-tailing 
reaction we performed incubations for 30 min each at 20°C and 65°C instead of 5 min 
each. Second, we adjusted the ligation reaction time to 30 minutes at room temperature 
instead of 10 minutes per the protocol. We also found that loading between ~200-500 
ng of the final library onto the flowcell was the most optimal. Loading more library 
resulted in severe loss in throughput as can be seen for the R2C2 runs 
PB3_depleted_R1 and PB19_depleted_R1 (Table S3.2). R2C2 libraries were 
sequenced on a MinION device using the 48hr sequencing protocol using the FLO-
Min106 R9.4 Rev D chemistry flowcells. All reads were basecalled with Albacore 
v2.1.3. 
 
Smart-seq2 Library Preparation and Illumina Sequencing  
Illumina libraries of the depleted and non-depleted samples were prepared using a 
tagmentation based method using our own Tn5 (Picelli, Faridani, et al. 2014). The Tn5 
enzyme was custom loaded with Tn5ME-A/R and Tn5ME-B/R adapters (Table S3.2). 
The Tn5 reaction contained 5μL of the full-length cDNA product, 1μL of the loaded 
Tn5 enzyme, 10μL of ultrapure water and 4μL of the 5X TAPS-PEG buffer and 
incubated at 55°C for 7 minutes. After incubation, 5μL of 0.2% of Sodium Dodecyl 
Sulfate (SDS) was added to the product to inactivate the Tn5 enzyme. Due to the Tn5 
generating gaps, 5μL of the Tn5 product had to be nick translated at 72°C for 5 mins. 
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The Tn5 product was then amplified using KAPA Hifi Polymerase (KAPA) with 10 
cycles of PCR using (98°C for 10 s, 63°C for 30 s, 72°C for 2 min) with a final 
extension at 72°C for 5 min. The final reaction volume was 25μL and contained 0.5μL 
KAPA Hifi Polymerase (KAPA), 5μL of  5X Buffer, 0.8μL of dNTPs (10mM each), 
11.7μL of ultrapure water, 5μL of the nick-translated product and 1μL each of 
Nextera_Primer_A and Nextera_Primer_B primers (Table S3.2). The amplified Tn5 
libraries were then size selected from 300 - 800 bp on a 2% EX E-gel (Thermofisher) 
and purified using QIAquick gel extraction kit (Qiagen). The libraries were then pooled 
at equal concentrations and ran on a HiSeq X 2x151 bp run.  
 
R2C2 read processing and isoform analysis 
R2C2 consensus reads were generated from raw reads using the C3POa pipeline 
(https://github.com/rvolden/C3POa). C3POa identifies subreads in the raw reads and 
uses poaV2 (Lee, Grasso, and Sharlow 2002) and racon (Vaser et al. 2017) to determine 
a more accurate consensus of these subreads. The consensus reads were then aligned 
to the polar bear genome (Liu et al. 2014) using minimap2 (H. Li 2017) using standard 
setting and the ‘-ax splice’ flag. The resulting sam files are converted to psl files using 
samtools (H. Li et al. 2009) and jvarkit samtopsl utility (Lindenbaum 2015).  
The resulting psl, sam, and fasta files of all depleted samples were merged and 
used as input into the Mandalorion (https://github.com/rvolden/Mandalorion-Episode-
II) pipeline to determine isoforms. To accomodate issues regarding RNA degradation 
and genomic DNA contamination, we integrated two new optional filter into 
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Mandalorion. We implemented the filtering of isoforms that are entirely contained 
within one other isoform, which indicates degraded input RNA molecules, and the 
filtering of unspliced isoforms which might stem from DNA contamination. 
Accuracy of R2C2 reads and Mandalorion isoforms were determined using 
alignments in sam format containing md-strings and a custom script that calculates  
 
Accuracy= Matches/(Matches+Mismatches+Indels) 
 
Smart-seq2 read processing 
Paired fastq files were downloaded from basespace and aligned to the polar bear 
genome using STAR with standard settings. The STAR index for the polar bear genome 
was built without a transcriptome reference because the gff file provided by (Liu et al. 
2014) did not conform to gff standard (no “exon” features) and could therefore not be 
used. Read alignments in ordered bam format were converted to psl as described above. 
 
Hemoglobin and gene expression quantification.  
Hemoglobin content was determined through a kmer based counting method using a 
custom script. In short, all possible 10nt kmers were extracted from the sequence of 
hemoglobin alpha and beta transcripts. The presence of these kmers were then 
determined in each R2C2 or Smart-seq2 read from depleted and undepleted samples. 
Cutoffs for read assignments to hemoglobin were then determined by also analyzing 
R2C2 and Illumina reads of the GM12878 cell line which does not express hemoglobin.  
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Gene expression was determined using Smart-seq2 (Illumina) read alignments 
in psl format and a custom script. Reads aligning to hemoglobin loci were not counted 
towards total aligned reads in the RPM calculations.  
Both script are available are available at https://github.com/christopher-
vollmers/PB_scripts. 
 
Data Visualization  
Schematics were prepared using inkscape (https://inkscape.org). All others figures 
were prepared using python/matplotlib/numpy/scipy (Millman and Aivazis 2011; 
Jones, Oliphant, and Peterson 2001--; van der Walt, Colbert, and Varoquaux 2011; 
Hunter 2007) 
 
Data Availability 
All Illumina and ONT raw read data is available at SRA under Bioproject accession 
PRJNA514749. 
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Supplemental 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3.1: Long-DASH sgRNA also depletes human hemoglobin transcripts 
from full-lengthcDNA.  
Technical replicates of depleted (D) or undepleted (U) human whole blood cDNA were 
visualized on an agarose gel. DNA ladder (L) suggests highly abundant cDNA species - 
putatively hemoglobin around ~700bp.  
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Figure S3.2: Depletion of hemoglobin affects expression levels within but not fold-
change between samples 
Expression levels(bottom) as well as the changes in differential expression between polar 
bears pre- and post-depletion are shown for genes that are upregulated in all 3 polar bears 
post-depletion (Systematically “UP”) and a random selection of genes with similar 
expression distribution (Random).  
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A) Hemoglobin, alpha (HBA) 
 
XM_008696690.1   --------------------CCGCCCCGCACATTTCTGGTCCTCACAGACTCAGAAAGAA    40 
NM_000558.4     
 CATAAACCCTGGCGCGCTCGCGGCCCGGCACTCTTCTGGTCCCCACAGACTCAGAGAGAA    
60 
NM_000517.4     
 CATAAACCCTGGCGCGCTCGCGGGCCGGCACTCTTCTGGTCCCCACAGACTCAGAGAGAA    
60 
                                        * * ** ****  ********* ************ **** 
 
XM_008696690.1  
 GCCACCATGGTGCTGTCTCCCGCCGACAAGAGCAACGTCAAGGCCACCTGGGATAAGATC    
100 
NM_000558.4     
 CCCACCATGGTGCTGTCTCCTGCCGACAAGACCAACGTCAAGGCCGCCTGGGGTAAGGTC    
120 
NM_000517.4     
 CCCACCATGGTGCTGTCTCCTGCCGACAAGACCAACGTCAAGGCCGCCTGGGGTAAGGTC    
120 
                   ******************* ********** ************* ****** **** ** 
 
XM_008696690.1  
 GGCAGCCACGCTGGCGAGTATGGCGGCGAGGCTCTGGAGAGGACCTTCGCGTCCTTCCCC    
160 
NM_000558.4     
 GGCGCGCACGCTGGCGAGTATGGTGCGGAGGCCCTGGAGAGGATGTTCCTGTCCTTCCCC    
180 
NM_000517.4     
 GGCGCGCACGCTGGCGAGTATGGTGCGGAGGCCCTGGAGAGGATGTTCCTGTCCTTCCCC    
180 
                 ***   ***************** *  ***** **********  ***  ********** 
 
XM_008696690.1  
 ACCACCAAGACCTACTTCCCCCACTTCGACCTGAGCCCTGGCTCCGCCCAGGTCAAGGCC    
220 
NM_000558.4     
 ACCACCAAGACCTACTTCCCGCACTTCGACCTGAGCCACGGCTCTGCCCAGGTTAAGGGC    
240 
NM_000517.4     
 ACCACCAAGACCTACTTCCCGCACTTCGACCTGAGCCACGGCTCTGCCCAGGTTAAGGG
C    240 
                 ******************** ****************  ***** ******** **** * 
 
XM_008696690.1  
 CACGGCAAGAAGGTGGCCGACGCCCTGACCACCGCCGCAGGCCACCTGGACGACCTGCCG    
280 
NM_000558.4     
 CACGGCAAGAAGGTGGCCGACGCGCTGACCAACGCCGTGGCGCACGTGGACGACATGCCC    
300 
NM_000517.4     
 CACGGCAAGAAGGTGGCCGACGCGCTGACCAACGCCGTGGCGCACGTGGACGACATGCCC    
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300 
                 ************************ ******* *****  *  *** ******** **** 
 
XM_008696690.1  
 GGCGCCCTGTCCGCTCTGAGCGACCTGCACGCGCACAAGCTGCGAGTGGACCCGGTCAAC    
340 
NM_000558.4     
 AACGCGCTGTCCGCCCTGAGCGACCTGCACGCGCACAAGCTTCGGGTGGACCCGGTCAAC    
360 
NM_000517.4     
 AACGCGCTGTCCGCCCTGAGCGACCTGCACGCGCACAAGCTTCGGGTGGACCCGGTCAA
C    360 
                    *** ******** ************************** ** *************** 
 
XM_008696690.1  
 TTCAAGTTCCTGAGCCACTGCCTGCTGGTGACCCTGGCCAGCCACCACCCCGCGGAGTTC    
400 
NM_000558.4     
 TTCAAGCTCCTAAGCCACTGCCTGCTGGTGACCCTGGCCGCCCACCTCCCCGCCGAGTTC    
420 
NM_000517.4     
 TTCAAGCTCCTAAGCCACTGCCTGCTGGTGACCCTGGCCGCCCACCTCCCCGCCGAGTTC    
420 
                 ****** **** ***************************  ***** ****** ****** 
 
XM_008696690.1  
 ACCCCTGCCGTCCACGCCTCCCTGGACAAGTTCTTCAGCGCCGTGAGCACCGTGCTCACC    
460 
NM_000558.4     
 ACCCCTGCGGTGCACGCCTCCCTGGACAAGTTCCTGGCTTCTGTGAGCACCGTGCTGACC    
480 
NM_000517.4     
 ACCCCTGCGGTGCACGCCTCCCTGGACAAGTTCCTGGCTTCTGTGAGCACCGTGCTGACC    
480 
                 ******** ** ********************* *  * ********************* 
 
XM_008696690.1  
 TCCAAATACCGTTAAGCTGGAGCCGCGCGACCCTCCCGCTCCCGGCCTGGGGCCTCTTGC    
520 
NM_000558.4     
 TCCAAATACCGTTAAGCTGGAGCCTCGGTGGCCATGCTTCTTGCCCCTTGGGCCTCCCCC    
540 
NM_000517.4     
 TCCAAATACCGTTAAGCTGGAGCCTCGGTAGCCGTTCCTCCTGCCCGCTGGGCCTCCCAA    
540 
                 ************************ **  ***  *     *   *******     
 
XM_008696690.1   GC--------------TCCACGCGCCTGAACTTCCCGATCTTTGAATAAAGTCTGAGTGG    
566 
NM_000558.4     
 CAGCCCCTCCTCCCCTTCCTGCACCCGTACCCCCGTGGTCTTTGAATAAAGTCTGAGTGG    
600 
NM_000517.4      CGGGCCCTCCTCCCCTCCTTGCACC-
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GGCCCTTCCTGGTCTTTGAATAAAGTCTGAGTGG    599 
                                   *      *     *  *  * ********************** 
 
XM_008696690.1   GCTGCAG--------------------    573 
NM_000558.4      GCGGCAAAAAAAAAAAAAAAAAAAAAA    627 
NM_000517.4      GCAGCAAAAAAAAAAAAAAAAAA----    622 
                 **  ** 
 
B) Hemoglobin, beta (HBB)                   
 
 
XM_008709611.1  
 GAGCAGGGCCAGCTGCTGCTTATACTTGCTTCTGACACAACCGTGTTCACTAGCAACCAC    
60 
NM_000518.4      ---------------------ACATTTGCTTCTGACACAACTGTGTTCACTAGCAACCTC    39 
                                      * * **************** **************** * 
 
XM_008709611.1  
 AAAGAGACACCATGGTGCATCTGACTGGTGAGGAGAAGTCTCTCGTCACCGGCCTGTGGG    
120 
NM_000518.4     
 AAACAGACACCATGGTGCATCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGG    
99 
                 *** **********************  *************  *** ** * ******** 
 
XM_008709611.1  
 GCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGGCTTCTGGTTGTCTACC    
180 
NM_000518.4     
 GCAAGGTGAACGTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGGCTGCTGGTGGTCTAC
C    159 
                 ********************************************** ***** ******* 
 
XM_008709611.1  
 CCTGGACTCAGAGGTTCTTTGACTCCTTTGGGGACCTGTCCTCTGCTGATGCTATTATGA    
240 
NM_000518.4     
 CTTGGACCCAGAGGTTCTTTGAGTCCTTTGGGGATCTGTCCACTCCTGATGCTGTTATGG    
219 
                 * ***** ************** *********** ****** ** ******** ***** 
 
XM_008709611.1  
 ACAACCCCAAGGTCAAGGCCCATGGCAAGAAGGTGCTGAACTCCTTTAGTGATGGCCTGA    
300 
NM_000518.4     
 GCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGG    
279 
                   ****** ***** ***** *********** *****     ***************** 
 
XM_008709611.1  
 AGAATCTGGACAACCTCAAGGGCACCTTTGCTAAGCTGAGCGAGCTGCACTGTGACAAGC    
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360 
NM_000518.4     
 CTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGC    
339 
                       * ************************** *  ***** ******************* 
 
XM_008709611.1  
 TGCACGTGGATCCCGAGAACTTCAAGCTCCTGGGCAACGTGCTGGTGTGTGTGCTGGCTC    
420 
NM_000518.4     
 TGCACGTGGATCCTGAGAACTTCAGGCTCCTGGGCAACGTGCTGGTCTGTGTGCTGGCCC    
399 
                 ************* ********** ********************* *********** * 
 
XM_008709611.1  
 ACCACTTTGGCAAAGAGTTCACCCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTG    
480 
NM_000518.4     
 ATCACTTTGGCAAAGAATTCACCCCACCAGTGCAGGCTGCCTATCAGAAAGTGGTGGCT
G    459 
                 * ************** ******** *  ******************** ********** 
 
XM_008709611.1  
 GTGTGGCCAACGCCCTGGCCCACAAGTACCACTGAGCTCCTGGCCTGTTTCCTGGTGATC    
540 
NM_000518.4     
 GTGTGGCTAATGCCCTGGCCCACAAGTATCACTAAGCTCGCTTTCTTGCTGTCCAATTTC    
519 
                 ******* ** ***************** **** *****     **   *        ** 
 
XM_008709611.1   CCTG-
GAAGACCCTGTTCCCCTAAATTCTATCTTCTGAACTGGGGGAAATAATGTCCACC    599 
NM_000518.4     
 TATTAAAGGTTCCTTTGTTCCCTAAGTCCAACTACTAAACTGGGGGATATTATGAAGGGC    
579 
                     *   * *  *** *   **  ** ** * ** ** ********** ** ***     * 
 
XM_008709611.1   ATCAAGGGTATGGTTTCTGCCTAATAAAGAACCTTCAGCTCAA----    642 
NM_000518.4      CTTGAGCATCTGGATTCTGCCTAATAAAAAACATTTATTTTCATTGC    626 
                   *  **  * *** ************** *** ** *  *  *     
 
 
Figure S3.3. Alignment of orthologous HBA and HBB mRNA sequences in 
human and polar bear. Multi-sequence alignment from Clustal Omega v1.2.4. * 
indicates a match. Underline and bold indicates target sequences used for sgRNA 
design for Globin depletion. Red indicates (N-GG) PAM sequence  a) Hemoglobin, 
alpha (HBA) b) Hemoglobin, beta (HBB).  
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A) Construction of sgRNAs  
 
#1 tracrRNA oligo (in Reverse Orientation/Anti-sense) 
   <-------------------tracrRNA--------------------------------- <-------Primer-----> 
5’–
AAAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTT 
GCTATTTCTAGCTCTAAAAC–3’ 
 
The oligo above is a universal tracrRNA template which allows you to generate full sgRNA templates 
with any target sequence oligo as long as the target sequence oligo meets the following requirements 
below: 
1. The oligo contains the reverse complement of the primer sequence on the 3' end. 
2. the oligo contains 'GG' on the 3' end of the target sequence for T7 RT. 
 
#1 HBA1/HBA2 target oligos based upon mRNA prediction of Polar Bear/Human genes. 
 
       <--------T7-----------------><--target_sequence--><-------Primer------> 
oligo 1 5'-GAAATTAATACGACTCACTATAGG AAGGSCCACGGCAAGAAGG 
GTTTTAGAGCTAGAAATAGC-3' 
       <--------T7-----------------><--target_sequence--><-------Primer------> 
oligo 2 5'-GAAATTAATACGACTCACTATAGG CACTGCCTGCTGGTGACCC 
GTTTTAGAGCTAGAAATAGC-3' 
       <--------T7-----------------><--target_sequence--><-------Primer------> 
oligo 3 5'-GAAATTAATACGACTCACTATAGG GGTYAAGGSCCACGGCAAGA 
GTTTTAGAGCTAGAAATAGC-3' 
       <--------T7-----------------><--target_sequence--><-------Primer------> 
oligo 4 5'-GAAATTAATACGACTCACTATAGG ACCTCCAAATACCGTTAAGC 
GTTTTAGAGCTAGAAATAGC-3' 
        <-------T7----------------><--target_sequence--><-------Primer------> 
oligo 5 5'-GAAATTAATACGACTCACTATAGG GCCGACAAGASCAACGTCA 
GTTTTAGAGCTAGAAATAGC-3' 
        <-------T7----------------><--target_sequence--><-------Primer------> 
oligo 6 5'-GAAATTAATACGACTCACTATAGG GGGAAGTAGGTCTTGGTGGTG 
GTTTTAGAGCTAGAAATAGC-3' 
        <-------T7----------------><--target_sequence--><-------Primer------> 
oligo 7 5'-GAAATTAATACGACTCACTATAGG TCCTRAGCCACTGCCTGC 
GTTTTAGAGCTAGAAATAGC-3' 
        <-------T7----------------><--target_sequence--><-------Primer------> 
oligo 8 5'-GAAATTAATACGACTCACTATAGG CAGGTCGCTCAGRGCGGACA 
GTTTTAGAGCTAGAAATAGC-3' 
 
#2 HBB target oligos based upon mRNA prediction of Polar Bear/Human gene. 
 
      <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 1 5'-GAAATTAATACGACTCACTATAGG CACTGTGACAAGCTGCACG 
GTTTTAGAGCTAGAAATAGC-3' 
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       <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 2 5'-GAAATTAATACGACTCACTATAGG GAAGTTGGTGGTGAGGCCCT 
GTTTTAGAGCTAGAAATAGC-3' 
       <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 3 5'-GAAATTAATACGACTCACTATAGG CAGGCTGCCTATCAGAARG 
GTTTTAGAGCTAGAAATAGC-3' 
       <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 4 5'-GAAATTAATACGACTCACTATAGG GCAACCWCAAASAGACACCA 
GTTTTAGAGCTAGAAATAGC-3' 
       <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 5 5'-GAAATTAATACGACTCACTATAGG GAGGTTCTTTGABTCCTTTG 
GTTTTAGAGCTAGAAATAGC-3' 
      <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 6 5’-GAAATTAATACGACTCACTATAGG AAGGTGAACGTGGATGAAGT 
GTTTTAGAGCTAGAAATAGC-3' 
      <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 7 5’-GAAATTAATACGACTCACTATAGG GCTCCTGGGCAACGTGC 
GTTTTAGAGCTAGAAATAGC-3' 
      <-------T7-----------------><--target_sequence--><-------Primer------> 
oligo 8 5’-GAAATTAATACGACTCACTATAGG CAGAARGTGGTGGCTGGTG 
GTTTTAGAGCTAGAAATAGC-3' 
 
B) Target sequences and oligo sequences for hemoglobin depletion 
 
HBA targets  
 
   (1) AAGGSCCACGGCAAGAAGG 
Human- AAGGGCCACGGCAAGAAGG 
Polar- AAGGCCCACGGCAAGAAGG 
 
   (2) CACTGCCTGCTGGTGACCC 
Human- CACTGCCTGCTGGTGACCC 
Polar- CACTGCCTGCTGGTGACCC 
 
   (3) GGTYAAGGSCCACGGCAAGA 
Human- GGTTAAGGGCCACGGCAAGA 
Polar- GGTCAAGGCCCACGGCAAGA 
 
   (4) ACCTCCAAATACCGTTAAGC 
Human- ACCTCCAAATACCGTTAAGC 
Polar- ACCTCCAAATACCGTTAAGC 
 
   (5) GCCGACAAGASCAACGTCA 
Human- GCCGACAAGACCAACGTCA 
Polar- GCCGACAAGAGCAACGTCA 
HBB targets  
 
   (1) CACTGTGACAAGCTGCACG 
Human- CACTGTGACAAGCTGCACG 
Polar- CACTGTGACAAGCTGCACG 
 
   (2) GAAGTTGGTGGTGAGGCCCT 
Human- GAAGTTGGTGGTGAGGCCCT 
Polar- GAAGTTGGTGGTGAGGCCCT 
 
   (3) CAGGCTGCCTATCAGAARG 
Human- CAGGCTGCCTATCAGAAAG 
Polar- CAGGCTGCCTATCAGAAGG 
 
   (4) GCAACCWCAAASAGACACCA 
Human- GCAACCTCAAACAGACACCA 
Polar- GCAACCACAAAGAGACACCA 
 
   (5) GAGGTTCTTTGABTCCTTTG 
Human- GAGGTTCTTTGAGTCCTTTG 
Polar- GAGGTTCTTTGACTCCTTTG 
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   (6) GGGAAGTAGGTCTTGGTGGTG (r) 
Human- GGGAAGTAGGTCTTGGTGGTG 
Polar- GGGAAGTAGGTCTTGGTGGTG 
 
   (7) TCCTRAGCCACTGCCTGC 
Human- TCCTAAGCCACTGCCTGC 
Polar- TCCTGAGCCACTGCCTGC 
 
   (8) CAGGTCGCTCAGRGCGGACA (r) 
Human- CAGGTCGCTCAGGGCGGACA 
(Lost PAM sequence) 
Polar- CAGGTCGCTCAGAGCGGACA 
 
 
 
   (6) AAGGTGAACGTGGATGAAGT 
Human- AAGGTGAACGTGGATGAAGT 
Polar- AAGGTGAACGTGGATGAAGT 
 
   (7) GCTCCTGGGCAACGTGC 
Human- GCTCCTGGGCAACGTGC 
Polar- GCTCCTGGGCAACGTGC 
 
   (8) CAGAARGTGGTGGCTGGTG 
Human- CAGAAAGTGGTGGCTGGTG 
Polar- CAGAAGGTGGTGGCTGGTG 
 
 
Figure S3.4. sgRNA design and construction.  
Oligonucleotides designed for hemoglobin depletion from full-length cDNA. Oligos were 
chosen to deplete Hemoglobin mRNA transcripts from Human and Polar Bear whole 
blood. A) To generate sgRNAs a template free PCR was performed to anneal the 
tracrRNA oligo to an oligo containing the target sequence to generate a full-length oligo. 
The full-length oligos were converted into sgRNA templates using in-vitro transcription. 
B) Target oligos used for generating sgRNAs. Degenerate bases are highlighted in grey. 
(r) indicates reverse orientation 
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Sample Name Sequencer Run Type Library Prep Read Number Median 
Accuracy 
PB3_depleted Illumina HiSeqX 2X151 Smart-seq2 22322746 N/A 
PB19_depleted Illumina HiSeqX 2X151 Smart-seq2 19418607 N/A 
PB21_depleted Illumina HiSeqX 2X151 Smart-seq2 22467660 N/A 
PB3_undepleted Illumina HiSeqX 2X151 Smart-seq2 58088942 N/A 
PB19_undepleted Illumina HiSeqX 2X151 Smart-seq2 105936701 N/A 
PB21_undepleted Illumina HiSeqX 2X151 Smart-seq2 63096050 N/A 
PB19_undepleted ONT MinION 9.4.1/LSK109  R2C2 5313 93% 
PB3_depleted_R1 ONT MinION 9.4.1/LSK109  R2C2 390526 93% 
PB3_depleted_R2 ONT MinION 9.4.1/LSK109  R2C2 1691780 94% 
PB19_depleted_R1 ONT MinION 9.4.1/LSK109  R2C2 59097 93% 
PB19_depleted_R2 ONT MinION 9.4.1/LSK109 R2C2 866087 97.5% 
PB21_depleted ONT MinION 9.4.1/LSK109 R2C2 830952 92% 
 
Table S3.1: High-throughput sequencing runs and characteristics  
For R2C2/ONT MinION runs, fully processed R2C2 read numbers and median 
accuracies are given. Some R2C2/ONT MinION runs were multiplexed, sometimes with 
samples unrelated to this study. Samples PB19_depleted_R2 and PB3_depleted_R2 
represent the current output of the R2C2/ONT MinION combination. 
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RT 
>Oligo-dT-smartseq2 
/5Me-
isodC/AAGCAGTGGTATCAACGCAGAGTACTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVN 
>TSO_Smartseq2 
AAGCAGTGGTATCAACGCAGAGTACATrGrGrG 
  
Primers  for  amplifying  cDNA 
>ISPCR 
AAGCAGTGGTATCAACGCAGAGT 
  
Tn5  Oligos (Smart-seq2 library prep) 
>Tn5ME-R 
[phos]CTGTCTCTTATACACATCT 
>Tn5ME-A 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 
>Tn5ME-B 
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG 
  
Primers  for  amplifying  Tn5  Product  
>Nextera_Primer_A 
AATGATACGGCGACCACCGAGATCTACAC  [8bp  i5  index]  TCGTCGGCAGCGTCAGATG 
>Nextera_Primer_B 
CAAGCAGAAGACGGCATACGAGAT  [8bp  i7  index]  GTCTCGTGGGCTCGGAGATGTGTAT 
  
R2C2 Splint_Oligos 
>UMI_Splint_1_Forward_ISPCR (Matches ISPCR Primer) 
ACTCTGCGTTGATACCACTGCTTTGAGGCTGATGAGTTCCATANNNNNTATATNNNNNAT
CACTACTTAGTTTTTTGATAGCTTCAAGCCAGAGTTGTCTTTTTCTCTTTGCTGGCAGTAAA
AG     
>UMI_Splint_1_Reverse_ISPCR (Matches ISPCR Primer) 
ACTCTGCGTTGATACCACTGCTTAAAGGGATATTTTCGATCGCNNNNNATATANNNNNTT
AGTGCATTTGATCCTTTTACTCCTCCTAAAGAACAACCTGACCCAGCAAAAGGTACACAA
TACTTTTACTGCCAGCAAAGAG 
>UMI_Splint_2_Forward_ISPCR (Matches ISPCR Primer) 
ACTCTGCGTTGATACCACTGCTTTGCCGGTTGGGTATCAATAANNNNNTATATNNNNNATT
GCCTTTATTCTATCTACTTAGTTTTGGCGATGTAGTCTACCTATCCTGATGCTGAATAAAG
GC 
>UMI_Splint_2_Reverse_ISPCR (Matches ISPCR Primer) 
ACTCTGCGTTGATACCACTGCTTAATTAGGTTCTAGGATCACGNNNNNATATANNNNNCT
GCCATCGAAAATTTTTCACCCGTAACAAGAACTTACAACTCTCTGACGCCTATATCATGAA
GGCCTTTATTCAGCATCAGGA 
Table  S3.2  Oligos  used  in  the  Long-DASH 
Oligos  are  shown  5’->3’  and  were  ordered  from  Integrated  DNA  Technologies  
(IDT). Lower  case  ‘r’ = RNA  bases.  Spaces  are  for  visual emphasis  only. 
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Conclusions 
 The work I present here showcases how we can overcome current limitations 
for capturing an accurate transcriptome. Short-read RNAseq still suffers from 
inherent issues of limited read length, making full-length mRNA transcript structure 
analysis challenging. This is particularly true when analyzing the ends of the 
molecules (Fig. 0.1) where annotating transcription start-sites and end-sites becomes 
difficult. In order to define these features a targeted approach must be considered. 
Thus, I have developed Tn5Prime, a single cell 5’ capturing technique capable of 
analyzing transcription start sites. This approach allows one to define 5’ ends of 
molecules that often get lost in standard RNAseq methods. Identifying features like 
these globally can help us understand how genes are regulated at the level of 
transcription, such as identifying cell-type specific transcriptional regulatory 
networks, where transcription factor binding motifs can be inferred near promoter 
regions. Elucidating such features can also help predict novel transcripts, bringing 
more data to the emerging thought that alternative transcription and not alternative 
splicing are the main drivers of promoting isoform diversity across different tissues 
(Pal et al. 2011). Although this method was developed as a 5’ enrichment tool, it 
could easily be adapted for a 3’ enrichment method as well. By integrating both data 
types it could offer insight into translational control by identifying regulatory 
elements within both the 5’ and 3’ UTRs and their effect on translational outcomes. 
Although certain features can be specifically targeted using short-read 
technology, it is simpler to capture from ‘end-to-end’ complete transcripts from single 
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cells. Here, I have shown that using a long-read sequencing approach it is possible to 
quantify and identify isoforms at the single cell level. This study also highlights how 
much mRNA isoform heterogeneity occurs within surface receptors among a seeming 
homogenous B cell population. This begs the question of how much surface receptor 
diversity is there? And how much of our receptor landscape is actually targetable? 
Beyond increasing our understanding of B cell receptor expression, I believe this 
method can be a powerful tool for patients undergoing cancer immunotherapies. 
Interactions between the immune system and cancer cells are dynamic and are always 
evolving from the initial progression of cancer to the development of metastasis. 
Cancer specific splicing events are known to alter the receptor landscape, conferring 
drug/therapy resistance due to antigen loss. The interface between immune cells and 
cancer cells are dynamic, but it can be manipulated by changing the antigen 
landscape. Patients suffering from lymphomas may contain a specific clonal 
population expressing similar isoforms, which could be targeted by immunotherapy. 
By incorporating this long-read single cell method we could make better genetic 
predictions in a preclinical setting, increasing the odds of successful treatment. 
There have already been major improvements to this method by incorporating 
R2C2 (Volden et al. 2018), which has improved the read accuracy from the standard 
84% to 97.5%. Improving base accuracy is beneficial for observing allele specific 
transcription, somatic mutations and helps resolve unique isoforms with better 
precision. Increase in base accuracy also expands the throughput capacity by 
resolving cellular barcodes, necessary for multiplexing thousands of single cells. 
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With the introduction of single-molecule sequencing, such as purveyed by 
PacBio and Oxford Nanopore Technologies (ONT), it has proven advantageous for 
identifying novel isoforms, long-noncoding RNAs and fusion transcripts. However, 
sequencing throughput and accuracy still wanes compared to the short-read 
technology. With the implementation of our R2C2 method we have improved the 
base accuracy, but throughput still remains a limitation (Table 0.1). To increase the 
read throughput, I developed Long-DASH to remove unwanted abundant transcripts 
from the sequencing pool to capture more rare transcripts. This method excludes 
transcripts that could account for the majority of sequencing reads, greatly improving 
throughput. By eliminating highly abundant transcripts such as hemoglobin and 
rRNA (unpublished), Long-DASH serves as an enrichment strategy that captures 
information about the transcriptome that would have otherwise been missed or 
require a much greater amount of sequencing reads to be detected. 
   
Future Outlook 
Another hurdle to overcome when analyzing the transcriptome is the issue 
regarding length bias. Length bias is often attributed to how samples are prepared 
specifically during PCR amplification and library preparation. PCR becomes 
problematic in that within a few cycles of PCR, longer transcripts tend to be 
overwhelmed by smaller transcripts, which tend to be picked up more easily during 
sequencing. This can lead the researcher to believe that these longer transcripts are 
rarer or simply never expressed in a given sample. One way to get around this is to 
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eliminate PCR. R2C2 is ideal for making it into a PCR-free method due to Phi29’s 
ability to copy transcripts at equal lengths independent of the raw transcript size (Fig. 
4.1). This is likely due to Phi29’s high processivity. Additionally, Phi29 performs a 
linear amplification versus exponential amplification which greatly reduces 
amplification bias. Below is a schematic of how a PCR-free method would be 
incorporated (Fig.4.2A). Preliminary data shows that transcript length distributions 
are skewed towards shorter transcripts when PCR is performed compared to the 
newest R2C2v2 where PCR is not performed (Fig.4.2B). By eliminating PCR from 
our R2C2 method, this could eliminate false chimeric molecules, PCR errors, or 
skewed quantification all of which are by-products of PCR. 
When RNAseq was first developed in the early 1990’s there were great 
expectations as to what a researcher could accomplish. It was thought that not only 
would we be able to take inventory of all the RNA species within a sample but the 
transcript structure would also be known. Short read RNAseq is most adept at 
interrogating transcriptomes to observe global changes in gene expression but fail to 
capture structure and all RNA within a single sample. Long read full-length 
sequencing opens the door to the possibility of not only capturing structural 
information, but can be quantitative as well.  Capturing all RNA species still remains 
a challenge as most long read technologies struggle with smaller RNAs. However, 
using the R2C2 approach multiple copies are made into one long concatenated read, 
making it possible to sequence smaller RNAs as well such as tRNAs.  Just like 
assembling an excellent genome requires different types of methods to be combined, 
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maybe annotating an excellent transcriptome may require different technologies as 
well. However, it is possible that in the foreseeable future ONT will dramatically 
increase their sequencing capacity and base accuracy. Since these sequencing errors 
are fairly systematic this will however be a herculean task. Until then, researchers like 
myself have been at the forefront at making changes in order to harness the power of 
the long-read technology to making the best snapshot of transcriptomes. 
 
Figure 4.1. Simple schematic of Phi29 amplification. Transcripts of varying sizes are 
amplified using linear amplification each transcript contains a different number of copies 
but the raw read length stays the same. Not shown is the branching caused by Phi29 
polymerase.  
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Figure 4.2: PCR-free R2C2 method improves transcript read length. 
A) Schematic of PCR-free method. RNA is reverse transcribed and second strand is made. 
cDNA is then circularized using Gibson Assembly. Rolling circle is performed and the 
sample is cleaned up and debranched prior to sequencing. B) Swarmplots of length 
distributions of 1000 randomly sampled PacBio (Tilgner et al. 2014), ONT dRNA, and  
dcDNA (Workman et al. 2018), R2C2 reads with no adjustments (v1) and R2C2 reads 
generated from PCR-free method covering the GM12878 (human lymphoblast cell line) 
transcriptome. These distributions are not representative of the length distribution of the 
human transcriptome as annotated by GENCODE.  *While we show the most recent data 
set on GM12878 the data provided PacBio technology is several years old and might not 
be fully representative of current platform performance. 
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